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a calf is born 
Stellingen 
1) De 'onafhankelijke' deskundigen in het onderhavige debat zijn elk verbunden met 
bepaalde maatschappelijke belangen, (hoofdstuk 4) 
2) Er zouden meer bedrijven moeten zijn zoals Gene Pharming in haar eerste jaren: 
behoorlijk transparant en bereid het publieke debat aan te gaan. (dit proefschrift) 
3) Publieke debatten zijn in de eerste plaats gericht op het overtuigen van het brede 
publiek en niet op wederzijds begrip of overeenstemming. (hoofdstuk 7) 
4) De inhoud van de ethische principes 'respect voor autonomie' en 
'rechtvaardigheid' verändert wezenlijk als deze principes getransformeerd worden 
naar principes die toepasbaar zijn op dieren of op de natuur. (hoofdstuk 5) 
5) Zonder casus geen publiek debat. De wens om een breed publiek debat te laten 
plaatsvinden voorafgaand aan het ingangzetten van technologische innovaties is 
derhalve niet realistisch, (hoofdstuk 3) 
6) Respect voor de integriteit van dieren maakt een goede kans om een breed 
gedragen norm voor de omgang met dieren te worden, (hoofdstuk 5 en 6) 
7) Een internationaal georiënteerde universiteit die haar dissertaties graag in het 
Engels ziet verschijnen zou zieh mede verantwoordelijk moeten voelen voor de 
kwaliteit van het Engels in deze dissertaties. 
8) Een veilige auto is een gevaar op de weg. 
9) Het centraal stellen van het dier in de toekomstige veehouderij betekent niet altijd 
dat het systeem aan het dier moet worden aangepast. Vaak betekent het een keuze 
voor andere dieren. 
10) De ontwikkeling van het dierendebat is een tegenvoorbeeld voor het hellend vlak 
argument. Immers, de lat voor de omgang met dieren wordt steeds hoger gelegd. 
Stellingen behorende bij het proefschrift 'A calf is born. A reconstruction of the public 
debate on animal biotechnology' van Elmar Theune, dat in het openbaar wordt 
verdedigd op dinsdag 13 november 2001 des namiddags om vier uur in de Aula van 
Wageningen Universiteit. 
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1. Introduction 
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Dierenbescherming absolutely against the genetic manipulation of animals 
Calf with new gene opens debate 
Queen warns in Christmas-speech against genetic engineering 
Herman i s t h e r e for our w e l l b e i n g 
There is something wrong about Herman's testicles 
Herman may have his offspring 
The real purpose behind Herman 
Herman should not be blamed 
A licence will be needed for genetic experiments with animals 
Agriculture and Gene Pharmlng break the contract on Herman the bull 
Herman the bull becomes a grandpa 
Mould beats cow 
Pressure groups as a new business risk 
Just a few headlines taken from some major Dutch newspapers 1. The Dutch debate 
on animal transgenesis has focused on Herman the bull and has lasted for about 
nine years. It is quite amazing that a single bull has initiated such a lengthy public 
debate. Ask an average Dutch citizen and he or she will know about Herman. The 
least he or she will know is that there has been a lot of fuss about this bull. 
How could a bull have been so intriguing? What was the debate about? How could 
a debate have lasted that long? What happened during this debate? Has it had any 
impact? What can we learn from this particular debate about public debates in 
The headlines in this order are taken from: De Staatscourant 11 December 1989, Het Parool 7 
December 1990, Telegraaf 27 December 1990, Algemeen Dagblad 15 December 1992, De 
Volkskrant 17 December 1992, Trouw 18 December 1992, Trouw 24 November 1993, Volkskrant 
10 October 1994, Volkskrant 1 October 1994, Algemeen Dagblad 9 November 1994, Algemeen 
Dagblad 23 May 1995, NRC 18 July 1996, NRC 5 September 1996. All translations of headlines 
are mine (ET). The Dierenbescherming is the short name of the Dutch Society for the Protection of 
Animals. And the Ministry of Agriculture, Nature Management, and Fisheries is usually shortened 
to Ministry of Agriculture or, if the context is clear, just Agriculture. 
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general? These and other questions will be central to this book on the Dutch public 
debate on animal biotechnology. 
In this introductory chapter, I will introduce the debate on animal transgenesis, set 
out my views on public debates, formulate my guiding questions, and sketch how I 
will answer these questions in the course of this book. 
Herman the bull 
In 1990, the Leiden biotechnology firm Gene Pharming succeeded in inserting an 
exotic gene in the genome of a bull, thus making this bull transgenic. This gene 
was supposed to come to expression in the mammary glands of his lactating 
daughters. If the gene came to expression, it would cause the excretion of human 
lactoferrin in the milk. Lactoferrin is supposed to prevent and control infections. 
The excretion would start after the birth of the grandchildren of Herman the bull. 
Only then would the success of the project become clear. The announcements of 
the project in 1989 and more particularly of the birth of the first transgenic calf in 
December 1990 initiated an extensive public debate on animal transgenesis. This 
debate has lasted for almost nine years. 
The genetic engineering of cattle has been discussed as a case in the domain of 
animal ethics. People were concerned about the impact of genetic engineering on 
the animals. They were concerned, for instance, about their wellbeing, about their 
integrity, and about the mingling of species. During the debate, people have hardly 
ever referred to any other context in which genetic engineering took place. This is 
quite remarkable, since there had been a debate on the genetic engineering of 
micro-organisms in the seventies. And parallel to the debate on animal transgenesis 
there has also been an ongoing debate about genetically modified crops. This lack 
of interference is probably due to the different focuses of these debates. The debate 
on micro-organisms had focused on safety aspects regarding humans and the 
human environment. The debate on the deliberate release of genetically modified 
crops has mainly concentrated on potential ecological damage, next to human 
safety aspects. The debate on animal transgenesis, however, has focused on what 
we do to the animals, which is a question of animal ethics. This focus has not been 
questioned by any of the participants; at the most participants have put forward 
major human goals that might overrule this focus on animal ethics. This also means 
that arguments that apply specifically to animals have been much more important 
in the debate than arguments that hardly distinguish between animals and plants or 
between animals and micro-organisms. 
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But this still does not explain why there has been such an extensive debate. Issues 
in animal ethics have never been discussed so thoroughly in the media before in the 
Netherlands. The debate in the media could be compared with the upheaval around 
a major medical-ethical issue like abortion or a major infra-structural issue like the 
Schiphol debate. It probably made a difference that Herman was a bull instead of a 
less appealing animal 2. Many Dutchmen consider dairy cattle as part of the Dutch 
identity- The Dutch were cattlemen from way back; even the polders with their wet 
pastures and ditches specifically had been made for cattlefarming3. Even now, 
farmers are associated with cattlemen, although most farmers do not have dairy 
cattle anymore. Furthermore, a description of a typical Dutch landscape will 
contain pastures, ditches, and cows. Most Dutch people also identify themselves 
with cows to a certain extent. For instance, they give cows human names 4, like they 
also do with horses, pets, and zoo animals, while sheep, pigs, poultry, and 
laboratory animals usually have no name. They regard cows as gentle, innocent and 
useful animals that are completely dependent on human care. They are prepared to 
pay extra respect to these animals. 
As an animal near to us, Herman has appealed to people's imagination, more than a 
laboratory animal could ever do. And as a photogenic animal, he was a willing 
subject for the (poster) campaigns of the Dierenbescherming5, for the media 6 and 
for the promotion of animal transgenesis by Gene Pharming 7. Herman's creator, 
Dr. Herman de Boer, has referred several times to his agrarian background while 
stressing that he would never do anything to cows that he would not be able to 
explain to his grandchildren8. This cultural background has certainly played an 
important part in the large public involvement in the debate on animal transgenesis. 
Another reason for the lengthiness of the debate was the time it took from the 
2 In a lecture at the workshop "The social management of biotechnology' at Tilburg University, 
Michiel Linskens of the Dierenbescherming has stressed that the fact of Herman being a bull has 
made it a lot easier for the Dierenbescherming to publicly discuss animal transgenesis. 
3 See also Koos van Zomeren in the NRC Handelsblad of 7 March 1997. 
4 In the practice of very large and highly computerised firms, cattle will usually not be known by 
name. This does not match, however, with the views of many Dutchmen. 
5 In this book, I will use the common name of the Dutch Society for the Protection of Animals, to 
wit the Dierenbescherming. 
6 A VPRO documentary on television made Herman the bull a media star in 1992 as K. Glastra van 
Loon and K. Kuiper (1994) have stated in their book 'Herman - biography of a genetically 
engineered bull'. 
7 Gene Pharming did not want to have Herman the bull killed at the end of the experiment, since the 
bull had become an attraction for their firm. According to them, all visitors to the firm want to see 
the bull. 
8 See for instance his statement in Mare April 18 1991 'If I will cycle with my grandson through the 
polders some day, I must be able to say: that is a real cow' (my translation, E.T.) 
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planning of the creation of transgenic calves (1989) to the lactation of the 
daughters of one of these calves (1995). The time it took to arrive at an Animal 
Health and Welfare Act (from 1981 to 1992) and subsequently the regulation of 
animal biotechnology (from 1992 to 1996) probably have had an influence on the 
prolongation of the debate as well. 
Debates and the public 
Public debates are an intriguing phenomenon. Major shifts in ways of thinking and 
acting may occur in a society while no one is able to pinpoint the moment it 
happened and to say what exactly happened at that moment. An issue is argued for 
and against, arguments are substantiated, commented, articulated, differentiated, 
adapted and ... after some time people start acting differently. Something has 
changed in their overall way of thinking. Something has changed in what they 
think is important or morally required. And I assume that they have committed 
themselves to the outcome of the debate, which means that people have been 
intrinsically motivated to change their way of doing things. A changed opinion 
causes things to change. The pragmatist Pierce has stated throughout his writings 
that whatever we believe, we believe to be true. This means that we cannot but act 
according to our beliefs 9. 
Sumner and Phelps have argued that the convictions of people about what should 
be considered normal and deviant behaviour will change because of new 
information provided and discussions about this information. 1 0 I, for one, am 
convinced that the general attitude of researchers (and the public) towards the use 
of animals in laboratory experiments is determined by the ongoing debate on the 
human-animal relationship. Such societal transformation processes are intriguing 
because they raise many questions about what public debates are and about what 
happens in a public debate. 
The most conspicuous of public debates are the informal debates in the media in 
which public opinion leaders, like experts, politicians, senior civil servants, 
spokespersons of (public and economic) interest groups, and concerned parties, 
express their views on a certain subject. But there are many other public debates as 
well, like the institutionalised political debates in Parliament and the more or less 
formalised scientific, juridical, ethical and aesthetic debates in specialised forums 
like journals, workshops, and conferences. Subjects of public interest are discussed 
9 This is a central point in his essay "The Fixation of Belief [Die Festlegung der Überzeugung. E.g. 
par. 5.375. In: Ch.S. Pierce (1967) Schriften I, Theorie Suhrkamp Verlag]. 
1 0 See for instance W. G. Sumner and W.L. Phelps (1940) Folkways. Boston. 
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in all kinds of organisations from political parties to community associations, and 
spontaneously in public places, at work, and at kitchen tables as well. No, this is 
not a mistake. I do mean kitchen tables. I do not make distinctions of principle 
between a discussion on a public issue at a kitchen table among members of a 
family, at work among colleagues, or in a pub among friends. Not only are these 
minor debates part of the major debate on an issue, they are very important as well. 
Simone Chambers 1 1, for instance, conceives a public debate as consisting of many 
interrelated smaller debates that may also take place in the private sphere. For 
forming their opinion people do not only need the information presented by the 
media, but they also need to cope with this information, which they do in the direct 
communications with friends, colleagues and relatives 1 2. Chambers adds 
convincingly that opinion formation does not take place during these discussions, 
but in between discussions, as people think over the arguments and prepare 
themselves for a next round of the discussion. This means that these many small 
discussions have an impact on the formation of a considered opinion. Gabriel 
Weimann 1 3 has substantiated these arguments by showing empirically that public 
opinions are not only influenced by a top-down flow of information (media to 
opinion leaders to ordinary people). A bottom-up flow and a horizontal flow of 
information also is very important for opinion formation. Each discussion on a 
subject may count and may help people to arrive at a considered opinion. 
This means that these small-scale debates are influential as they produce public 
reasons that may be put forward in discussions in other places. In this sense, even 
the arguments put forward at kitchen tables are potentially fruitful and may enter 
into broader discussions. They are public because of their content, not because of 
their context. The vitality of these discussions depends on a continuous flow of 
information about the subject, which stresses the role of the media. 
Public debates are primarily associated with informal, spontaneous, non-organised 
debates in which potentially every citizen is involved. The debates in the media are 
exemplary, since these debates take place before the public as a whole. Although 
the public in a media debate is basically an audience, the members of this audience 
can discuss the arguments, preferences, and views put forward among themselves. 
1 1 Simone Chambers (1995) Discourse and democratic practices. In: S.K. White (Ed.) The 
Cambridge companion to Habermas. Cambridge University Press. Cambridge/New 
York/Melbourne, p.233-259 
1 2 See also Schenk, M. and P. Rössler (1994) Das unterschätzte Publikum. Wie Themenbewusstsein 
und politische Meinungsbildung im Alltag von Massenmedien und interpersonaler 
Kommunikation beeinflusst werden. In: F. Neidhart (Ed.) Öffentlichkeit, öffentliche Meinung, 
soziale Bewegungen. Köllner Zeitschrift für Soziologie und Sozialpsychologie, Sonderheft 34. 
1 3 Gabriel Weimann (1994) The Influential. People Who Influence People. SUNY Press, Albany NY 
p.243-254 
14 
And they are able to write a letter to the editor or to react in an interactive radio-
prograrnme, and, so, still participate. This does not mean, however, that every 
citizen will actively follow the debates in the media. People will only follow 
debates on the topics they are interested in. And they expect others to adequately 
deal with the other issues they think important. 1 4 
Figure 1.1: The public sphere exists of many interrelated public debates with their own 
sub-spheres. 
Public debates in the media are also characterised by a specific kind of openness. 
They are not aimed at reaching consensus, but at convincing the public and so at 
gaining public support and impact. Therefore public debates will hardly ever be 
closed. Of course, people may reach consent on some aspects of the issue, but 
people will continue to disagree on other aspects. Such disagreement will not 
necessarily cause ongoing debate. If no new arguments or insights can be put 
forward, the discussion will usually fade away and people will reconcile 
themselves to dissent until they have reasons for reopening the debate. For the time 
being, they will agree to disagree. Issues that are closed may also be reopened as 
new reasons or insights arise. 
This insight is developed in my discussions with Geert Munnichs. See also his book G.M. 
Munnichs (2000) Publiek ongenoegen en politieke geloofwaardigheid. Democratische legitimiteit 
in een ontzuilde samenleving. [Public discontent and political credibility. Democratic legitimacy in 
a post-traditional society.] Van Gorcum. Assen. 
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Public debates and Western democracies 
Public debates on all kinds of subjects are inherent to modern Western societies. 
The concept of a public sphere refers to the sphere of public life in which the 
citizens discuss matters of common concern and in which their opinions are 
formed. This concept refers to a politicised public sphere. Such a public sphere has 
emerged out of a non-politicised public sphere that dates back to feudal t imes 1 5 . At 
the feudal courts, civil intellectuals discussed literary subjects. These discussions 
developed into a literary public sphere that flourished in the 17 t h and 18 t h century 
'salons' in France, the 'coffee-houses' in England, and the Tischgesellschaften' in 
Germany. Looking back, these literary discussions can be regarded as preparation 
for the struggle of the citizens with the Government on the rules of the economic 
markets and the labour market 1 6 . About the same time, the first newspapers appear. 
The Government starts to use this new medium to address itself to its citizens, for 
instance, to announce regulations and taxes. These governmental activities stir up 
public criticism, which forces the Government to legitimate its acts. Public 
discussions develop into an intermediary between the needs of the citizens and the 
state. In these discussions, a critical public opinion is formed. Around 1800, a truly 
political public sphere can be detected in England. Citizens who wanted to 
influence governmental decisions were appealing to the broader public in order to 
legitimate their claims. By then, some obstacles for the emergence of a public 
sphere have already disappeared. Censorship has ended and the first cabinet 
government has been installed. The first political periodicals have appeared and the 
press has started to be a critical institution of a public discussing political topics. At 
the end of the 18 t h century, journalists had been allowed to be present in 
Parliament, which meant that the public could critically follow Parliament. Now, 
parliamentary minorities had a means to appeal to the judgement of the public, and 
majorities could legitimate their views in front of the public. With the emergence 
of political parties, members of the public even become the 'direct' discussion-
partners of their representatives. But this also means that political parties have 
become an intermediary between the public and the Government. This interaction 
between public and politics still exists. During the 20th century some new players 
appeared on the stage, namely all kinds of societal (public interest) organisations. 
1 5 Habermas (1962/1984) Strukturwandel der öffentlichtkeit. Untersuchungen zu einer Kategorie der 
bürgerlichen Gesellschaft. [Structural change of the public sphere. Research into a category of 
civil society.] Herman Luchterhand Verlag, Darmstadt und Neuwied 
1 6 See Keulartz (1992) De verkeerde wereld van Jürgen Habermas [The reversed world of Jürgen 
Habermas] Boom. Meppel 
16 
They became important voices in public debates, and they are lobbying in the 
wings of Parliament. The first entails a reinforcement of public debates, but 
lobbying means that parts of political decision-making have become less 
transparent. Because of the emergence of political parties and all kinds of other 
intermediate organisations that represent 'the public', a gap has developed between 
the public and politics. Citizens, however, can actively participate in the 
discussions within these intermediate organisations, and they can be a critical 
audience for the discussions in the media. Between organisations, within 
organisations, and in the media vivid public debates on all kinds of subjects are 
going on. 
From this historical sketch, I can derive some characteristics of public debates. 
Politicians are forced to explain their judgements to the public, which means that 
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they have to be sensitive to the needs and views of the public . There is a strong 
urge for citizens and their organisations to critically follow the activities of the 
political parties, of politicians, and of the intermediate organisations. Their views 
will be discussed in public as well. The function of the press is to be an 
intermediate between politics, the public, and organisations. 
Because of the diversity of opinions and reasons put forward in public, people can 
reflect on their views, preferences, and interests, and so arrive at a more or less 
considered (critical, reflexive) opinion and will. Such opinions and wills, joined 
together, are basic to what can be called a considered public opinion. Considered 
public opinions are considered because of the way in which these opinions have 
been arrived at, and because of the reflective assent on which the outcome may 
reckon, since the outcome is the result of an active public sphere. 
Public debates may have a major political impact. The arguments put forward may 
convince political decision-makers. And if a considered public opinion does not 
cohere with the views of the politicians, it may form a source of political power, 
since democratic political decisions are in need of public support. The outcome of a 
public debate is an indicator for the extent to which a political decision may reckon 
on public support. Public debates can thus be regarded as a vital complement to 
political decision-making . 
1 7 See also G.M. Munnichs (2000) Publiek ongenoegen en politieke geloofwaardigheid. 
Democratische legitimiteit in een ontzuilde samenleving. [Public discontent and political 
credibility. Democratic legitimacy in a post-traditional society.] Van Gorcum. Assen. 
1 8 See also: B. Manin (1987) On legitimacy and political deliberation. In: Political Theory 15/3 p. 
338-368 
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Guiding questions and approach 
My starting point is that debating in public makes sense. Debates may pass off 
well; they can have impact; and so be successful. My central claim in this book is 
that, although this debate on animal transgenesis has not been perfect, it still is an 
example of how a debate can be. I have the strong assumption that this has been a 
successful debate, because it has had continuity; it has had development in 
argumentation; the participants have reacted to each other's argumentation; new 
concepts have been introduced; lapses have been criticised; all relevant viewpoints 
and interests have been well argued for; the quality of the debating itself has been 
discussed if necessary; and the debate has had impact. By examining this debate on 
animal transgenesis, we can learn a lot about this particular debate. But this inquiry 
will also give an answer to the question why this has been an exemplary debate. I 
will analyse the factors that have determined the success of this particular debate, 
that is to say, I will explain why this debate can be considered a successful and 
exemplary debate. In this way I can, by examining this particular debate, learn 
something about debates in general. An empirical analysis of a single, though 
exemplary debate will therefore be relevant for understanding public debates in 
general. 
The following questions will be guiding my research: 
- what has kept this debate going? 
. what has been the internal dynamics of the debate? 
. what were the external influences that have kept the debate going? 
. what has been the role of the participants? 
- what has been the development regarding the content of the debate? 
. have any new concepts been suggested and substantiated? 
. has there been progress in the positions and the lines of argumentation of 
the participants? 
. what has been the influence of the participants on each other? 
- what has been the impact of the debate? 
. have the members of the broader public been enabled to form a 
considered opinion? 
. has it had any impact on the development of ethical standards? 
. has it had any impact on political decision making? 
- has the debate passed off well? 
. were participants receptive to critiques of their behaviour? 
. have the participants taken the debate and the audience of the broader 
public seriously? 
. have all relevant views been heard? 
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Many Dutch authors have investigated public debates. Some of them were 
primarily interested in the substance of a specific debate in a certain context. They 
have focused on reasons, lines of argumentation, and sometimes on the rhetoric of 
the debate. This has resulted in some fine analyses of written and spoken texts. 
Others have concentrated on debates as a whole, trying to grasp general shifts in 
ways of speaking and writing. These analyses usually did not differentiate among 
the different debates I have distinguished, but focused on the overall development 
or the characteristic structure of the debating about a certain issue. Among these 
analyses, two approaches can be distinguished. Some researchers take an 
observational stance: they analyse a debate from outside. Others take a 
participatory perspective: they analyse a debate from within. By being part of what 
is going on, it will be possible to reconstruct the reasons that are put forward by 
showing their contribution to the development of the debate. Such an inside 
perspective has priority over an outside perspective as one cannot even understand 
what an argument or an influence is, if one does not understand what has been 
going on. An observational stance, however, is needed for gaining insight into 
influences from outside on the debate. 
I have concentrated on the debate in the media, as it is only through the media that 
the general public is involved in the debates among experts, politicians, societal 
organisations, and policymakers. Consequently, I have not used the very interesting 
and thorough reports with very sophisticated lines of reasoning that were written by 
experts and governmental committees. I have only made use of the abstracts and 
comments in the media referring to those reports, since these abstracts and 
comments have facilitated the opinion and will formation of the general public. 
I am not primarily interested in the detailed arguments and rhetoric at a micro 
level, nor in major overall shifts of reasoning in the debate as a whole. But I am 
interested in the participants, their lines of reasoning, shifts in their reasoning, their 
persuasiveness, and the clashes with other lines of argument. So, I am interested in 
the internal development of the debate19. 
This does not mean, however, that I did restrict myself to the content of the debate. 
I do not want to regard a debate as an argumentation only, but as a debate. This 
means that I want to understand what has kept this debate on animal transgenesis 
going (its internal dynamics) and what has caused the debate (its underlying 
controversies and external dynamics). 
Margo Trappenburg, I have mentioned her before, also has directed her research at this level. She 
has chosen a participatory perspective. She, however, was interested in the debate as an 
argumentation only, not as a debate. M. Trappenburg (1993) Soorten van gelijk. Medisch-ethische 
discussies in Nederland. [Discussing medical ethics in the Netherlands] Tjeenk Willink. Zwolle. 
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And I want to develop an inherent set of parameters for evaluating the quality of 
this debate (its process) by asking and discussing the question how the participants 
evaluated the debate themselves. In doing so, I take the debate itself as a point of 
departure. This means that I have adopted an inductive approach in grasping the 
debate as a debate. 
One might expect a personal viewpoint, evaluation, or position regarding animal 
transgenesis. Most of the time I did not take a stance, however, for two reasons: I 
was primarily interested in what public debates are and for this reason I did not 
need to take position; and I have not come to a specific general position regarding 
the issue. All positions have their merits and weaknesses. 
Outline of the book 
In the next chapter (chapter 2), I will give a chronological sketch of the Dutch 
debate on animal biotechnology. We will get to know the themes and sub-themes 
of the debate. We will meet the participants and their main lines of argumentation. 
And we will get a glimpse of the outcomes. 
My analysis starts in chapter 3 (How the debate proceeded: rounds and issues) with 
an investigation of the structure and internal dynamics of the debate. Debates in the 
media have a specific dynamic, since for the media topicality is a major motivation 
for publishing about a certain issue. As the debate on animal transgenesis extended 
over some nine years, it will be possible to distinguish a number of episodes in the 
debate on animal transgenesis that are connected with specific events. I will discuss 
these episodes and I will discuss the events that initiated and closed these episodes. 
The participants of the debate and their roles in the debate will be the focus of 
chapter 4 (Players, related debates, and roles). The many voices that were heard 
will be clustered to a manageable number. I will show that each voice had its 
specific role in the debate. I will also elaborate on some general notions I 
mentioned in the introductory chapter regarding the characteristics of some 
different debates and on the interrelation of these debates, which will result in 
specific roles for experts, politicians, and the Government in this debate in the 
media. 
Chapter 5 (Animal integrity contested. A reconstruction of the lines of reasoning) 
will concentrate on the content of the debate. The arguments that substantiate the 
major positions will be classified with reference to some guiding moral principles. 
I will also discuss the differences between a 'yes, i f policy and a 'no, unless' 
policy. I will argue that this distinction goes back to different valuations of animals 
and to different valuations of technology. This last issue will be briefly discussed in 
the same chapter. 
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The influence of the context in which the debate took place will be the subject of 
chapter 6 [Which practice, what norms?]. Not only animal transgenesis in general, 
several applications of this technology have been discussed as well. In discussing 
these applications, it turned out that the transgenic animals in the experiment 
(cattle) do not easily accord with the traditional categories of l i n k i n g about 
animals. They are not just rats in a laboratory experiment, or cattle in a dairy farm, 
or sick animals in a veterinary clinic, or laboratory animals producing inoculates. 
All these contexts have, however, influenced the way in which people evaluated 
the Herman project. 
Chapter 7 [The process] will deal with the process of debating. The process of 
debating has been an issue itself during the debate. Participants that did not comply 
with a 'standard' of 'good' debating were criticised by other participants. I will try 
to grasp what the requirements of a 'good' debate are, in order to evaluate the 
debate and to evaluate the internal critiques. I will do so by confronting some 
theoretical notions of 'good' debating with the reconstructed notions of the 
participants. 
In my Conclusion (chapter 8) I will recapitulate the guiding questions and the 
answers I have found. This will result in a discussion about what makes a public 
debate a successful debate. 
Choices concerning the empirical material 
It is obvious that the public is primarily informed by way of television. I have, 
however, taken my material from the newspapers. Except for the very practical 
reason of accessibility for the researcher, this also had a substantive reason. Events 
on television have a major impact on the agenda of the wider public, because of the 
images that accompany the topics. On the other hand, items in news programs are 
rather short and only a few items will be better articulated in informative 
programmes. Dutch newspapers offer much more opportunity for discussing 
contested topics. They literally have more space and can therefore allow more 
room for background information on many issues. They have their opinion and 
forum pages (each day one or two full pages), so allowing room for a broad variety 
of opinions and being open to the public for writing a letter to the editor or an 
opinion page article. This means that newspapers will offer a broader and deeper 
view on an issue. Consequently, newspaper readers will be better informed than 
television viewers. Most Dutch households have a subscription to a newspaper. So 
they have an opportunity to follow the topics they are interested in not only on 
television but also in their newspaper. 
The Netherlands has many newspapers. Six general newspapers, two sectoral 
newspapers, and two ecclesiastical newspapers have a nation-wide coverage. Next, 
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there are some dozens of regional newspapers. For practical reasons, I had to 
restrict myself. I have concentrated on the six national newspapers 2 0, for two 
reasons. Firstly, I have assumed that all newspapers cover national news roughly 
the same way, which would mean that including all newspapers would produce 
much redundancy. Secondly, one might expect more and better articulated articles 
on animal biotechnology in the general national newspapers, as these give more 
background information and allow more space for national topics. 
By the way, in this specific case the second reason is not true for the sectoral 
newspaper 'Het Agrarisch Dagblad' [The Agrarian Daily], as this newspaper has 
followed the debate on animal biotechnology most actively. But, since it is a 
sectoral newspaper, this information did not reach the general public which formed 
my focus of interest. 
Most articles have been obtained from the archives of the Dierenbescherming. 
Michiel Linskens, during the debate staff officer of the Dierenbescherming, has 
been collecting cuttings from national and regional newspapers from the very 
beginning of the discussion on animal biotechnology. This collection provides a 
good coverage of the debate 2 1. 
The general national newspapers are 'De Telegraaf (circulation approximately 725.000), the 
'Algemeen Dagblad' (415.000), the 'NRC-Handelsblad* (250.000), 'De Volkskrant' (320.000), 
'Trouw' (110.000) and 'Het Parool' (110.000). These circulation figures pertain to the moment 
half-way through the debate. 'Het Parool' has become a regional newspaper by now. 
I have roughly checked the coverage of the archive. Two years of De Volkskrant on CD-ROM and 
four years of cutting by myself of the NRC-Handelsblad did not reveal serious gaps in the 
coverage. So, I suppose the archive is rather complete. 
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2. A calf is born 
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December 1990, the Netherlands was startled by the news that a transgenic calf was 
born. This first (female) calf did not prove to be transgenic after all. A bull-calf 
(named Herman) born out of the same experiment, however, was! Herman the bull 
became the focal point of a public debate about animal biotechnology. The births of 
these calves, however, did not start the debate. It already had started one and a half-
year before, at the occasion of the announcement of the project by Gene Pharming 1. 
The debate, as it has taken place in the newspapers, can be reconstructed into several 
episodes concentrated either on a more specific aspect of animal transgenesis or on the 
doings of one of the main actors in the debate. An underlying and continuing 
discussion has dealt with the ethics of animal biotechnology as such. The main actors2 
are Gene Pharming; the Dierenbescherming3; Parliament; and the Minister of 
Agriculture4. 
The announcement 
March 1989, a small report in the national newspapers5 announces that Gene Pharming 
plans to create transgenic dairy cattle that will produce milk of a changed chemical 
composition. Herman de Boer, scientific manager of Gene Pharming, argues that a 
whole range of opportunities will arise if this project succeeds. To wit: the production 
of biomedical proteins; an increase of the inherited resistance against diseases and 
parasites; and an alteration in quality of the milk. 
The firm has changed its name several times. It started as Gene Pharming Europe, then it was called 
Gene Pharming and later just Pharming. During the debate, it was called Gene Pharming for the 
longest period. Therefore, this name will be used throughout this book. 
2 A complete overview of the actors can be found in supplement 3. 
3 In full: de Nederlandse Vereniging voor de Bescherming van Dieren [the Dutch Society for the 
Protection of Animals]. 
4 In full: Ministry of Agriculture, Nature Management, and Fisheries. Several persons have been 
Minister of Agriculture, Nature Management, and Fisheries during the debate, to wit in chronological 
order: Minister Braks, Minister Bukman and Minister Aartsen. State Secretary Gabor has also spoken 
several times about the subject. 
5 NRC 9 March 1989 and De Volkskrant 11 March 1989 
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The Ministry of Agriculture is directly involved, since one of its research institutions 
(IVO-DLO) 6 is housing the facilities of Gene Pharming. 
This announcement coincides with a parliamentary debate on the proposal for an 
Animal Health and Welfare Act in April 1989. This coincidence has given this debate 
an interesting turn. Animal transgenesis is discussed as a new technology of which the 
development cannot be anticipated. It is realised that as technological developments 
cannot be anticipated, it will also be impossible to develop a limited list of conditions 
or restrictions regarding the handling of animals. Some political parties suggest that 
it would be a good thing to change the operating principle of the Act from a 'yes, if 
a limited list of conditions is fulfilled' principle to a 'no, unless there are good reasons 
to do so' principle. Minister Braks of Agriculture does not want to meet this 
suggestion (yet). 
A few months later the Dierenbescherming changes its position regarding animal 
biotechnology 7to an absolute 'no ' . The Dierenbescherming argues that changing the 
genetic code of animals does not agree with respect for the mtrinsic value of animals. 
A few days later Minister Braks 8, as an honorary guest at the 125 t h anniversary of the 
Dierenbescherming, also argues that the Animal Health and Welfare Act (AHWA) has 
to put a check on animal biotechnology 'because of ethical motives'. However, his 
conclusion differs substantially. He (then) announces that 'no, unless' will be the 
operating principle of the AHWA. 
The announcement of Gene Pharming that it is going to make transgenic dairy cattle 
also initiates a more general discussion about the ethics of creating transgenic animals. 
Most participants of the debate are convinced that animal biotechnology is ethically 
problematic. Especially the Christelijke Plattelands Jongeren9 are very explicit in their 
argumentation 1 0. In their view, a transgression of the species barrier is a violation of 
God's creation. Some researchers, however, indicate that they do not even want to 
discuss the ethical aspects of animal transgenesis, because they fear that such a 
discussion might lead to a limitation of scientific autonomy". Herman de Boer 1 2, 
manager of Gene Pharming, does not regard the creation of transgenic animals 
6 IVO-DLO (Instituut voor Veeteeltkundig Onderzoek, in English: Institute for Animal Husbandry 
Research)) is later called ID-DLO which stands for Instituut voor Dierhouderij en Diergezondheid 
of the Dienst Landbouwkundig Onderzoek [Institute for Animal Science and Health of the 
Agricultural Research Department]. I will use the name ID-DLO from now on. 
7 Staatscourant 11 November 1989, Algemeen Dagblad 2 December 1989 
8 Staatscourant 11 November 1989 
9 Christian Rural Youngsters 
1 0 NRC 5 April 1989 
1 1 NRC 5 April 1989 
1 2 De Volkskrant 11 March 1989 
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ethically problematic as such. In his opinion, there is nothing ethically new about it, 
because transgenic laboratory animals already exist. He stresses that animal 
biotechnology should be restricted if negative effects on animal health or welfare will 
occur. 
Although most people seem to conceive animal biotechnology as ethically 
problematic, this does not imply that they are in favour of a ban on biotechnology as 
well. As, for instance, Minister Braks argues: "Not enough is known about the subject 
and there might be good reasons in favour of biotechnology as well" 1 3. The Minister 
installs a Committee on Ethics and Biotechnology in Animals (CEBD) 1 4 to advise him 
about how to deal with the issue of animal biotechnology. 
The advice 
One year passes before the CEBD publishes its report1 5 on the matter (May 1990). The 
CEBD distinguishes three problem areas requiring regulation from an ethical point of 
view. The Committee is convinced that in these three areas the intrinsic value of the 
animals might be harmed: 
gene transfer in animals (recombinant DNA techniques in animals) 
embryo technology (cloning and the creation of chimeras) 
- the administration to animals of substances that are obtained through recombinant 
DNA-technology and of modified micro-organisms. 
Therefore the CEBD advises to install an Ethics and Biotechnology Council that 
should advise the Minister and promote public debate, and to incorporate a 'no, 
unless' policy principle in the AHWA. The Dierenbescherrning does not support this 
advice 1 6. The Dierenbescherrning argues that if animals have intrinsic value, they 
ought not be used as mere instruments. The genetic engineering of animals should be 
forbidden. 
October 1990 Parliament meets the advice of the CEBD. In practice this implies that 
animal biotechnology activities have to be licensed1 7. 
1 3 De Volkskrant of 4 April 1989 
1 4 This committee is also called Schroten Committee after its chairperson. 
1 5 NRC, De Volkskrant 10 May 1990. See also: Commissie van Advies Ethiek en Biotechnologie bij 
Dieren (1990) Rapport van de Commissie van Advies Ethiek en Biotechnologie bij Dieren. [Report 
of the Advisory Committee Ethics and Biotechnology in Animals.] NRLO. Wageningen. 
1 6 Staatscourant 11 May 1990 
1 7 De Volkskrant, Het Parool 30 October 1990 
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A calf is born 
On 4 December 1990 the first calf, Adriana, is born. She is supposed to produce extra 
lactoferrin in her milk. Gene Phanning argues that this will protect her against 
mastitis, an infection of the udders. This extra lactoferrin will make the cows healthier 
which is also profitable for the owners. 
The birth gives rise to many reactions. Some reactions can be seen as a refresher of the 
debate on the ethics of animal biotechnology in general. Some reactions deal with this 
specific case of lactoferrin production and the assessment procedure used (see the next 
section). 
The most prominent person who addresses her concern is Queen Beatrix. In her 
Christmas speech 1 8 she explicitly asks whether everything that is possible should also 
be allowed. She considers animal biotechnology as ethically problematic for reason 
of expressing disrespect for nature and for life, and lacking harmony with God's 
creation. The Dierenbescherrning, Lekker Dier 1 9, and the Nederlands Agrarisch 
Jongeren Kontakt 2 0 stress that transgenic animals should not be made, since the 
intrinsic value of the animals, and in particular their integrity, will be harmed 2 1. 
Especially Gene Pharrning is denying that animal biotechnology is ethically 
problematic. It argues that genetic engineering is in line with traditional breeding. And 
therefore transgenic breeding as such is not ethically new 2 2. In its view, Adriana is just 
a normal calf with one extra gene out of 100.000. 
From the newspaper comments, it transpires that most people are convinced that 
animal biotechnology is ethically problematic. Everybody seems to agree that 
chimeras (also called hybrids, 'new' animals, or mixes of two species) should not be 
made at all. The introduction of minor changes in the genome which induce the 
production of 'exotic' proteins in the milk remains debatable, however. 
April 1991, a majority in Parliament 2 3 is in favour of animal biotechnology to be 
licensed, because it expects that life saving medicine may be produced in time. Thus, 
Parliament proposes a case-by-case assessment procedure. 
1 8 All Newspapers 27 December 1990 
1 9 'Tasty Animal', an organisation against factory fanning 
2 0 Dutch Agrarian Youngsters 
2 1 HetParool 7 December 1990 
2 2 E.g. O. Postma of Gene Pharrning in the NRC of 5 January 1991 
2 3 A minority in Parliament, consisting of GroenLinks (left wing environmentalists), D66 (liberals), and 
the SGP (small christian party), wants the experiment to be stopped (Trouw 23 April 1991). 
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Mastitis prevention 
A fierce debate develops in the newspapers on whether mastitis prevention is a 
sufficient reason for making transgenic animals. Some argue that mastitis is a multi-
factorial disease and that high productivity farming is one of these factors. Hence, 
there might be other ways to reduce the incidence 2 4. During the debate it becomes 
apparent that economic interests, or an increase in productivity are not accepted as a 
sufficient reason for creating transgenic (farm) animals; neither is the production of 
luxury products, or the production of cosmetics 2 5. Human health is mentioned as a 
major interest that might be a sufficient reason to allow for animal transgenesis. 
June 1992, more than a year later, Minister Bukman argues that transgenesis is 
ethically problematic in farm animals, since transgressing the species barrier for 
commercial reasons cannot reckon on public support. This means that mastitis 
prevention no longer can be brought forward as a legitimate reason for making 
transgenic animals. 
Human genes? 
April/May 1991, it turns out that the calves will produce human lactoferrin. This gives 
rise to a rather academic discussion. Fact is that the transgenic calves will produce 
human lactoferrin. The question is whether this means that a human gene is used. All 
political parties agree that the incorporation of human DNA should not be allowed. 
According to a minority in Parliament 2 6 the gene used has to be human-identical, as 
the lactoferrin produced will be human-identical. In its view it does not matter how 
the gene is made. Minister Bukman claims that the gene is a chemical construct and 
therefore is neither human-identical nor animal-identical. Dr. Tj. de Cock Buning 2 7 
stresses that it is evident that Gene Pharming wants to make a human product. A 
difference between human and human identical seems to him irrelevant in this respect. 
This discussion stimulates P. Borst to react in his column in the NRC 2 8 : in his view, 
scientists should have been asked for advice. Henceforth scientists would have 
explained how important transgenic animals are for the developments in medical 
research; how indispensable the technique is in medical biology; and that human 
medicine will be obtained cheaper and more easily. 
E.g. Dr. Brand (NRC 8 December 1990), Drs Bart Rutgers (De Volkskrant 11 December 1990), Dr. 
Jan Grommers (NRC 5 January 1991). 
See e.g. Dr. E. Schroten in Algemeen Dagblad 11 December 1990. 
This minority consisted of GroenLinks (left wing environmentalists), D66 (liberals), and the SGP 
(small Christian party). 
NRC 7 May 1991 
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The non-transgenic foetuses 
Another discussion evolves around the issue what to do with the non-transgenic 
foetuses2 9. Only a few animals out of every experiment will be transgenic, while all 
the animals are kept, which is very costly. Hitherto Gene Phanning has asked the 
Minister for an allowance to abort or to sell the calves superfluous to the experiment. 
Gene Pharming itself is in favour of sale, since it expects ethical disapproval of 
abortion. The vCOGEM 3 0 advises negatively on bringing the superfluous ariimal in the 
(human) food chain. It doubts the quality of the method used to determine whether or 
not a foetus is transgenic. Furthermore, once the animals are sold, the experiment 
cannot be evaluated fully later in time, because the effect on the health and welfare of 
the non-transgenic calves cannot be monitored. The Minister adds to the debate that 
even if the experiment has failed in most animals, these experimental animals might 
still be transgenic after all and should therefore not be mixed with other cattle. All the 
animals procreated have to be kept for evaluation purposes. 
Health and welfare 1 
August 1991, the results of the research into the health and welfare of the experimental 
animals are made public 3 1. Minister Bukman concludes that since the calves are in 
good health the experiment may go on. Out of 21 cows-in-calf 19 calves were born 
of which three died shortly after birth. Only two calves proved to be transgenic. From 
the limited information available, the Dierenbescherming32 concludes that the animals 
were harmed, since only 16 living calves were born and many cows had delivery 
problems. It suggests that further experiments should be forbidden. And it asks for 
publication of the whole report, since it wants to be able to fully evaluate the effects. 
This last request is met by minister Bukman 3 3. The experiments may proceed. 
NRC summer '91 (exact date unknown to me) 
2 9 NRC, De Volkskrant, Trouw 2 February 1991 
3 0 This is the provisional Committee on Genetic Modification that has to assess the safety of the 
handling of genetically modified organisms. 
3 1 De Telegraaf 6 August 1991; Trouw, De Volkskrant 7 August 1991 
3 2 Algemeen Dagblad, De Volkskrant 26 September 1991 
3 3 Gene Pharming Europe B.V. and DLO-Instituut voor Veeteeltkundig Onderzœk "Schoonoord" (TVO-
DLO) (1991) Eerste resultaten van een experiment inzake genetische modificatie van rundvee ten 
behoeve van mastitisbestrijding. Project P 796 (Weefselspecifleke expressie van genen in de 
melkklier van gemodiflceerde runderen') [First results of an experiment concerning the genetic 
modification of cattle for mastitis control. Project P 796 (Tissue specific expression of genes in the 
mammal gland of modified cattle.)] 
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Breeding with Herman the bull 
Every new project of Gene Pharming already is in need of a license because the 
Minister thinks this appropriate for its own research institution ID-DLO. This also 
applies to the next step taken by Gene Pharming in November 1992 namely to produce 
lactating daughters of Herman the bull. Only after having delivered calve will it prove 
whether or not the milk contains human lactoferrin. If this lactoferrin is recoverable 
and can be purified in a sufficient quantity, the project will have succeeded. The 
Minister has asked the provisional Committee on Ethical Evaluation of Genetic 
Modification in Animals (vCEEGMD) 3 4 for advice. This committee, however, gives 
a dual advice 3 5. A majority of five persons are in favour of giving a license. This 
majority argues that in time important medical proteins might become available, while 
harm for the animals is not expected. The minority argues that the integrity of the 
animals will be affected and the animals might be harmed, while no convincing 
reasons are given by Gene Pharming for proceeding the experiment. They state that 
Gene Pharming is only pointing at expectations instead of facts, and that it did not 
really look for alternatives. 
The Dierenbescherming, of course, is in favour of the minority point of view 3 6. 
For the first time a patients organisation speaks up. Margreet van Bladeren of the 
Rheumatics Patients Association argues in favour of the majority point of view 3 7. She 
states that there are no effective medicine against rheumatics now. Contemporary 
medicine only ease the symptoms. She has high expectations of the production of 
medicine by way of transgenic animals, since proteins out of fungi might cause 
immune response reactions in patients. She is very critical about the 
Dierenbescherming, for only standing up for the interests of animals. The 
Dierenbescherming responds that Van Bladeren has been misled by Gene Pharming 3 8. 
It argues that Gene Pharming is creating false hope, since the production of medicine 
is not under discussion. 
This committee is usually called the Committee Schroten 2 
Het Parool van 28 November 1992. See also: Voorlopige Commissie Ethische Toetsing Genetische 
Modificatie van Dieren (1992) Advies inzake het dossier "Weefselspecifieke expressie van genen in 
de melkklier van genetische gemodificeerde runderen " [ Advice concerning the file 'Tissue specific 
expression of genes in the mammal glad of modified cattle.] Supplement to a letter of the Minister of 
Agriculture, Nature Management, and Fisheries to the Chairman of the Permanent Committee on 
Agriculture and Nature Management of the Second House of Parliament, dated October 28 1992 
Algemeen Dagblad 5 December 1992 
Algemeen Dagblad 15 December 1992 
Algemeen Dagblad 16 December 1992 
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Minister Bukman advises Parliament to continue the experiment3 9. Parliament agrees, 
although a substantial minority, consisting of GroenLinks, D66, GPV, RPF, and some 
members of the PvdA, the W D , and the CDA 4 0, does not agree 4 1. This minority is not 
convinced of the necessity of the experiment. It asks for an investigation into 
alternative production methods for producing medicine. The majority of Parliament 
hopes that in time it will be possible to produce human medicine by way of this 
technique. But for the moment it wants to be careful and so a number of restrictions 
are imposed: 
Herman the bull is allowed to have offspring only once; 
the offspring should not be used for human consumption; 
all male animals as well as the second generation should be destroyed 
immediately; 
- the experiment has to be stopped as soon as alternative production methods prove 
to be sound. 
Only after a motion in the first Chamber of Parliament starts the Minister of 
Agriculture an inquiry into how to deal with alternatives4 2. 
April 1993, the Dierenbescherrning goes to court for the first time 4 3, together with the 
Stichting Natuur en Milieu 4 4, 4 5. Its main objection is that the 'no, unless' principle is 
not taken seriously, since alternative production methods have not been investigated. 
Cees Smit of the Dutch Association of Haemophiliacs (NVHP) is trying to turn the 
balance of the first trial in the favour of animal biotechnology by writing an opinion 
page article in which he expresses his hope that in time medicine against Haemophilia 
will be produced in cattle4 6. The Dierenbescherrning reacts instantly by accusing Cees 
Smit of propaganda, and Gene Pharrning of misusing patients and their organisations47. 
In its view, Gene Pharrning is using the production of medicine as a crowbar for 
animal biotechnology. 
October and November 1993, the first offspring of Herman the bull is born 4 8. 
3 9 De Volkskrant 31 October 1992 
4 0 Left environmentalists, liberals, two small Christian parties, social democrats, conservatives and the 
Christian democrats. 
4 1 Het Parool 17 December 1992 
4 2 Trouw21 April 1993 
4 3 They will go to court four times, but none of these actions will be successful. (Algemeen Dagblad 25 
March 1994) 
4 4 Foundation Nature and Environment 
4 5 Het Parool 30 January 1993 
4 6 De Volkskrant 7 April 1993 
4 7 De Volkskrant 16 April 1993 
4 8 De Volkskrant, Algemeen Dagblad 23 October 1993, Trouw, De Volkskrant 10 November 1993 
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The campaign 1 
Meanwhile, autumn 1992, the Dierenbescherming starts a campaign against animal 
biotechnology 4 9. It seeks publicity for its views; it makes teaching packages; it has 
advertisement campaigns; and so on and so forth. It stresses that animal interests 
should have more priority, in stead of always having secondary importance. And it 
argues that now a 'no, unless' policy is agreed upon in Parliament, it should also be 
applied. Especially the way alternative production methods are handled is a thorn in 
its flesh. 
During 1993 a new aspect comes up, namely that Gene Pharming is up to make 
mothers' milk out of cows 5 0. 
Health and welfare 2 
Animal health and welfare are a returning topic for discussion. Information about how 
transgenic cattle are made, and about the effects on the animals only gradually 
becomes available. For instance, it turns out that for producing transgenic animals 
many embryos have to be inserted in one cow. This cow is slaughtered after a while 
for taking out the embryos to test them on transgenicity. The transgenic embryos are 
replaced in another cow for maturing 5 1. The Dierenbescherming argues that this 
treatment of the 'mother' cows is disgusting. Its complaint is in vain, since there is no 
regulation for such treatment. 
Research into the health and welfare of the offspring of Herman the bull 5 2 reveals 
health and welfare problems during pregnancy and at birth. There were, for instance, 
many spontaneous abortions (17 out of 75); 6 out of 45 calves died at birth, and 17 
Caesareans were needed. Gene Pharming claims that these problems were not due to 
the exotic gene that was inserted, but to the transfer of the gene as such, or to the 
treatment and/or cultivation of the embryo's. Changes in the process did diminish 
these problems but could not remove them completely. 
9 Trouw 6 November 1992 
5 0 Trouw 24 November 1993 
5 1 De Volkskrant 24 August 1993 
5 2 Het Parool 31 May 1993. See also: Gene Pharming Europe B.V. and DLO-Instituut voor 
Veeteeltkundig Onderzœk (IVO-DLO) (1993) Overzichtsnotitie van een experiment inzake genetische 
modificatie ten behoeve van de produktie van lactoferrine en lysozyme in de melkklier. Project P796 
('Weefselspecifieke expressie van genen in de melkklier van genetische gemodificeerde runderen'). 
[Overview memorandum of an experiment concerning genetic modification for producing lactoferrrin 
and lysozyme in the mammal gland. Project P796 ('Tissue specific expression of genes in the 
mammal gland of genetically modified cattle')]. Supplement to a letter of the Minister of Agriculture, 
Nature Management and Fisheries to the Chairman of the Permanent Committee on Agriculture and 
Nature Management of the Second House of Parliament, dated April 5 1993 
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Grown up cattle do not seem to have health or welfare problems, which implies that 
the gene for lactoferrin production does not affect the animal in a harmful way. The 
Dierenbescherming, however, stresses that the problems around birth are ignored and 
that only the effects on healthy animals are taken into account. 
The campaign 2 
1994 is started with a poster campaign by the Dierenbescherming5 3. The most striking 
of these posters shows a breast-feeding mother with cows' udders, saying 'NEW. 
Mothers' milk from cows!'. This campaign is meant to encourage discussion. Which 
it does, as the letters to the editor in the newspapers reveal. But it causes another kind 
of discussion than the Dierenbescherming expected5 4. People are shocked. They write 
that the poster is disgusting, or disrespectful to women, or mocking God's Creation, 
or an insult to biologists. And, it is called demagogic and misleading. Some people 
even complain at the Advertising Code Foundation 5 5. This complaint will not be 
granted, however. 
A loan ofDfl 20 million 
Gene Pharming has asked the Ministry of Economic Affairs for a loan of Dfl 20 
million as to continue its research into cows' milk containing human proteins. This 
loan is granted under the condition that the experiments will be assessed by the 
vCEEGMD 5 6. Gene Pharming does not want its experiments to be assessed and claims 
that it still is not obligatory57. The Minister of Economic Affairs acknowledges that he 
cannot pose conditions yet. As an alternative, he will block the loan until the Royal 
Decree on Animal Biotechnology is approved of. Now Gene Pharming agrees with the 
assessment of its experiments. 
Mothers' milk from cows 
March 1994, Nutricia publishes its plans for a joint venture with Gene Pharming. 
Nutricia wants to use the lactoferrin produced by Gene Pharming in infant formula in 
Algemeen Dagblad / Trouw /Volkskraiit 18 January 1994 
5 4 De Volkskrant 22 January and 29 January 1994, Trouw 25 January, De Telegraaf 27 January 1994 
and 2 February, Parool 3 February 1994 
5 5 Het Parool 19 March 1994 
5 4 De Volkskrant 3 February 1994, Algemeen Dagblad 4 February 1994, Staatscourant 25 February 1994 
5 7 De Volkskrant/NRC 10 February 1994 
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order to make it better resemble to mothers' milk 5 8. This does not cohere with the two 
purposes Gene Pharming has mentioned until now, namely mastitis prevention and 
human pharmaceuticals. The chairperson of the vCEEGMD, Dr. Schroten, assumes 
that Gene Pharming did not mislead the committee, since producing baby food was 
not under discussion in 1992. Gene Pharming states that it certainly is not up to 
produce lactoferrin for baby food, but only for clinical uses, such as food for 
premature babies. Parliament has only granted permission for producing lactoferrin 
as a medicine. A few days later Nutricia claims that the lactoferrin will be used in 
clinical nutrition only that is to say in food to be used under medical supervision5 9. In 
time, however, human lactoferrin and also human lysoizyme might be added to infant 
nutrition as well. For the time being, Nutricia is interested in medical and paramedical 
products only. Gene Pharming mentions some categories of patients that would benefit 
from such products, namely sepsis patients and AIDS patients. 
A discussion arises on whether the addition of lactoferrin and lysozyme to the 
nutrition of these patients will work, since proteins usually denaturalise in the stomach 
of a mature person. This might be different in patients though. 
The Dierenbescherming is warning Nutricia that it takes a commercial risk, since 
people might not be interested in genetically modified baby milk 6 0. In its view, 
Nutricia and Gene Pharming have commercial reasons for developing transgenic cattle 
only, as lactoferrin is not a vital medicine. This implies that the 'no, unless' principle 
is violated. Hence Parliament ought not grant permission. 
Gene Pharming sketches a future in which herds of transgenic cattle will exist that 
produce several kinds of medicine in the milk 6 1. Its activities are directed at the 
production of medicine that cannot be made in an alternative way. For these activities 
government has granted permission. 
Dr. Herman de Boer, who no longer is scientific manager of Gene Pharming, stands 
up for the choices made by Gene Pharming 6 2. He points at the future possibilities of 
this technique, namely the production of human medicine. This is the main purpose 
of Gene Pharming. De Boer he makes a sharp distinction between adding one gene to 
a species and the mixing of species, and concludes that there is no ethical problem at 
hand. He repeats that animal health and welfare always has been and should be a 
condition for creating transgenic animals. Since the products of Gene Pharming will 
arrive in the milk, no negative health and welfare effects are to be expected. 
NRC 25 February 1994 & 26 February, Algemeen Dagblad 26 February & 1 March 
NRC 1 March 1994 
Algemeen Dagblad 11 March 1994 
Algemeen Dagblad 1 April 1994 
Algemeen Dagblad 7 May 1994 
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Secret sponsoring by Nutricia 
June 1994, it transpires that Nutricia has secretly been sponsoring Gene Pharming 6 3 
all the time. Now a crucial period arises for the project, as the production of infant 
formula might have been a major reason for starting the project. Van der Wielen of 
Nutricia, indicates that the only reason for keeping this contract secret has been the 
acquirement of Europeans marketing licenses for proteins obtained from the process. 
At the time, there was no reason to fear public opinion, since he could not imagine any 
objections. After all, the public debate about recombinant DNA had calmed down; the 
project was approved of by the vCOGEM; government was sponsoring the project; 
and the opinion of the Dierenbescherming was not known. 
The Minister claims that he did not know about the contract, but that he can 
understand the secrecy6 4. Dr. L. Layendecker, member of the vCEEGMD, is annoyed, 
since the vCEEGMD should have known about the contract. As we know, the 
vCEEGMD was divided about the project. A small majority agreed because of the 
idealistic objectives of the project. These objectives cannot be matched with the 
production of infant formula. Schroten, chairperson of the vCEEGMD, is still willing 
to defend the decision of the majority of the committee. In his view, the committee did 
have enough information, since it knew that Gene Pharming was seeking finance. 
The Dierenbescherming, supported by the Stichting Natuur en Milieu and the 
Alternatieve Konsumenten Bond 6 5, 6 6, threatens to organise a boycott, if Nutricia does 
not quit the joint venture. Nutricia gives in and postpones the joint venture 6 7. Gene 
Phaiming is annoyed, since it claims that it was always open for debate and has made 
itself vulnerable to criticism. A few days later, Gene Pharming by mouth of 
Hersbach 6 8, states not to agree with the boycott. Hersbach states that he is also glad 
that everything is made public now, which means that it can be discussed. 
Meanwhile the Minister of Agriculture is called to account by Parliament, since 
Nutricia claims that the Minister knew about the sponsoring6 9. So, the Minister might 
have misled Parliament by withholding relevant information. Secretary of State Gabor 
and Minister Bukman answer that they knew about a contract but did know the content 
NRC 2 June. Algemeen Dagblad, Trouw 3 June 1994. See also: NV Verenigde bedrijven Nutricia, 
Gene Pharming Europe B.V. and Genpharm Internationale, INC (1990) Research Agreement 
De Volkskrant 4 June 1994 
Alternative Consumer's Union 
Algemeen Dagblad, De Volkskrant 7 June 1994 
NRC, Trouw, Algemeen Dagblad 10 June 1994 
Trouw 16 June 1994 
Algemeen Dagblad 11 June 1994 
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of this contract7 0. After all, in the contract of Gene Pharming and ID-DLO only 
biomedical purposes were mentioned, and only these purposes were approved of. 
Gabor claims to be shocked about the content of the contract and argues that he should 
have been informed actively by Gene Pharming about its content7 1. Minister Bukman 
asks the Government Prosecutor to re-examine the contract of the Ministry (i.e. DLO) 
and Gene Pharming, since he prefers the contract to be ended 7 2. A few weeks later it 
turns out that it will not be possible to end the contract. Instead he proposes that the 
project has to be directed at the production of human medicine only. Gene Pharming 
agrees to this condition 7 3. 
Meanwhile the discussion goes on. De Boer, former manager of Gene Pharming, 
explains that the original project had a very broad scope 7 4. The project was meant to 
develop a technique for producing human proteins in cattle. There are many possible 
applications for these proteins. In order to approve of the project the Minister of 
Agriculture asked for a specific application. So, Gene Pharming has chosen one of the 
options for agriculture namely mastitis prevention. Adding lactoferrin to infant 
formula might also be a more specific and realistic application, so a co-operation with 
Nutricia was not foreign to the project. 
Schroten of the vCEEGMD now acknowledges that it would have made a difference 
if this had been known in 1992. The issues now under discussion would have been 
discussed then 7 5. He suggests that the committee might have been more specific in its 
approval. 
Looking back Gene Pharming admits that it ought to have been more open and 
professional in its information supply. 
July, Gene Pharming announces to start new experiments with an improved genetic 
construct7 6. 
Alternatives 
The Kooreman committee publishes its study7 7 into alternative production methods for 
breeding with Herman the bull in June 1994. The purification of lactoferrin out of 
7 0 NRC 16 June 1994 
7 1 De Volkskrant 16 June 1994 
7 2 NRC, Algemeen Dagblad, De Volkskrant, De Telegraaf 17 June 1994 
7 3 NRC, De Telegraaf, Trouw, Algemeen Dagblad, De Volkskrant 29 June 1994 
7 4 De Volkskrant 18 June 1994 
7 5 Ibidem 
7 6 De Volkskrant 31 June 1994 
7 7 De Volkskrant 25 June 1994 and NRC 18 July 1996. See also: H.J. Kooreman, D.D. Breimer, W.P.M. 
Hoekstra and A. Bekkers (1994) Technische studie naar alternatieve mogelijkheden voor de produktie 
van humaan lactoferrine. In opdracht van het Ministerie van Landbouw, Natuurbeheer en Visserij 
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mothers' milk does not seem a reasonable alternative, since there is not enough 
mothers' milk available. The production of lactoferrin in transgenic fungi will lead to 
a sufficient quantity and a reasonable price. But, lactoferrin from fungi and lactoferrin 
from cattle will not be identical, so their effects have to be tested clinically in order 
to make qan adequate comparison. Therefore the committee advises to continue the 
experiment as to be able to make such a comparison. 
The Dierenbescherming is furious, since this will make a fake out of the 'no, unless' 
principle. The Minister, however, follows the advice of the committee. 
The 'Besluit Biotechnologie' 
A concept of a Royal Decree on animal biotechnology, called 'Besluit 
Biotechnologie', is released in October 1994 7 8. This 'Besluit' is directed at the 
implementation of the 'no, unless' policy that is agreed upon in the Animal Health and 
Welfare Act. The approval of this 'Besluit' will make all biotechnological research in 
animals in need of a license. 
A year later the Royal Dutch Academy of Sciences (KNAW) 7 9 reacts to this proposal 8 0 
and advises to exclude mice, rats, and other rodents from the Decree. It argues that this 
Decree will make Dutch regulation too extreme compared to other countries, since it 
will require an extra assessment. All animal experiments are already under strong 
supervision of an animal experimentation committee and the COGEM already assesses 
the risks of every genetic modification of organisms. The KNAW does not fear 
rejection, but delay, which might slow down medical research. In its view, the Decree 
is developed to regulate experiments with production-animals like Herman the bull 
and his descendants that will produce medicine. It should not be applied to laboratory-
animals that are used for medical research. Several researchers81 also question the 'no, 
[Technical study into alternatives for the production of humane lactoferrin. By order of the Ministry 
of Agriculture, Nature Management, and Fisheries.]. Two other reports on alternatives are published 
at the same time, namely: L. Fretz and J. Vorstenbosch (1994) Reëel, rationeel en redelijk. Een 
onderzoek naar normatieve wagen rond alternatieven voor transgenese bij dieren. In opdracht van 
het Ministerie van Landbouw, Natuurbeheer en Visserij. [Realistic, rational and reasonable. An 
investigation into the normative questions concerning alternatives for transgenesis in animals. By 
order of the Ministry of Agriculture, Nature Management, and Fisheries]. Amersfoort/Utrecht, and 
Voorlopige Commissie Ethische Toetsing Genetische Modificatie van Dieren (1994) Discussienota 
'Alternatieven '. De beoordeling van mogelijke alternatieven in het kader van de ethische evaluatie 
van transgenese bij dieren. ['Alternatives'. The assessment of possible alternatives as part of the 
ethical evaluation of transgenesis in animals.] 
8 Staatscourant 3 October 1994 
9 Supported by 13 other organisations such as biomedical funds and patients' organisations 
0 De Volkskrant 30 November 1995 and 37 January 1996 
1 NRC 4 April 1996 
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unless' principle and the concept of intrinsic value that supports is principle. In their 
view, the concept of intrinsic value is too vague. Gene Pharming supports this view 
and adds that the harming of animal health and welfare ought to be a restriction in the 
context of a 'yes, i f policy*2. 
The Dierenbescherming 8 3 does not agree with making an exception for laboratory 
animals8 4. It does not see any difference between laboratory animals and other animals. 
Respect should be paid to all animals, which also is the meaning of the concept of 
intrinsic value. The Dierenbescherming suggests that a fear for delay be exaggerated. 
And it points at the outcomes of a NIPO questionnaire. This questionnaire reveals that 
changing the genome of animal is controversial. And it reveals that about half of the 
Dutchmen do not favour any kind of animal biotechnology, not even in the case of 
medical research. 
Parliament is divided. The PvdA agrees with the arguments provided by the KNAW; 
CDA, D66, and Groenlinks do not want to make an exception for rats and mice 8 5. The 
Minister explains that he does not know how to balance a careful assessment and a 
hampering progress in research. 
The Dierenbescherming suggests a possible breakthrough. It suggests that after a 
while, when the effects of the experiments are better known, certain groups of 
experiments might follow a more mild procedure or might only be assessed 
afterwards. From the side of the researchers8 6 it is suggested to have projects assessed 
instead of each single experiment that comes under a project. This would imply that 
the 'no, unless' principle will be uphold, but the procedure shortened. The Minister 
initiates a consultation of the organisations involved8 7. November 1996, the council 
of Ministers affirms the 'Besluit Biotechnologie', motivating that only those 
experiments should be allowed that are ethically sound 8 8. A Committee on 
Biotechnology in Animals, again chaired by Dr. Schroten, will be installed to advise 
the Minister about the licenses. 
Further developments 
In the middle of 1996, the experiment with Herman the bull and his daughters will be 
ended, which means that the animals have to be killed as was agreed upon in 
De Volkskrant 27 January 1996 
Supported by the Stichting Natuur en Milieu and the Alternatieve Konsumenten Bond, 
Ibidem and NRC 4 April 1996 
Trouw, de Volkskrant 2 February 1996 
Ibidem, NRC 4 April 1996 
Ibidem 
NRC 30 November 1996 and de Volkskrant 12 April 1997 
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Parliament. Gene Pharming does not want Herman to be killed, as many people are 
interested in Herman. Every visitor of the firm wants to see the bull 8 9. The Minister 
gives permission to keep the bull alive on condition of Herman being castrated as to 
prevent him from breeding 9 0. The attraction park 'Het Land van Ooit' ['Everland'] 
proposes to buy the bull as to make him the centre of an educational exhibition, but 
this suggestion is not met by Gene Pharming 9 1. 
Several biochemical companies, such as Gist-Brocades and Organon, are openly 
choosing for producing human proteins by way of micro-organisms or tissue culture9 2. 
Organon even states that it prefers tissue culture because of the public controversy 
about Herman the bull. 
In a background article in the NRC, it is suggested that pressure groups have become 
a business risk, since they can influence the behaviour of consumers 9 3. The relation of 
Nutricia and the Dierenbescherming is mentioned as an example. 
Dutch government makes known that the KNAW and other societal organisations will 
be asked to be more involved in ethical and other legislation concerning research than 
before. It wants to prevent uncertainly, confusion and indignation among societal 
organisations, researchers and citizens 9 4. 
Conclusion 
In this chapter, I have summarised the debate about animal transgenesis. In the next 
chapters, I will analyse this debate. In chapter 3,1 will show the internal dynamics of 
the debate. Chapter 4 will discuss the roles of the participants. The content of the 
debate will be analysed in chapters 5 and 6. Chapter 7 will go into the process of 
debating. And I will conclude my findings in chapter 8. 
Volkskrant 27 January 1996 
NRC 22 June 1996 and De Volkskrant 8 February 1997 
NRC 22 June 1996 
NRC 18 July 1996 
NRC 5 September 1996 
NRC 17 September 1996 
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3. How the debate has proceeded 
The media debate on animal transgenesis has taken some nine years. It started in 
March 1989 with the announcement of the intention of Gene Pharming to create 
transgenic cattle. And it vanished from the newspapers in 1997. From 1997 onwards 
other aspects of animal biotechnology were publicly discussed. 
In this chapter, I will investigate why the debate has proceeded as it proceeded. For 
this, I will analyse the structure and the internal dynamics of this debate. A debate in 
the media proceeds differently from other debates, as for the media topicality is a 
major reason for publishing about an issue. It will be possible to distinguish several 
episodes. Periods in which hardly any articles were published on the matter are 
followed by episodes in which a substantial number of articles appeared. In each 
episode one or several aspects of animal transgenesis will be discussed. These 
episodes, the aspects that have initiated these episodes, and the development over time 
of the debate will be central to this chapter. 
Rounds of discussion 
Some 300 articles concerning animal transgenesis were collected from the six national 
newspapers. 
These articles had to be transcribed into a manageable format, so as to provide an 
insight into the debate. Matthias Kettner has been of great help in finding a way of 
handling the material. As arguments are crucial in every debate, these were taken as 
a starting point. This has led to the following transcription mode: Actors put forward 
arguments (reasons) to explain a position. A position is taken with respect to a subject. 
In the transcription, every reason or line of reasoning has been codified as a reason 
given by a certain participant to defend a position regarding an issue. So: reasons or 
lines of reasoning (R) are used by an actor (A) to defend a position (P) with respect 
to an issue (I). In supplement 2, an example is given of an article that has been 
codified according to this method. This transcribed material has been used for writing 
this book. 
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In figure 3.1,1 have plotted the distribution of the articles over time. I have chosen for 
a monthly distribution. A distribution over years or trimesters does not differentiate 
enough; a distribution over weeks or days does not provide additional information. 
The articles did not appear evenly distributed over time, but in more or less 
distinguishable episodes concentrated in relatively short periods of time as can be 
concluded from the distribution of the articles over time. The figure shows ten peaks 
in the number of publications, to wit: 1) March/April 1989, 2) May 1990, 3) 
December 1990, 4) May 1991, 5) August 1991, 6) December 1992, 7) April/May 
1993, 8) January/February 1994, 9) June 1994 and 10) September 1994. After this last 
peak, no further peaks arise, but a continuous number of articles occurs (11). From 
May 1997 
onwards, no further articles were collected, since by then the emphasis in the debate 
on animal biotechnology had shifted from animal transgenesis to the cloning of 
animals. 
Each peak signifies an episode in the debate. An episode defined by such a climax will 
be called a round of discussion. The ten peaks therefore mark ten rounds of the debate. 
The steady stream of articles from 1995 onwards does not have a climax and can, 
strictly taken, not be called a round in the sense I have just defined. Most articles in 
this period address subjects that have been discussed before or that are relevant to the 
debate as a whole. These articles will be clustered in what will be called round 11 in 
order to have a means to address these articles together. 
In each round one or several aspects of animal transgenesis or of the doings of the 
participants was discussed. A closer look at the eleven rounds of the debate reveals 
that most rounds have a demonstrable beginning and end: 
1. March/Apr. '89 A press release of Gene Pharming announces its intention to 
create transgenic cattle (9 March). This announcement gives rise 
to a turn in the discussion in Parliament about the Animal Health 
and Welfare Act (AHWA). Last report 27 April. 
2. May 1990 The advise of the ministerial advisory Committee on Ethics and 
Biotechnology in Animals (CEBD) is published (10 May) and 
discussed (until 19 May) 1 . In October, this discussion has a 
Commissie van Advies Ethiek en Biotechnologie bij Dieren (1990) Rapport van de Commissie van 
Advies Ethiek en Biotechnologie bij Dieren. [Report of the Advisory Committee Ethics and 
Biotechnology in Animals] NRLO. Wageningen. 
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small train as Parliament agrees that the Minister should 
incorporate the suggestions of the CEBD in the AHWA. 
3. December 1990 The first calf is born. It is said to have a genetic resistance against 
mastitis, an udder-infection (5 December). Background articles 
and interviews appear, and the first letter to the editor is 
published (5 January). Even Queen Beatrix addresses these new 
biotechnological techniques in her Christmas Speech. 
4. May 1991 Some background articles are preluding the parliamentary 
discussion about the handling of animal biotechnology in the 
AHWA (17 April). The papers concentrate on whether human 
genes were used by Gene Pharming and whether it is allowed to 
use such genes, and on what should be done with the non-
transgenic calves. The AHWA is accepted and the 
Dierenbescherming expresses its satisfaction (1 June). 
5. August 1991 The results of the investigation of the health and welfare of the 
animals are made public (6 August) and discussed till 26 
September. 
6. December 1992 The request of Gene Pharming to breed with Herman-the-bull 
starts a discussion about the continuation of the project (31 
October). And the Dierenbescherming starts a campaign against 
animal biotechnology. Many background and opinion page 
articles appear. Parliament deliberates and decides in favour of 
the project (19 December), but the discussion in the newspapers 
does not stop before 4 February. 
7. April/May 1993 The Dierenbescherming goes to court (30 January) in order to 
stop breeding with Herman the bull. The judge does not meet the 
demand which gives rise to some reactions in the newspapers 
(12 May). 
8. January/Feb. '94 The Dierenbescherming intensifies its campaign amongst others 
by distributing a confronting poster showing a breastfeeding 
woman with udders. This poster gives rise to many reactions (18 
January). This round ends with the judgement of the Advertising 
Code Foundation that the poster is not considered misleading 
(19 March). 
9. June 1994 Nutricia and Gene Pharming Europe start of a joint venture (25 
February). The objective of this co-operation, to wit the use 
transgenic cattle for producing infant formula ('mothers' milk 
from cows'), gives rise to much discussion. It turns out that 
Nutricia has been sponsoring Gene Pharming all along (2 June), 
and a few days later that the Minister was informed, but 
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Parliament was not. After much discussion the Minister allows 
the project to continue conditionally (30 June). 
10. September '94 Gene Pharming wants to end the contract with the Ministry of 
Agriculture, Nature Management and Fisheries (15 September). 
The Minister agrees conditionally (7 December). 
11. 1994 to 1997 During these 3 years much was reported about the doings of 
Gene Pharming and the developments in the 'Herman project'. 
Discussion arises about the Royal Decree on animal 
biotechnology that has implement the AHWA (3 October 1994). 
The Decree is accepted in April 1997. 
The rounds of discussion have a well-defined start. Three times a development in the 
project of Gene Pharming has started a round of discussion (1, 3, and 6). The results 
of a report that was asked for by the Minister started a new round two times (2 and 5). 
Two rounds were initiated by a parliamentary debate about the (implementation of 
the) AHWA (4 and 11). Two times, it was action undertaken by the 
Dierenbescherming (7 and 8). Another two times a discussion started about the 
collaboration of Gene Pharming with Nutricia and with the Ministry of Agriculture 
successively (9 and 10). 
Most rounds also have a well-demarcated closing. Six rounds ended with either a 
report on a parliamentary discussion (1, 6) or a political decision (4, 9 ,10, 11). One 
round ended with a juridical verdict (7) and another one with a judgement by the 
Advertising Code Foundation (8). The other rounds just ended. (2, 3, 5). The second 
round had a definite closing a few months after the parliamentary debate, namely with 
a parliamentary decision. 
This means that the debate as it has proceeded in the newspapers did not just happen 
to come into distinguishable episodes. New impulses caused new rounds of 
discussion. Each round ended after a relatively short period. And ending most of the 
times really means ending, since an episode really was closed and there were no 
developments to report. Only a new impulse could inject new life into the debate. This 
has happened ten times. 
I suppose that this pattern is typical for a media debate. Scientific and policy-making 
debates have a much more regular pattern and much more continuity. And 
parliamentary debate has its own dynamics, which, as we just saw, affects the debate 
in the media. 
At this point, it becomes interesting what sorts of impulses have caused the debate to 
be reopened. What can be detected from the brief explanation of the rounds that I have 
given above is that in most rounds a new aspect of the debate has been discussed and 
that as the debate continued also the activities of the different actors have become 
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subject of the discussion. In the next section, these aspects will be reconstructed in 
more detail as issues of the debate. 
Issues 
A round of discussion not only has a demonstrable beginning and end, it also has a 
topic that is discussed. Some of these topics return in almost each round, but in many 
rounds a new aspect of the project is discussed as well. 16 different issues were 
distinguished, to wit: 
1. Should transgenic animals be made at all? 
2. How should the Animal Health and Welfare Act (AHWA) handle animal 
biotechnology? 
3. Should transgenic cattle be made for producing 'mothers' milk"? 
4. Should they be made for producing valuable/medical proteins (such as 
lactoferrin)? 
5. Is it a good idea to make transgenic cattle with an inherent resistance against 
mastitis? 
6. Is it admissible to make transgenic cattle with a 'human' gene? 
7. Should the project of Gene Pharming (further experiments) continue? 
8. Should it be allowed to abort or sell of the non-transgenic calves? 
9. Are animal health and welfare harmed and what consequences should this have? 
10. Should be bred with Herman the bull? 
11. How to value the campaign of the Dierenbescherming? 
12. Is a joint venture of Gene Pharming and Nutricia desirable? 
13. How to deal with the secret contract of Gene Pharming and Nutricia of 1990? 
14. What should be the consequences for the involvement of the Minister of 
Agriculture? 
15. Should the contract of Gene Pharming with the governmental research institution 
ID-DLO be continued? 
16. What should the Royal Decree on Animal Biotechnology do? 
In figure 3.2, the issues are plotted against the subsequent rounds of the discussion. 
The table shows that in almost each subsequent round of the debate one or several new 
aspects of animal transgenesis were discussed. At the start of the debate the discussion 
has focussed on different aspects of content. At the end of the debate, the activities of 
the main participants became the main theme of the debate. These discussions did not 
so much concern the content of the debate as the process of debating. 
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Two issues returned in almost each round of the discussion, to wit animal transgenesis 
in general and legislation. The other substantive issues were clustered around these 
central issues. 
Figure 3.2: The number o f articles in which an issue is discussed in each round per round of 
the discussion. (The issues discussed the most in each round are plotted boldly.) 
issues subsequent 
rounds 
1 2 3 4 5 6 7 8 9 10 11 tot 
1. Should transgenic animals be 
made? 
7 6 14 4 3 20 8 1 1 2 6 78 
2. Should the AHWA include 
licensing of biotechnology? 
8 11 2 12 3 5 4 2 47 
3. Should 'mothers'milk'be 
produced? 
1 1 3 1 13 19 
4. Should valuable/medical 
proteins be produced? 
1 1 1 8 4 13 2 30 
5. Should cattle be made resistant 
against mastitis? 
17 4 3 1 25 
6. Should human genes be used? 16 1 3 20 
7. Should Gene Pharming continue 
its experiments? 
1 3 4 5 3 1 4 21 
8. What to do with the non-
transgenic calves? 
11 11 
9. How to handle animal health 
and welfare? 
10 3 3 7 23 
10. Should be bred with Herman 
the bull? 
23 12 10 2 7 54 
11. How to value the campaign of 
the Dierenbescherming? 
4 2 15 6 1 1 29 
12. Is the joint venture with 
Nutricia desirable? 
16 2 18 
13. How to deal with the secret 
contract with Nutricia? 
18 18 
14. Did the Min. of Agriculture 
handle this issue well? 
14 14 
15. Should the contract with the 
Min. of Agriculture be 
continued? 
1 11 12 
16. What should the Decree on 
Animal Biotech, regulate? 
3 8 11 
total 17 17 34 48 21 66 41 22 104 19 39 
Discussions about animal transgenesis in general were almost each time triggered by 
a development in or a result of the project of Gene Pharming. The first round was 
triggered by the announcement of the project; the third round started with the birth of 
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a transgenic calf and the sixth round began with a request for a license to breed with 
the transgenic bull Herman. The seventh round can be seen as an extension of the 
sixth, since the license granted by Parliament was discussed before a court of law. 
Specific aspects of animal transgenesis were discussed in rounds 3, 4, 5, 6, 7, and 9, 
to wit issues regarding the purpose and the implications of changing the genetic make 
up of the animals. The project of Gene Pharming, and in particular the 'Herman' case, 
has served as a case to sharpen people's opinions and wills. 
The other substantive theme concerns legislation. An Animal Health and Welfare Act 
(AHWA) was already in preparation for several years at the time the debate started. 
The announcement of the project of Gene Pharming happened to coincide with a 
discussion in Parliament on this bill. The announcement by Gene Pharming implied 
a development in the use of animals. This means that the AHWA in preparation had 
to be extended to animal biotechnology. In the first round, it was discussed how 
animal biotechnology had to be incorporated in the AHWA. A committee was 
installed to advise about the incorporation of animal transgenesis in this act. The 
advice was released and discussed in the second round of the debate. This advice was 
incorporated in the Animal Health and Welfare Act that was decided on in the fourth 
round. A Royal Decree regarding the implementation of the AHWA was discussed 
and decided on in the eleventh round. 
This means that what at first sight seemed to be a single public debate on animal 
transgenesis, was in fact two debates, namely one on animal transgenesis and one on 
the legislation regarding animal health and welfare. The last debate obviously had a 
much broader scope than the first one, but during this period animal transgenesis, and 
in particular the Herman case, has been the focus of the discussion on the animal 
welfare legislation as well. 
The activities of the diverse participants discussed in rounds 8, 9, and 10 can be 
viewed as a third, non-substantive theme in the debate. Here the discussions were not 
directed at the production of arguments concerning one of the substantive themes, but 
at the process of debating itself. It is evident that such a debate on the debate can only 
emerge after a debate has been going on for a while, since only by then will motives 
as well as activities of the participants have become clear. 
In the next three sections, I will reconstruct the two substantive debates distinguished 
as well as the meta-debate on the process of debating 2. Hereafter, I will resume the 
questions regarding the continuity and discontinuity of the debate. 
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Animal transgenesis 
The central case in the debate on animal transgenesis was the project of Gene 
Pharming to change the genetic make up of cattle in order to produce specific proteins 
in the milk, and in particular the Herman project, that aimed at the production of 
lactoferrin in cattle milk. Other reasons for genetically modifying animals, such as 
biomedical research, were hardly mentioned. 
The announcement by Gene Pharming of being up to change the genetic code of 
animals as to produce specific proteins in the milk started the debate. No specific 
reason was mentioned for making transgenic animals, although a number of 
possibilities were mentioned. The discussion concentrated on concerns about the 
making of transgenic animals (issue 1). Many contributors to the debate were 
convinced that animal transgenesis was morally problematic. It should be noted that 
most contributors did not simply oppose this technology. Most of them did not yet 
take position, but were delving for reasons. They wanted to critically review reasons 
pro and contra this new technology. At first, even the Dierenbescherming shared this 
attitude, but not for long. Shortly after the start of the debate the Dierenbescherming 
revealed itself as the main opponent of animal transgenesis, arguing that animal 
biotechnology is incompatible with respect for the intrinsic value of animals. 
After the first calf3 was bora in December 1990, the debate entered the third round. 
Again, it was stressed that animal biotechnology is morally problematic (issue 1), the 
arguments, however, were much more specific now. It was argued that animal 
biotechnology does not respect nature and life, and more in particular that it does not 
respect the integrity and therefore the intrinsic value of the animals. And it was 
stressed that animal transgenesis is not in harmony with God's creation. Others, 
however, argued that genetic engineering is in line with traditional breeding and 
therefore nothing morally new. Furthermore, people started to make a difference 
between 'new' animals (chimeras) that should not be made and minor changes for 
good reasons that are open for debate. The birth of the calf brought about a discussion 
on such reasons. It was questioned whether mastitis prevention is a sufficient reason 
for making such an animal (issue 4). And the question was raised whether there were 
alternative means for solving the incidence of this udder infection. It also was 
discussed whether an increase of productivity (which is seen as one of the causes of 
mastitis) was a compelling reason for making transgenic animals. 
2 I will analyse these sub-debates in the chapter 5, 6 and 7. 
3 This first calf is not the bull-calf Herman, but a female calf that proved not be transgenic after all. 
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In the fourth round of the debate two issues were discussed, namely whether the gene 
used was of human origin (issue 6) and what should be done with the redundant 
animals (issue 8). 
It was realised that the gene inserted in the animals might be of human origin, as 
human lactoferrin would be produced. If this were true, the animal created would be 
a mixture of an animal and a human, which was thought to constitute an independent 
moral problem by a substantial part of the parliamentarians. This resulted in a 
technical discussion on whether the gene used could be understood as a human gene 
or not. The result of this minor debate was twofold. Firstly, the insertion of properties 
of one species into another species was not objected by a majority in Parliament as 
long as minor changes of the genome were concerned. And secondly, Parliament was 
in agreement on the prohibition of the insertion of human DNA in animals. 
The other issue discussed in the fourth round was about the non-transgenic foetuses. 
Gene Pharming had requested the Minister to be allowed to sell the cows-in-calf, as 
the calves were too expensive to raise. This request was not granted for two reasons. 
Parliament did not want to take the risk of 'material' out of the experiment being 
mixed with the normal livestock. The other reason only applied to this experiment, 
since it was agreed upon that the effects on the health and welfare of the calves had 
to be measured. Therefore the calves, including the non-transgenic ones, should 
remain in the experiment. 
In the fifth round, an outline of the first report on the effects on the health and welfare 
of the animals was published (issue 9). The Minister concluded that the calves that 
survived the experiment were in good health, which meant that the experiment could 
continue. The Dierenbescherming disagreed with this conclusion, since more calves 
than on average had died before or during birth, and there were many delivery 
problems. This controversy remained unsolved. 
This discussion in a way repeated itself in the last (eleventh) round of the debate. 
Then, the discussion was between the Dierenbescherming and Herman de Boer, by 
then former manager of Gene Pharming. De Boer had always stated that no harm 
should be done to the animals and he has claimed to act accordingly. The 
Dierenbescherming, however, accused him of not being consistent, for reason of not 
taking into account all harm that is done during the process of making transgenic 
animals. 
The debate on animal transgenesis has culminated around the question whether 
breeding with Herman the bull should be allowed or not (issue 10) in the sixth round. 
The reason for making these animals and whether harm was to be expected were 
49 
central to this discussion. The controversy revealed itself in the dual advice 4 of the 
advisory Committee Ethical Assessment Genetic Modification of Animals. A majority 
argued that human medicine might become available (issue 3), without harm being 
done to the animals. The minority argued that the 'integrity' of the animals will be 
affected and that harm might be done, while no convincing reasons for the 
continuation of the project were mentioned and alternative production methods were 
not investigated. Here a new aspect entered the debate, namely that the recognition of 
the intrinsic value of animals implies that alternative production methods should be 
investigated seriously. A majority in Parliament agreed with the majority of the 
committee and granted the license. So, short term purposes were not decisive, but the 
opportunities that might become available in time. A restriction is added, however, 
namely that as soon as an alternative becomes available this alternative will be 
preferred and the project ended. A substantial minority in Parliament were of the 
opinion that alternative production methods should be investigated first. So, medicine 
that might be produced in the future have been decisive for allowing Herman to have 
offspring. 
The Dierenbescherming, together with the Nature and Environment Foundation, even 
went to Court to enforce an investigation into alternatives before a license would be 
granted, but lost the trial (the seventh round). 
In 1994, it was made known that Nutricia would enter a co-operation with Gene 
Pharming (ninth round). This caused a discussion on the 'real' purpose of the project: 
medicine or infant formula? Nutricia explained that it wanted to develop infant 
formula which would resemble mothers' milk as best as possible. This purpose was 
broadly considered a commercial reason, and therefore not a satisfactory reason for 
creating transgenic animals. A week later, Gene Pharming and Nutricia both stated 
that they were not aiming at ordinary infant formula, but at the production of clinical 
food (food for patients). This caused a technical discussion on whether lactoferrin in 
clinical food might be of help for these patients, which did not come to a conclusion. 
But the project was allowed to continue for reason of the expectation that human 
medicine might become available in time. The Dierenbescherming expressed its 
distrust in the motives of Gene Pharming and Nutricia. 
In chapters 5 and 6,1 will further analyse the content of the debate. 
4 Voorlopige Commissie Ethische Toetsing Genetische Modificatie van Dieren (1992) Advies inzake 
het dossier "Weefselspecifleke expressie van genen in de melkklier van genetisch gemodificeerde 
runderen " [Advice concerning 'Tissue-specific expression of genes in the mammary gland of 
genetically modified cattle']. Supplement added to a letter by the Minister of Agriculture, Nature 
Management and Fisheries to the President of the Permanent Committee on Agriculture and Nature 
Management of the Second House of Parliament, dated October 28 1992. 
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Legislation 
The second debate that can be distinguished concerns legislation. The first Dutch act 
against the maltreatment of animals dates from 1886. This law did not come about 
because maltreatment causes animal suffering, but because people could not stand this 
maltreatment and were pitying the animals (maltreatment was seen as an indecency). 
Only in the renewal of this act in 1961 was the focus directed at the animals 
themselves. Under the new act hurting or harassing animals 'without reasonable 
purpose or when exceeding what would be necessary for achieving the purpose' was 
punishable. This act still concerned animal health only. At the end of the sixties and 
with the rise of intensive farming people started to question how animals were kept. 
It was argued that there is more about animals than their usefulness. Animal welfare 
became an issue and the Minster of Agriculture, Nature management and Fisheries 
started the procedure to arrive at a new Act, the Animal Health and Welfare Act 
(AHWA). 
A Parliamentary debate about this Animal Health and Welfare Act coincided with the 
announcement of Gene Pharming's plan for creating transgenic cattle. A discussion 
emerged on how animal biotechnology should be incorporated into this Act {the first 
round). The Dierenbescherming always had advocated that a 'no, unless there are 
good reasons for doing so' policy principle should be the operative principle of the 
Act. The proposed act had as its leading principle a 'yes, if a certain set of conditions 
is fulfilled' policy, which would mean that animal transgenesis would only be 
restricted instead of licensed. Now Parliament argued that such a limited list of 
conditions would not be adequate for this rapidly developing technology, and so 
suggested that a 'no, unless' policy principle would be more adequate as the operative 
principle of the AHWA The Minister installed a committee to prepare an advice about 
animal biotechnology. 
After a year the provisional Advisory Committee on Ethics and Biotechnology in 
Animals (Schroten 1) published its report (the second round). According to the 
committee, the use of the recombinant DNA techniques in animals (the making of 
transgenic animals) is morally problematic. Therefore, a 'no, unless' policy principle 
should be adopted; all applications of this technology should be reviewed; an advisory 
council be installed; and ethical assessment stimulated. Five months later Parliament 
adopts the 'no, unless' policy. 
In the spring of 1992, the final version of the AHWA is accepted in Parliament (the 
fourth round). As this law is only enabling legislation, implementation orders (called 
Royal Decrees) are needed to specify the general directions of the Act for specific 
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problem areas. Parliament argued that animal biotechnology should be licensed and 
that a Royal Decree be made. Governmental research institutions already were in need 
of a license 5. Only one person publicly expressed bis worries about this development, 
namely Professor Piet Borst. He argued that experiments with transgenic animals are 
of eminent importance for medical research, that this technique is indispensable to 
medical biology, and that human medicine will be obtained more cheaply and more 
easily. Furthermore, he states that all animal experiments are already reviewed by 
animal experimentation committees. 
The publication of the concept of a Royal Decree, called 'Besluit Biotechnologie', 
opened the last round of the debate in October 1994. The 'Besluit' would make all 
biotechnological research in need of a license. The Royal Dutch Academy of Sciences 
(KNAW), supported by 13 medical organisations and funds, questioned this 'Besluit'. 
It argued that Dutch regulation will be too strong compared to other countries; that all 
animal experiments are already under strong supervision; and that an extra assessment 
procedure would be too time-consuming and would therefore hamper medical 
research. They were in favour of a conditional allowance (a 'yes, i f policy) for 
laboratory animals like rodents, and the licensing of other uses of animals according 
to the 'no, unless' policy. The Dierenbescherming reacted that it is not proper to 
differentiate among species. Parliament was divided and the Minister indecisive. The 
Dierenbescherming was the first who publicly created a possible breakthrough. It 
suggested that in time, when the effects of the experiments would be better known, 
certain groups of experiments might follow a more mild procedure or might even be 
assessed afterwards. Researchers suggested a shortening of the procedure as a way 
out. Both suggestions refer to the implementation of the 'Besluit', so the Minister 
advises to affirm the 'Besluit Biotechnologie' as it is, since only experiments that are 
ethically sound should be allowed. A Committee on Biotechnology in Animals was 
installed to execute the assessment procedure. 
Most remarkable of this second theme is that the most influential decisions regarding 
legislation were taken in the first two rounds of the debate. The direction chosen in 
these episodes has guided future actions of the Minister as well as of the political 
parties. To be able to control this new technology, animal biotechnology should not 
be restricted, but licensed, because licensing means that every development has to be 
assessed carefully, while familiar experiments can be assessed in a more mild 
procedure or even afterwards. 
5 For breeding with Herman the bull, for instance, a license was needed because ID-DLO was involved 
in the project. The discussion about this license has taken place in rounds 6 and 7 of the debate. 
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Participants 
Later in the debate, the main participants became subjects of debate themselves. The 
Dierenbescherming was the first to be criticised after the intensification of its 
campaign against animal biotechnology (the eighth round). Many people wrote a letter 
to editor right after the release of a poster showing a breastfeeding mother with cows' 
udders all over the country. This poster was called disgusting, disrespectful, offending, 
insulting, demagogic, and misleading. This last accusation was even brought before 
the Advertising Code Foundation, that, however, did not consider the poster 
misleading in its message. The Dierenbescherming explained that the campaign was 
meant to encourage discussion and accused, in its turn, Gene Pharming of not being 
clear about its reasons for making transgenic animals. The discussion regarding this 
issue was almost completely limited to this specific round. 
Gene Pharming, Nutricia, and the Minister of Agriculture were disputed in the ninth 
round. The publication of the joint venture of Gene Pharming with Nutricia gave rise 
to questions regarding the real intentions of Gene Pharming, as Nutricia explained that 
it wanted to produce infant formula that better resembles mother's milk. Shortly 
thereafter, it turned out that Nutricia had been sponsoring Gene Pharming from the 
very beginning of the project 6, which was kept secret for competitive reasons. The 
question was raised whether Gene Pharming had misled the Government and 
Parliament. Gene Pharming replied that it did not want to produce lactoferrin for 
infant formula, but only for uses in clinical food, another branch of Nutricia's 
activities. The Dierenbescherming reacted that baby food must have been the real 
purpose of the project all along, since this is where the money is. And it argued that 
the project now is in conflict with the permission granted by Parliament. Nutricia is 
threatened with a boycott. Herman de Boer, by now former manager of Gene 
Pharming, responded that the firm is exploring a technique that might in time be used 
for producing medicine. Furthermore, Gene Pharming claims that it had informed the 
Minister about the co-operation with Nutricia. 
Now the Minister of Agriculture had to explain to Parliament why he had withheld 
information (the other issue of this round). Minister Bukman answered that he knew 
about the contract, but that he did not know its content. He had assumed that the 
contract was in line with the contract of the DLO and Gene Pharming. Parliament 
accepted this explanation. 
6 At the start of the project, Gene Pharming mentioned that the changing of the quality of the milk is 
one of the options opened by animal transgenesis. People have not interpreted this option as entering 
the production of infant formula. 
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The tenth round started with the request of Gene Pharrning to break off the contract 
with DLO. Minister van Aartsen, the new Minister of Agriculture, agreed, since he did 
not consider the involvement of government in research activities proper. In his view, 
Government should only be involved in the regulation of research. 
During the eleventh round, the press followed the activities of Gene Pharrning, 
because of the contestability of its projects, but also because of the innovativeness of 
the firm. 
This debate has reconstructed the activities of some of the most important participants. 
In chapter 7,1 will evaluate this process of debating. 
Conclusion. 
What at first sight seemed to be a single debate on animal transgenesis, on close 
inspection turns out to be a more complex debate. Two distinctive debates regarding 
content can be distinguished that are both fed by the activities of Gene Pharrning and 
in particular the Herman project. The first one is a debate on animal transgenesis. This 
debate was triggered by the research project of Gene Pharrning. The second one was 
the discussion about the Animal Health and Welfare Act in which animal 
biotechnology had to be incorporated. It is interesting to recognise the impact of the 
project of Gene Pharrning on both debates. 
The project (as a case) has been a necessary focal point of the debate. This has become 
obvious from the reconstruction of the debate on animal transgenesis in general. Many 
aspects of the case were discussed as the project developed. In discussing these 
aspects, it has become clear how to value and handle cases like this. From the debate 
as it has proceeded, it can be deduced that these substantial aspects only could have 
been discussed on the basis of such a case, since as long as the case was still 
hypothetical only general aspects of animal biotechnology were discussed. Only after 
the birth of the calf and only after each development did a discussion arise in which 
the specific aspect at stake was discussed. The debate has proceeded as commenting 
on the developments in the project of Gene Pharrning ('the urges'). There always is 
a risk, however, that the general question is overlooked because of the attention paid 
to specific aspects of the case. In this case, some people have complained that too 
much attention was paid to side-issues, but hardly anybody has complained that the 
general issues were overlooked. 
So, the case has provided new causes to articulate, to re-evaluate, or to be more 
specific on the reasons pro and con. This means that a theme like animal transgenesis 
cannot be discussed in hot air, but needs substance. Direct causes were needed to 
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make the debate urgent. A public urge is necessary to feed a public debate, but this is 
not enough. Societal organisations are needed to recognise and to articulate these 
urges. Furthermore, the media will have to recognise the news-value of the events. I 
will discuss the actors in the next chapter. 
Not only will a case cause dynamics in the debate, it will also give structure to the 
debate. In the second section ('rounds of discussion'), I have defined a new round of 
the discussion by a peak in the number of articles that appeared in the newspapers. 
From figure 3.2, it can be deduced that most climaxes in the number of articles can be 
explained from new issues appearing in the debate. The developments in the project 
by Gene Pharming are directly linked to one of these new issues. 
The rounds that cannot be directly linked to the project of Gene Pharming are the ones 
that are primarily concerning legislation. The proceeding of the debate on legislation 
had its own dynamics caused by the process of legislation. Nevertheless, the AHWA 
has been deeply influenced by the project. Animal transgenesis, as a development in 
animal biotechnology, has made very clear that a 'yes, if a certain set of conditions in 
fulfilled' policy principle cannot be effective concerning fast developing technologies. 
If such a 'yes, i f principle would be implemented the conditions have to be 
continuously re-adjusted as the technology is developing. This argument provoked the 
incorporation of a 'no, unless there are good reasons to do so' policy principle in the 
AHWA. Developments in the Herman project did cause discussions in Parliament, but 
these discussions did not lead to adaptations in the AHWA. 
In another respect, however, this specific case also has been a limitation to the debate. 
Animal transgenesis in order to produce specific proteins (such as medicine) in the 
milk is just one opportunity opened up by animal transgenesis, which involves only 
few animals if compared to the number of animals used in medical experiments. 
Animal experiments in a medical context have been extraneous to the debate. And 
arguments put forward in order to stress this already existing use of transgenic animals 
by for instance Piet Borst, by some science journalists, and by the KNAW did not 
really become part of the debate. The debate really has been shaped by the project of 
Gene Pharming. This means that the Herman case has not only been illuminating and 
stimulating for the debate, but limiting as well. 
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4. Actors, related debates, and roles 
Many voices were heard during the debate about animal transgenesis. These voices 
will be central to this chapter. I will cluster the contributors to the debate and discuss 
the roles they have taken. 
I will go into some general notions regarding different types of public debates and I 
will discuss the interrelations between these public debates, which will result in a 
discussion about the specific roles of experts, politicians, and expert committees in 
this media debate. The input regarding substance as well as the impact of the 
contributions of the participants will be discussed in the next two chapters. 
Mapping the actors 
Some 300 articles about animal transgenesis were collected from the six national 
newspapers . During the nine years the debate on animal transgenesis has lasted, 136 
persons or organisations were heard. 45 of these contributors were organisations and 
their spokespersons, and 91 were persons or groups of persons who spoke for 
themselves. A complete list of the participants can be found in supplement 3. In figure 
4.1, the actors who have contributed more than once to the debate are listed in order 
of appearance. 
The appearance of new actors on the stage is connected to the development of the 
debate. First, the main participants arrived on the stage, namely Gene Pharming 
Europe and soon thereafter its main partner the ministerial research institution IVO-
DLO (later called ID-DLO) and the Minister of Agriculture, Nature Management and 
Fisheries. This Minister is responsible for the activities of the ministerial research 
institutions, as well as for the preparation and implementation of legislation 
concerning animal biotechnology. 
I speak about voices. This means that all the spokespersons of a particular organisation are counted 
as one voice, namely as the voice of that organisation. 
2 In chapter 3,1 have explained how I have obtained my material and how I have handled it. 
3 This fraction encompasses the non-specified minorities and majorities in parliament or within a 
committee. 
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Participants Round 1 2 3 4 5 6 7 8 9 10 11 tota 
( Articles per round): 12 11 22 20 12 39 57 21 67 19 33 
Gene Pharming 3 5 5 2 7 9 4 20 8 9 72 
Ministry of Agriculture 4 2 1 10 6 9 3 23 14 7 79 
Dierenbescherming 3 6 3 3 2 14 163 7 20 1 7 82 
St. Natuur en Milieu 1 , 1 3 3 1 9 
biotech. researchers 4 3 3 2 6 22 
(part of) Parliament 1 1 1 5 7 1 16 
D66 (liberals) 1 1 9 5 2 1 19 
RPF (small Christian party) 2 4 6 
GrL (green socialists) 2 i 1 9 5 3 . 22 CDA (Christian democrats) 2 2 3 1 5 2 2 17 
PvdA (social democrats) 2 2 1 6 3 2 16 
W D (conservatives) i 2 5 1 . 10 CEBD (Schroten 1) 5 1 5 7 
philosophers and ethicists 1 6 1 5 5 2 6 26 
animal (welfare) scientists 1 1 7 
IVO-DLO (later ID-DLO) 2 1 . 4 
Lekker Dier (Tasty Animal) 3 3 
Queen Beatrix 8 1 9 
SGP (small Christian party) 7 1 1 9 
vCOGEM 3 , 3 
NIABA 2 1 4 
journalists and editors 2 2 2 i 1 6 13 individuals not being experts 2 4 9 2 2 20 
vCEEGMD (Schroten 2) 3 4 3 
1 
6 
patients organisations 2 3 7 
GPV (small Christian party) 3 6 6 
a lay panel 6 
Ministry of Economic Affairs 4 3 1 8 
Nutricia 17 3 20 
Herman de Boer as a person 3 4 7 
SP (socialists) 5 6 
AKB (consumers organisation) 3 3 
Dutch dairy firms 4 4 
KNAW 4 4 
(total of contributions): 26 19 36 59 14 90 5« 26 756 25 5« 
Figure 4.1: The contribution of the diverse participants (including spokespersons) to the diverse rounds 
of discussion. Only the actors who have contributed more than once are listed. (A complete 
list of the actors can be found in supplement 3). 
Then the Dierenbescherming had its first contribution and started to develop itself into 
the main opponent of animal transgenesis. Several times it has spoken in behalf of the 
Stichting Natuur en Milieu [Nature and Environment Foundation] and the Alternative 
Konsumentenbond [Alternative Consumer Foundation] as well. 
Next, the political parties had their say as a discussion in Parliament came about on 
legislation regarding animals, to wit the liberals (D66), the small Christian parties 
(RPF and GPV), left wing environmentalists (GrL), the Christian democrats (CDA), 
the social democrats (PvdA), the conservatives ( W D ) , and the socialists (SP). In the 
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meantime, some experts and interest groups got publicly involved because they were 
asked for their opinion by some journalists. From this moment onwards, they will have 
their share in broadening and deepening the debate by adding new and more 
sophisticated lines of reasoning. The report of the Committee Ethics and 
Biotechnology in Animals (Schroten 1) arrived in 1990. The first letter to the editor, 
written by an ethical expert, was published in December 1990 just after the birth of the 
first calf, so was the first cartoon, the first poem and the Christmas speech of Queen 
Beatrix. From the third year onwards citizens, experts, columnists, journalists et cetera 
have expressed their opinions in opinion page articles, in letters to editor and in 
interviews. 
Only in 1992 did a whole new actor enter the debate, namely the patients' organisation 
of the Rheumatics, who articulated a new, namely the patients, point of view. Shortly 
thereafter, in 1993, also the patients' organisation of the Haemophiliacs spoke up. 
Nutricia was pulled into the debate in 1994 after its co-operation with Gene Pharming 
became public. In 1995, the KNAW [the Royal Dutch Academy for Sciences] stood 
up for the interest of medical progress and Dutch medical research. A number of 
medical trusts and NWO [the Netherlands Research Organisation] supported this 
input. 
The main contributors to the debate 
Figure 4.2, on the next page, shows that Gene Pharming, the Minister of Agriculture, 
the Dierenbescherming; the political parties (incl. Parliament), and Nutricia have 
contributed most frequently to the debate. Patients organisations did not often 
contribute, but their voice was very well heard. Next to these organisations, also three 
groups of relatively independent experts, the advisory committees taken together, 
journalists and editors taken together, and the individual citizens taken together have 
contributed quite frequently to the debate. I have clustered these groups. If I would not 
have done so, I would not have been able to show their input and it would have 
appeared that only organisations had a prominent input in the debate. Grouped 
together, however, the impact of these related individuals can be made visible. I will 
discuss these clusters of individuals briefly. 
First, it should be noted that the three groups of independent experts do not comprise 
the experts working for or speaking for an organisation. These non-independent 
experts have spoken on behalf of their organisations, which means that they did not 
give an independent expert opinion. These experts are assessed as spokespersons of 
their respectively organisations. The relatively independent experts that I have 
clustered in three groups will express their expert opinion. I speak of relatively 
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independent experts as these experts also stand for specific interests that are related 
to their profession, which we will see in this and the next chapters. 
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Figure 4.2: The proportional contribution of the various participants to the subsequent rounds of the 
debate. The length of the bars indicates the number of articles in a particular round. The 
subdivision of the bars represents the relative contribution of the participants to the total of 
the articles. (Note: in one articles several participants may express their views.) 
This is also the reason why I have assessed these experts as representatives of a 
specific scientific or social expertise or interest rather than as citizens, which would 
have been an option as well. These experts can be roughly divided into three groups 
according to their different expertises and scientific or social interests, to wit: 
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• Researchers using or creating transgenic animals, for instance biotechnologists, 
medical researchers and zoo-technologists. Most of these experts have reasoned 
in favour of animal biotechnology, stipulating the expected benefits of the use of 
transgenic animals for, in particular, medical progress. And they have pointed at 
the analogy with animal experiments in which animals are harmed. 
• Animal scientists, like veterinarians and ethologists. They were concerned with 
the welfare of the animals. In several interviews, they were asked for their expert 
opinion regarding the impact of animal transgenesis on animal health and welfare. 
• Animal ethicists and philosophers. Some have developed and/or articulated moral 
standards regarding the use of animals; others have commented on the events and 
the decisions taken. Most of these experts had a double background: they were 
animal veterinarians or biologists as well as philosophers or ethicists. 
Five advisory committees were heard during the debate, to wit the provisional 
Committee Ethics and Biotechnology in Animals (Schroten 1), the provisional 
Committee Ethical Evaluation of Genetic Modification in Animals (Schroten 2), the 
provisional Kooreman Committee, the Committee Genetic Modification, and the 
Committee Biotechnology in Animals. These advisory committees also comprise of 
experts, but these experts fulfil a specific task namely advising of (in this case) the 
Minister of Agriculture, Nature Management and Fisheries or the Minister of Housing, 
Rural Planning, and Environment with respect to some aspect of (animal) 
biotechnology. 
One out of seven voices was a concerned citizen. Each of these citizens spoke up only 
once. Journalists and editors have several times expressed their views. The editors of 
all newspapers have used their editorials once, sometimes twice, to write a comment 
on the debate, mostly on the process of the debate. Some journalists, whose 
background articles were directed at providing reasons pro and con and so expressed 
their responsibility for the quality of the debate, also have expressed their personal 
views in opinion page articles, thereby stressing the arguments they thought 
convincing. These last articles were gathered in the group journalists and editors. 
In figure 4.3, a schematic diagram is made of the main participants of the debate. 
Central to my thesis is the mass-media mediated public debate on animal 
transgenesis, so I made this debate central to the diagram. Here opinions are made 
known tot the broader public, here discussions take place in front of the broader 
public, and here public preferences are formed. The Dierenbescherming, the 
patients' organisations, and the editors and journalists pretend to speak on behalf of 
the public but actually they speak up for specific interests of this public. 
Government has installed the advisory committees. The input of these committees 
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in the debate will usually be a spin-off of this advisory task. The Committee 
Schroten 2 (vCEEGMD), however, explicitly saw it as its task to stimulate public 
debate, which they did by making its dual advice public, allowing its members to 
continue the discussion in the media. 
Figure 4.3: Schematic diagram of the main contributors to the public debate on animal transgenesis. 
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The roles of the participants in comparison to their roles in an organised debate. 
The participants I have distinguished in this debate can also be found in other kinds 
of debates, for instance in organised debates. There is resemblance between an 
organised debate and a spontaneous debate on a public issues, but there are differences 
too. I will start with the similarities. 
Figure 4.4: The distribution of responsibilities over the diverse stakeholders and the accompanying 
roles in a process of stakeholder planning (Source: Vermeulen et al., 1998, page 66; my 
translation ET). 
Categories of players Specific roles in the considerations 
Elected representatives - political initiative 
- consultants during the process 
- final assessment 
- formal decision 
Administrators - commissioning authority 
- directing the process manager 
- consultants during the process with respect to: 
- quality of the input of the particular interests 
- monitoring the accountability 
Experts - knowledge transfer to the participants 
- identification and offering of knowledge gaps and 
uncertainties 
- perform analyses 
Professionals of interest groups - input of perception from the perspective of the particular 
interest 
- input of possible solutions and know-how 
- open attitude 
- roles towards supporters 
- roles in implementation 
(Groups of) individual citizens or - input of subjective valuations and normative positions 
firms - avoiding of particularism 
- valuation of legitimacy 
The diagram in figure 4.3 remarkably resembles the differentiation of the actors that 
is for instance made by Vermeulen et al. in a preliminary study for the Scientific 
Council for Government Policy (WRR). Vermeulen et al. 4 have evaluated twenty-two 
processes of participatory policymaking (stakeholder planning). Stakeholder planning 
4 Vermeulen, W.J. et al (1997) Duurzaamheid als uitdaging. De afweging van ecologische en 
maatschappelijke risico's in confrontatie en dialoog. [Sustainability as challenge. Balancing 
ecological and social risks in confrontation and dialogue] Sdu Uitgevers. Den Haag. 
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takes as its point of departure that effective and legitimate planning should be based 
on the active participation of the stakeholders that can be identified5. Stakeholders are 
the persons and organisations affected by the planning process 6. By actively involving 
these stakeholders, their insights and concerns will be taken into account from the very 
start of the planning process, in the hope that the results of the planning process will 
gain the support of these stakeholders. From a political point of view, not only persons 
and organisations affected should be involved, but also people who can add to the 
process of political will formation, such as experts. Such a process of stakeholder 
planning will not lead by itself to a consensus with respect to the issue at stake. To 
avoid ongoing dissent and to avoid particularism (standing up for only one or a few 
interests), decision making has to remain the responsibility of politics. So, the primacy 
of politics remains intact (WRR, page 130). The participants distinguished by 
Vermeulen et al. are: the elected representatives of the people, the administrators, the 
experts, the professionals of public interest groups, and the (groups of) individual 
citizens or firms, who will be affected by the outcomes of the process, or, as 
Vermeulen et al. calls them, the bearers of the risks (see figure 4.4). 
There are some differences too between both kinds of debates. These differences are 
due to the differences between an organised process of interactive planning and a 
spontaneous public debate in the media on a public issue. The stakeholders in a 
process of stakeholder planning are invited to join the process. The actors are 
physically brought together with a political objective, namely to participate in a 
process of political will formation (or as the WRR says preference formation) of 
which the limits are already politically defined and which is organised and 
facilitated by the administration. The planning process will be closed with an advice 
to politics after a limited time span. A public debate in the media, that takes place 
before the public as an audience, is much more open. Virtually everyone can 
participate. Individuals, experts, as well as interest groups can decide for themselves 
whether or not to participate by putting forward opinions, analysis, arguments, and 
concerns. In the debate on animal transgenesis, this has even caused unexpected 
participants, like artists and Queen Beatrix. A public debate does not have a defined 
closure; it is not even directed at realising an agreement or a closure, but at 
generating better arguments and at convincing the public (see chapter 7). 
5 Page 129 of WRR (1998) Ruimtelijke ontwikkelingspolitiek [Environmental Development Policy]. 
Sdu Uitgevers. Den Haag. 
6 Stakeholders, the people that will be affected by the results of the planning process, should be 
distinguished from the shareholders, that are the people and organisations that are proprietors of 
property and so have a direct say in the planning process. 
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A process of stakeholder planning may have some drawbacks. These drawbacks may 
also occur in public debates. Vermeulen et al. call particularism a serious drawback 
for a process of stakeholder planning, as participation by professionals of organised 
interest groups is usually quite dominant. These professionals tend to have a limited 
mandate because of the specific interests their organisation stands for. This means that 
they have limited autonomy to deal with other perspectives, which may inherently 
cause ongoing dissent. That is why a process of stakeholder planning should 
preferably include people from the public and firms that are represented by these 
groups and organisations. These participants are the true bearers of the risks; and they 
are seen as the ultimate forum. 
In a public debate, the interest groups will also have their voices better heard than 
individual citizens. So, particularism might be an inherent problem of public debates 
as well. I don not think it a serious drawback, however, for two reasons. First, a public 
debate is not directed at reaching consensus but at gaining public support. Therefore, 
it will not be as problematic if organisations and their spokespersons only try to 
articulated their own views as good as possible. Second, it might be a problem though, 
if relevant voices were not heard. Well, I can only speak for the particular debate at 
hand. It is obvious that the Dierenbescherming had its opinion very well heard. But 
quite a number of citizens spoke up as well. And there were a number of groups that 
have also spoken up in behalf of the public without being their representative or the 
representative of a specific public interest. I am trnnking of the journalists and editors. 
And in a way the experts were also speaking in behalf of the public as they have 
voiced specific public interests or concerns, like public health, animal wellbeing, and 
animal integrity. The firms involved in this specific public debate also seem to have 
been able to have their voice heard well enough 7. So, it seems that in the public debate 
about animal transgenesis the relevant voices were heard. 
In this particular debate, some experts were not just experts expressing expert 
opinions, but they were also bearers of risks. Researchers working with transgenic 
animals might be hindered by legislation concerning animal transgenesis. And, they 
were concerned about medical progress. So, medical researchers, biotechnologists and 
zoo-technologists and their scientific organisations did not only stand up for the 
perspective of their sciences, but also expressed the social interests at stake as soon as 
they realised what the impact would be of the implementation of the Decree on 
7 In the 'Herman the bull' case there were only two firms involved. These substantial firms could very 
well speak for themselves. If it were not one or two specific firms as in this specific debate but for 
instance a number of farmers, it might have been much more difficult for them to have their voices 
heard. In such cases there might be representing organisations that would speak up for these small 
firms. 
64 
Animal Biotechnology. They, however, reacted publicly at a rather late stage in the 
process of legislation. If their contribution would have been earlier, their voices might 
have had more impact on the debate. 
All in all, opinions and concerns present among the broader public seem to have been 
broadly discussed in this specific debate. This means that each interested citizen has 
been capable of forming his or her opinion and will. Therefore, the public opinion will 
be fairly well considered and so will public support. 
Some discussion concerning the roles of experts and citizens 
Many differences between a process of stakeholder planning and a public debate are, 
as I have indicated in the former section, the result of the inherent differences in the 
processes. Vermeulen et al., however, also have given specific roles to the experts, to 
professionals from interest groups, and to individual citizens and firms, that I did not 
find in the public debate at hand. I am not convinced that this differentiation follows 
from the differences in the processes. 
The WRR sees experts as experts operating external to a debate, while in the public 
debate on animal biotechnology experts also have participated with an expert opinion 
and with expert interests. I wonder whether in a process of stakeholder planning 
experts will really stick to the role of knowledge transfer, the identification and 
offering of lacks of knowledge and uncertainties, and the making of analysis, as the 
WRR states. We have seen in, for instance, the advice of the Second Committee 
Schroten (the provisional Committee Ethical Evaluation of Genetic Modification in 
Animals) that different experts will value facts, lacks of knowledge, and uncertainties 
differently. Such valuations are not only present in the advice of ethical committees, 
but also in the advises of for instance biologists, agronomists, and rural planners in a 
rural planning process, since valuations are inherent to these disciplines. This means 
that the experts cannot be seen as external to the debate or as giving disinterested 
advises. They should be considered as participating in the debate as well. 
It is evident that professionals from interest groups will put forward a perception from 
the point of view of the particular interest the group stands for and that they can raise 
possible solutions and expertise. Vermeulen et al. state that from a democratic point 
of view these groups should be open for other opinions and interests, should 
communicate the planning process to its members, and should have part in the 
implementation of the outcome. I can imagine that these are preconditions in a process 
of stakeholder planning aiming at democratic preference formation instead of neo-
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corporatistic bargaining (Vermeulen et al., page 131). In the process of public will 
formation of a public debate, however, it is also important that this process of will 
formation continues and is extended to the larger public. An organised interest group 
that is directed at keeping this process going shall not be as open and communicative 
as a group entering into a process of stakeholder planning, since it sees its role 
differently. Of course, organised interest groups should communicate what is going 
on to their members. But it is not obvious that they should feel responsible for the 
implementation of the outcomes of the process either. 
Vermeulen et al. attribute a specific role to (groups of) individual citizens and firms. 
Their role is the input of subjective valuations and normative positions, while avoiding 
particularism and while valuing the legitimacy of (the outcome of) the process. In this 
particular public debate, firms and the affected scientists may be severely harmed in 
their particular interests by the outcome of the debate. So, it will be hard for them to 
avoid particularism, even if they should want to. In a process of stakeholder planning, 
the participants are expected to transcend their private interests. In a public debate, this 
cannot be expected. Citizens who are not directly affected will usually be better 
equipped to form an independent opinion 8. 
It is noticeable that in the public debate on animal transgenesis, there was hardly a 
distinction between the views of Gene Pharming and the interest group speaking on 
the behalf of biotechnology firms (the NIABA). The same can be said about the 
scientists and their organisations. So in these cases, professionals of interests groups 
could not be said to have taken a different role from individual experts or firms. They 
were both speaking with one tongue. 
The interrelations of different kinds of public debates 
Most participants in the debate also have had debates amongst themselves. 
Discussions have taken place among citizens at kitchen tables, in coffee houses, and 
I wonder why Vermeulen et al. attribute the role of putting forward norms and values to firms and 
citizens only. Why cannot experts or interest groups do the same? Likewise, why can only 
professionals put forward possible solutions and expertise and why cannot experts, citizens, or firms? 
It is remarkable that Vermeulen et al. make such sharps distinctions between these groups. I would 
say that the responsibilities and roles the WRR attributes to these groups might be what they factually 
do most, but it would be wrong to suggest that people and organisations will stick to their attributed 
responsibilities and roles. Any input in the debate that in the scheme of Vermeulen et al. is restricted 
to one category of 'players' can in my view also be valuable if put forward by one of the other 
'players'. 
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during coffee and lunch breaks at work. People have discussed within the editorial 
staffs of the newspapers and other media, within firms, within interest organisations, 
and within Ministries. Here, I will focus on three more or less formalised and 
structured public debates namely those in politics, those among scientists, and those 
within advisory committees. I will discuss these debates from the perspective of the 
public debate in the media. 
I have summarised the main differences and similarities of these relevant public 
debates in figure 4.5. The figure is not meant to be complete, but it is supposed to give 
a good grasp of the characteristics of these (public) debates. I will not discuss the 
process of stakeholder planning here as this has not been part in the media debate 
about animal transgenesis 9. 
Political debates take place among elected representatives, in this case in Parliament. 
These representatives may enter into public discussions at party meetings, at public 
gatherings in the country, and with journalists, experts, or other politicians on 
television. In the newspapers, however, one may mostly find reports on parliamentary 
discussions. Sometimes politicians write an (opinion page) article and sometimes they 
are interviewed about a topic. 
In the Herman case, most reports on parliamentary discussions hardly contained 
reasoning. The positions of the diverse parties or politicians were mentioned, but not 
the reasons why these parties or politicians were willing to defend this position. No 
politicians were interviewed, and only one (Bas van der Vlies of the SGP) wrote an 
opinion page article. So, the impact of politicians on the public debate in the media has 
not been of substantial importance. Public opinion and public support may have 
affected parliamentary discussion, but the other way around there was hardly any 
influence. The Minister of Agriculture, Nature Management, and Fisheries, and his 
ministry did have a major impact on the public debate because of the legislation 
process it was involved in, but there was no active input in the debate from the side 
of the ministry in the sense of reasoning. The Minister has hardly ever expressed an 
opinion. He has ordered for advices by advisory committees, which have influenced 
public opinion, but he and his ministry only had a receptive attitude towards the public 
debate. 
9 Only at the end of the debate has the Minister organised a workshop with all parties in order to arrive 
at a satisfactory solution for the Decree on Animal Biotechnology. Neither the organisation of this 
workshop nor the outcomes were mentioned in the newspapers. 
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Figure 4.5: Some noticeable differences and sirnilarities among four kinds of public debate . 
public debates 
in the media 
political debates debates in advisory 
councils and advisory 
committees 
expert debates 
formality informal, 
spontaneous, 
and non-
organised 
formalised by law institutionalised in 
meetings with a set 
agenda. 
institutionalised in 
journals, 
workshops, and 
conferences 
openness ongoing 
discussion that 
may fade away 
closure by 
decision (time 
pressure) 
closure by a state of 
affairs (time pressure) 
ongoing 
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dissent 
type of 
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explaining, 
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differentiating, 
convincing 
decision-making, 
legitimating, 
bargaining 
articulating, 
differentiating, 
grounding 
articulating, 
differentiating 
grounding 
participants opinion leaders, 
like: experts, 
spokespersons, 
concerned 
parties 
elected 
representatives 
and Ministers 
experts and 
representatives of 
concerned parties 
experts 
kind of input views, opinions, 
interests, 
preferences 
views, opinions, 
interests, 
preferences 
views, opinions, 
interests, theories, 
preferences, 
views, facts, 
questions, proof, 
theories 
kind of output considered 
opinions, 
intrinsic 
motivations 
decisions, laws, 
acts 
memorandums, 
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concepts, views, 
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concerned 
party, and 
participant 
audience, voter, 
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audience as far as the 
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The debates in advisory committees had much more substantive impact on the public 
debate in the media. Most of their reports have initiated public discussion, not so much 
because of the advice itself, but because of the argumentation underlying the advice. 
One may expect that all debates are oriented at consensus. This may be true at some moments, but 
often debates are directed at convincing others. This is why articulating and differentiating are 
characteristic aspects of all debates. In a public debate people are not even primarily oriented at 
convincing each other but at convincing the public. In chapter seven, I will come back to the 
characteristics of public debates. 
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These committees and their members (mostly experts) have generated knowledge, 
valuations, normative positions, views, concepts, and possible ways of handling 
animal transgenesis. Their reports formally were addressed to Government, but the 
Ministers in question had to comment on the reports before sending them to 
Parliament and therefore they were public as well. In general, such advices are not 
discussed publicly. And most advisory committees do not actively seek the press. The 
advices in the Herman case, however, were very influential. Both Schroten 
Committees (CEBD and vCEEGMD) even explicitly wanted to stimulate public 
debate and they did so by actively seeking publicity for their findings.Most interesting 
was the dual advice of the Second Schroten Committee (vCEEGMD) on breeding with 
Herman the bull. This Committee could not agree on breeding with Herman the bull 
and it made its dual advice public in a press conference. This disagreement stimulated 
public debate even more than a consensual advice would ever have done. The 
members of both Schroten committees (CEBD and vCEEGMD) also actively 
participated in the public debate mostly by being interviewed, but also by writing 
opinion page articles. 
As there is a political sphere in which political deliberations and decision-making 
takes place there also is an academic sphere in which scientific and scholarly 
deliberations take place. It also is a sphere with its own mores. Deliberations are 
directed at bringing forth truth or solutions. This sphere is fragmented in many 
branches of science which also have their own mores, which may result in scientific 
controversies between various branches of science about social issues 1 1 . Different 
experts from different scientific or scholarly backgrounds may be committed to 
different (legitimate) social goals, such as human health (medical and biomedical 
scientists), food safety (environmental scientists, food scientists), human dignity 
(ethicists), or animal welfare (veterinarians and ethicists). These social goals will 
affect their inputs in the public debate. The opinions of the experts will be shaped in 
collegial meetings. 
With respect to animal transgenesis many expert meetings, workshops, and 
conferences were organised on many different aspects of the issue. Some of these 
meetings and conferences were public gatherings and so informative for, for instance, 
journalists. Hardly any reports on these gamerings were published in the newspapers. 
Many experts, however, have sought publicity for their views. They presented their 
views at press conferences, were interviewed and quite a number of them sought 
" Sec for instance R. von Schömberg (1997) Argumentie in de context van een wetenschappelijke 
controverse. Een analyse van de discussie over de introductie van genetisch gemodificeerde 
Organismen in het milieu. [Argumentation and scientific controversy. An analysis of the discussion 
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publicity for their views by writing an opinion page article. The different social 
(legitimate) goals to which their professions are committed were reflected in their 
opinions and lines of reasoning. Biomedical experts have stressed the importance of 
animal biotechnology for medical knowledge; animal scientists have stressed the 
backlashes for the animals; philosophers and ethicists have reflected on human and 
animal dignity. Together they have added relevant reasons and lines of reasoning to 
the debate, as all these social goals should be valued and re-valued as to come to a 
reflected public opinion about animal biotechnology. 
Conclusion 
A public debate can be made, or not, by a well-informed public of citizens, 
organisations, experts, firms et cetera. These participants bear the responsibility of 
bringing forward the relevant arguments as to arrive at a public will. In chapter 3,1 
have indicated two elements that are necessary for a public debate to develop and to 
continue, namely direct causes that make the debate urgent, and citizens, experts, or 
organisations that recognise and articulate these urges. The direct causes were 
discussed in chapter 3.1 have also argued that organisations are better equipped to 
keep a public debate going. Compared to individual citizens or experts, organisations 
will be better able to hold out long enough. This is what we observe in this debate 
about animal transgenesis. Many individuals and experts have contributed to the 
debate. There was one organisation, however, that has fulfilled the role of sustaining 
the debate, namely the Dierenbescherming. In this case the major firm involved, Gene 
Pharming, has provided the causes for continuing the debate; it did not fulfil the role 
of sustaining the debate like the Dierenbescherming did. The other two other major 
players, namely the Minister of Agriculture and Parliament, did not perform this role 
either. They have provided causes for discussion, but were not carrying the discussion. 
A public debate will only arrive and continue if the public is well informed. The flow 
of information in a public debate depends on: 
- the openness of actors that possess this information (in our case Gene Pharming 
and the Ministry of Agriculture) 
- politicians, interest groups, journalists, or experts, that can point out the disputable 
issues, 
- the media that have to spread the information and disputable issues. 
about the introduction of genetically modified organisms in the environment] WMW-publicatie 27 
Eburon. Delft. 
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The duration of the debate as well as the number of aspects discussed point out that 
the information flow in this debate was well enough provided. Thanks to all the 
groups and organisations mentioned. 
We have also witnessed interrelations with other debates, to wit the political debate, 
experts debates, and discussions in advisory committees. Political debate has primarily 
concentrated on the Animal Health and Welfare Act, but Parliament has also discussed 
many aspects of the Herman project. Unfortunately the discussions in Parliament were 
only marginally reported in the media, as only positions were mentioned instead of 
lines of reasoning as well. 
Most reports including the lines of reasoning of the advisory committees were well 
discussed in the media. In particular the dual advice concerning breeding with bull 
Herman has stimulated public debate. 
There have been many expert meetings. These were not published in the media. 
Experts, however, have communicated their views very well via the media. It should 
be realised, thought, that experts express expert views, but these views are not fully 
independent but shaped in collegial meetings organised around specific social goals. 
In the next two chapters, I will go into he content of the debate. In chapter 5,1 will 
analyse the general discussion about animal transgenesis. And in chapter 6 ,1 will 
analyse how is dealt with some specific applications. 
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5. Animal integrity contested. A reconstruction of the lines of 
reasoning. 
In the debate on animal transgenesis many reasons were put forward by many 
different actors. Using an adapted matrix of Mepham, I will unlock the richness of 
these reasons by presenting an overview of the arguments that were put forward. I 
will make a matrix for each of the main participants, as each of them represents a 
particular position in the debate. 
Next, I will zoom in on these positions and in particular on the arguments 
supporting these positions. We will see that a number of arguments is directed at 
specific applications of this technology, while others are directed at the technology 
itself. The arguments directed at animal transgenesis as such will be reconstructed 
in this chapter. The reasoning with respect to the applications of the technology 
will be the subject of the next chapter. 
I will first introduce the matrix (section one), which I will adapt to my purposes 
(section two). Then, I will use it (section three) and discuss the outcomes (section 
four). In the next sections, I will analyse the outcomes. First, I will detect the 
central theme of the debate (section five) and then I will show what this has meant 
for the lines of reasoning (section six). Next, I will make a side step and discuss 
some specific features of the political debate, and the consequences for policy 
making (section seven). Then I will discuss on the usefulness of the matrices 
(section eight). And I will end with a conclusion (section 9). 
Mepham's matrix 
For sorting out the arguments in this debate, I have turned to Ben Mepham 1 and his 
use of the four principles of Beauchamp and Childress. Beauchamp and Childress 2 
Mepham, B. (1996) Ethical analysis of food biotechnologies: an evaluative framework. In: B. 
Mepham, Food Ethics. 101-119. Routledge. London and New York, and Mepham, T.B. (1996). 
Ethical Impacts of Biotechnolgoy in Dairying. In: C.J.C. Phillips (Ed.) Progress in Dairy Science. 
CAB International. Wallingford. 
2 Beauchamp, T.L. and Childress, J.F. (1994) Principles of Biomedical Ethics, 4th edition. Oxford 
University Press. New York and Oxford. 
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have developed a set of prima-facie (non-absolute) ethical principles. These 
principles can be reconstructed as the underlying normative structure of our 
contemporary Western societies3. In our ethical thinking, we often refer to one of 
these principles without always designating them. These principles are articulated, 
specified, and so on in ethical debates in which next to contextual aspects, values, 
preferences, and other notions of the good life play roles 4. In my analysis, these 
principles as well as the matrices Mepham has developed will function as an 
instrument for sorting out reasons in order to get a better understanding of what has 
been going on in the debate. In my view, what is really doing the work in dealing 
with an ethical problem is not the ethical principles, but is the discussion on (the 
application of) these principles, that is the process of interpreting these principles 
concerning a specific situation5. 
Beauchamp and Childress have reconstructed four general principles 6, to wit: 
- Respect for autonomy (a norm of respecting the autonomous choices of other 
persons, by respecting the person's appreciation of information and 
independence); 
- Justice (a group of norms for distributing benefits, risks, and costs fairly, 
equitably, and appropriately in light of what is due or owed to persons); 
- Non-maleficence (a norm of not inflicting evil or harm intentionally to 
persons); 
- Beneficence (a norm of contributing to the welfare of other persons by 
preventing evil or harm, by removing evil or harm, or by doing or promoting 
good). 
Habermas, J. (1993) Justification and application: remarks on discourse ethics. Polity press. 
Cambridge 
4 Beauchamp, T.L. and Childress J.F. (1994), and Korthals, M. (2001) Ethical dilemmas in 
sustainable agriculture. In: Int. J. of Food Science and Technology. 38/8,898-911 
5 To better understand what is meant by applying principles, I have turned to the discourse ethics of 
Jttrgen Habermas and in particular to the notion of application discussions. From a discourse-
ethical perspective, the ethical principles have to be justified in moral discourses in which mainly 
(ethical) experts are involved. The four principles of Beauchamp and Childress can be regarded as 
the outcome of such a discourse. These principles will be articulated, specified, and so on in 
application-discussions in which next to contextual aspects, values, preferences, interests, and 
other notions of the good life are playing roles. Such discussions concern everybody involved and 
therefore should include everybody involved (as far as these persons want to participate). 
6 Beauchamp and Childress (1994) page 38 and chapters 3 to 6. See also Frankena, W.K. (1963, 
1973) Ethics second edition, Prentice-Hall, Inc, Englewoods Cliffs, New Jersey page 47 
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Mepham has combined the last two principles into 'wellbeing' as they are in his 
view reciprocally related. Furthermore, he stresses that in food biotechnology, the 
range of affected parties and interest groups is much broader than in biomedical 
ethics. This means that the principles have to be translated into terms that are 
meaningful to these other parties and groups. So, he has 'interpreted' the remaining 
principles in terms that he thinks appropriate to the interests of the treated 
organisms, producers, consumers, and biota, so developing a matrix in which the 
impact of a new technology on these interested categories will become transparent 
(see figure 5.1). He adds that these categories can be extended and specified at 
wish to what is most appropriate. 
Well-being Autonomy Justice 
Treated 
organism 
e.g. Animal welfare e.g. Behavioural 
freedom 
Respect for telos 
Producers 
(e.g. farmers) 
Adequate income and 
working conditions 
Freedom to adopt 
or not adopt 
Fair treatment in 
trade and law 
Consumers Availability of safe 
food, acceptability 
Respect for 
consumer choice 
(labelling) 
Universal 
affordability of 
food 
Biota Conservation of the 
biota 
Maintenance of 
biodiversity 
Sustainability of 
biotic populations 
Figure 5.1: Mepham's ethical matrix, showing, in twelve individual cells, the interpretation of the 
three principles of well-being, respect for autonomy and justice in terms appropriate to 
the interests of treated organisms (e.g. animals or crops), producers (e.g. farmers or 
biotechnology company employees), consumers, and biota. 
The principal aim Mepham has with the matrix is 'to facilitate rational public 
policy decision-making by articulating the ethical dimensions of any issue in a way 
which is widely comprehensible' (p. 107). My aim, however, is differently 
oriented. I want to reflect on a public debate that has taken place by identifying the 
reasons that support the main positions in this debate and by analysing these 
positions. I will use the matrix to get a better hold on what has happened in this 
particular debate. 
Developing Mepham's matrix into a heuristic instrument for analysing 
debates 
I have made some adaptations to Mepham's matrix. I will start with discussing four 
relatively small adaptations that have consequences for the make-up of the matrix. 
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Next, I will discuss and adapt the way in which Mepham has transformed the 
principles as to make them adequate for animals. 
1.1 will, in line with Hayry 7, keep benefits and harms apart. Matti Hayry argues 
that the tameness of Mepham's conclusions can be attributed to, amongst others, 
the way Mepham classifies the arguments for and against the use of rBST in dairy 
farming. Mepham's matrix contains, as we saw, only three ethical principles, as 
opposed to the four principles introduced by Beauchamp and Childress. The harms 
and benefits, however, mostly do not arrive at the same 'affected group'. Most of 
the time the harms arrive at one group and the benefits at another. So, Hayry 
proposes to evaluate the harms and benefits separately. In his view, such a 
separation is of the more importance if the avoidance of harm is seen as an 
important consideration. As all participants of the Dutch debate on animal 
transgenesis have stressed that no harm should be inflicted upon the animals 
involved, I will discuss harms and benefits separately. 
2 .1 will, in line with Korthals 8, add an extra column of 'notions of the good life 9 ' . 
In evaluating concrete cases and in the application of norms it is necessary to 
consider all the features of the concrete situation 1 0. This does not only imply that 
moral norms must be specified to overcome their lack of content and to handle 
moral conflict, but it also implies that values, preferences, and ideals as well as 
morally relevant facts need to be considered (Beauchamp, page 183). Michiel 
Korthals argues that 'in applying these principles, we mostly implicitly switch to 
the ideal side of the concepts and our values and preferences come into play. This 
means that the four principles do not cover the whole field of morality, and that 
another dimension, much more elusive, like that of values, ideals and preferences is 
of utmost importance in tackling moral dilemmas.' I will therefore summarise 
values, preferences, and ideals under a new heading called 'values'. 
7 Hayry, M. (1999) How to apply ethical principles to the biotechnological production of food. The 
case of bovine growth hormone. In: V. Beekman and F. Brom. Preprints of the first European 
Congress on Agricultural and Food ethics. 93-96. Wageningen. The Netherlands. 
8 Korthals, M. (2001) Ethical dilemmas in sustainable agriculture. In: Int. J. of Food Science and 
Technology im, 898-911 
9 With 'notions of the good life' I mean the notions about the persons, the people, and the society 
we want to be. These notions do refer to principles, but they do not have a universalistic claim like 
the principles. They only have a cultural specific claim: it is about our ideals, our values, our 
civilization, and our future. 
1 0 Gflnther, L. (1989) Impartial application of moral and legal norms: a contribution to discourse 
ethics. In: Philosophy and Social Criticism. 14/ %, 425-432. See also: Habermas, J. (1988) Recht 
en moraal. Kok Agora. Kampen; Habermas, J. (1993) Justification and Application: remarks on 
discourse ethics. Polity Press. Cambridge; and Korthals, M. (1994) Rechtvaardiging en 
toepassing. Twee kanten van het morele oordeel. [Justification and application. Two sides of 
moral judgement.] In: Psychologie en Maatschappij. 66,25-37 
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3. I will add a column of 'morally relevant facts that do not refer to a specific 
principle'. Most facts, namely the ones related to a principle or value, will be 
written down in the columns of the principle at stake. Other morally relevant facts 
will be mentioned in the column 'facts'. What remains are facts that refer to the 
existence of alternatives or to the working of method or the products, and so are 
referring to the necessity or senselessness of making transgenic animals. Others 
refer to the lack of knowledge about transgenic animals. And again others discuss 
whether the inserted gene should be regarded human or not. 
4. I will use the matrix in a different way, namely as a heuristic instrument for 
understanding what has happened in the public debate on animal transgenesis. This 
use, however, matches with Mepham's aim to articulate the ethical dimensions of 
the issue in a way, which is widely comprehensible. For understanding a public 
debate (as well as for policy making at which Mepham is aiming) it is not only 
interesting to know the different arguments, but it is also important to gain insight 
into the distribution of arguments over the different actors. This means that I will 
fill out the matrix for the reasons of each of the three main actors of the debate 
separately, in order to articulate their different views. By doing so, I can show what 
the stakes have been for each of the actors and I can also show the underlying 
reasons for the three major positions that have been taken in the debate, namely: 
'no ' , 'no, unless' and 'yes, if. So, I will make a matrix for each position in the 
debate, as to better articulate the different views in the debate. 
I have also made some adaptations that need to be explained more thoroughly. 
Mepham has 'translated' the principles as to make them adequate for animals and 
biota (i.e. flora and fauna in a specific area). It has long been doubted whether 
moral norms do apply to animals (and biota) or not. I will only mention this debate, 
and will discuss into more depth the consequences of its outcome. Central to the 
animal ethical debate was that animals do not belong to the moral community, as 
they cannot behave morally themselves. Since they are incapable of moral action, 
there cannot be reciprocity. Some consider them as moral patients as they cannot 
speak up for themselves. In this view they are like children. Others however 
contest this view as animals are in full health and fully dispose of their mental 
capacities. During the last 20 to 30 years, however, many people have realised that 
they may have other reasons for treating animals and biota morally that originate 
from a deeply rooted respect for living creatures and for nature (for an overview 
and analysis of this discussion see for instance: P.B. Thompson 1 1). In this view the 
moral status of animals more or less corresponds with the one of moral patients but 
" Thompson, P.B. (1997) Ethics and the genetic engineering of food animals. In: Journal of 
Agricultural and Environmental Ethics 10,1-23 
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for different reasons. The concept of animal welfare is now broadly recognised as 
an adequate concept regarding animals. Therefore, the principles of beneficence 
and non-maleficence are held fully to apply to these creatures. The principles of 
doing good and not doing evil or harm to animals are hardly disputed anymore. 
The principle of respect for autonomy and that of justice are still seen as 
problematic, however. These principles are inherently oriented to relations amongst 
humans and need to be substantially transformed to be adequate for the human 
treatment of animals. Consequently, these transformations will alter the content of 
the concepts 1 2. Mepham does not explain his transformations of these two 
principles; he just makes them. Backed by the Dutch discussion on these concepts, 
I do not think his transformations adequate. For the 'treated organisms', he 
transforms autonomy in behavioural freedom and justice in respect for telos (see 
the matrix). Respect for telos means in common language 'respect for the species-
specific nature of the animals' and so has, in my view, more to do with respect for 
autonomy than with justice. I will make use of the way the Dutch have interpreted 
the concepts. 
In The Netherlands, a discussion has emerged about whether and how these two 
principles should be used with respect to animals. The (Dutch) Advisory 
Committee Ethics and Biotechnology in Animals has made a first step in 
transforming these principles. It reconstructed respect for autonomy into respect for 
the survival instinct and the possibilities of individual animals for realising 
survival; and justice as that the end should justify the means, and that needless 
damage and needless risks should be avoided 1 3. Especially the first transformation 
has been discussed thoroughly. The (Dutch) Council for Animal Affairs has 
suggested that animal integrity should be adopted as an adequate equivalent for 
human autonomy. Grornmers, Rutgers, and Wijsmuller 1 4 have formulated a 
working definition of this concept: 'the wholeness and soundness of the animal and 
1 2 See also: Fretz, L and Vorstenbosch, J. (1994) ReSel, rationeel en redelijk. Een onderzoek naar 
normatieve vragen rond alternatieven voor transgenese bij dieren. [Realistic, rational, and 
reasonable. Research into the normative questions concerning alternatives for transgenesis in 
animals]. Amersfoort/Utrecht 
1 3 Advisory Committee Ethical and Biotechnology in Animals (1990) Ethics and Biotechnology in 
Animals (condensed translation). Ministry of Agriculture, Nature Management and Fisheries. The 
Hague. See also: Brom, F.W.A. and Schroten, E. (1993) Ethical questions around animal 
biotechnology. The Dutch approach. In: Livestock Production Science. 36, 99-107. 
1 4 Grornmers, F.J., Rutgers, L.J.E. and Wijsmuller, J.M. (1995) Welzijn - intrinsieke waarde -
integriteit. Ontwikkelingen in de herwaardering van het gedomesticeerde dier. [Wellbeing -
intrinsic value - integrity. Developments in the revaluation of the domesticated animal] In: 
Tijdschift voor Diergeneeskunde 120,490-494. 
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the balance of the species-specific nature, and the capability of autonomous 
maintenance in an environment that is suitable for the species' [my translation, 
ETj". This concept refers to individual animals as well as to species. Rutgers 1 5 
explains this definition from the notion that there are treatments of animals that do 
not cause severe pain, and that do not injure the health and welfare of the animals 
in the long run, but that nevertheless encounter moral objections. In his view such 
treatments consist of acts that are in themselves, despite the consequences, morally 
worrisome, because of the infringement on the life, or the integrity of the animals, 
which is in contradiction with respect for life (page 119). Mepham has translated 
autonomy as 'e.g. behavioural freedom' whereas he has translated justice as 
'respect for telos' which in common language means respect for the species-
specific nature of the animal. In the Dutch concept of 'integrity' as a the 
transformation of respect for autonomy, both elements are present. This means that 
the transformation of the concept of justice with respect to animals is still open. 
Rutgers (page 117 and 118) also has proposed a transformation of the justice 
concept in terms of equal treatment. He distinguishes two levels of equal treatment 
of animals: 
- Justice in the sense of the equal treatment of animals, which means that species 
that are biologically equal (homologous) should be treated equally, just as the 
individual animals of a particular species should be. 
- Justice in the sense of a fair, reasonable distribution of the good and the bad 
over humans and animals. Justice in this sense has to do with proportionality, 
to wit the 'good' that humans strive at in using and handling animals should be 
in reasonable proportion to the 'evil' done to the animal [my translation, ET]. 
The Advisory Committee has translated justice more or less accordingly, namely as 
'fair treatment', and in a 'no, unless' principle (which means that any use of 
animals should only be allowed on the basis of good reasons and provided that no 
alternatives exist and that unnecessary risks are avoided). 
As I am analysing a Dutch debate and as Mepham's transformations are not 
adequate, I will adhere to the Dutch 'transformations' of the principles of 
Beauchamp and Childress with respect to animals. This has resulted in a major 
adaptation of the matrix. 
1 5 Rutgers, L.J.E. (1993) Het wel en wee der dieren. Ethiek en diergeneeskundig handelen. [The 
weal and woe of animals. Ethics of veterinary practice.] Utrecht: Universiteit Utrecht, Faculteit 
Diergeneeskunde. 
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Mapping the arguments 
In the three matrices on the next few pages, the arguments of the three major 
positions in the debate are classified according to the adapted matrix of Mepham. 
These positions match with the views of the three main participants in the debate 
on animal biotechnology, to wit Gene Pharming ('yes, if a limited set of conditions 
is fulfilled'), the Dierenbescherming (an unconditioned 'no') and the Ministry of 
Agriculture ('no, unless there are good reasons for doing so'). The other 
participants are mentioned in the footnotes of the matrices. 
Mepham indicates (page 107) that the number of 'affected' parties can be extended 
at wish, which I did. The arguments regarding the main 'affected' parties are 
mentioned in the matrix. It is evident that depending on the views and interests of 
the participant involved different 'affected' parties were stressed. Three parties 
were only mentioned one or two times, to wit effects on nature, on the firm 
Nutricia, and on the Dutch economy. These 'parties' will not be put into the 
scheme 1 6 . 
In each of the matrices the arguments are classified that underline or weaken some 
principles, or that state that a particular principle is at stake or that it is not. The 
first two kinds of arguments stress or specify a principle with respect to a subject 
(e.g. all animals are equal, or different species should be treated differently). In 
these cases, the question is answered what the moral-ethical implications should be 
of a violation of a principle. For instance: not all harms will count the same. 
Intention might play a role (e.g. deliberate or non-deliberate harm). The kinds of 
subjects the harm is done to might have some impact (imprisonment for a snail is 
different from that of an ape). And it may be appropriate to differentiate between 
kinds of harm (serious and long lasting, or mild and short). 
The last two kinds of arguments are factual statements with respect to a principle 
that activate or de-activate the principle (e.g. there are health defects, so harm is 
done, or the gene has a similar structure and function, so the integrity is not 
violated). In these last cases, the question is what the facts on the matter are. This is 
primarily a cognitive question. The answer, however, has a direct moral-ethical 
I will briefly mention the arguments: About nature the Ministry has stressed that harmful effects 
should be taken into account, while Gene Pharming has stressed that making transgenic cattle will 
not be a risk for nature. Nutricia wants to produce food for target groups, which is beneficial to 
these groups. The Ministry has stressed that as long as The Netherlands stay in the race they can 
have an influence on the international developments. Dutch interests should be protected, and that 
international co-operation is needed, is stated by some experts. Other experts stress that the state 
should stand back and should only react to excesses. 
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implication, since if harm is done this will be a violation of the non-maleficence 
principle, and if the integrity is not harmed this objection dissolves. 
It was not always easy to classify the arguments, since people just have reasoned, 
without referring to a specific moral principle. So, I had to link the argument to one 
of the principles, to values or to facts. Most of the time it was obvious to which one 
of these a reason should be linked, but sometimes it was not. In these cases, I had 
to classify the reason under the heading that I thought to be most appropriate. I had 
expected that many arguments had to be classified under the heading of values i.e. 
that people would refer to notions of the good life (the people they want to be; the 
way they want to live). It turned out, however, that most statements are value-
laden, and context-bound specifications of principles and therefore had to be 
classified under the heading of a principle. The principle itself is mentioned at the 
top of a column and the specifications are made in the cells. Only the statements 
that were primarily referring to our cultural identity were classified under the 
heading of 'value ' . 
Additional cognitive arguments for or against animal transgenesis were usually 
classified as a fact. Most arguments put under the heading of 'facts' refer to the 
necessity or senselessness of using transgenic animals, because of the non-
existence or existence of a serious alternative. Some other arguments referred to the 
lack of cognitive and/or moral knowledge regarding transgenic animals. 
The resulting three matrices can be found on the next three pages. In the next 
section, I will analyse the content of these matrices. 
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Figure 5.2: View of Gene Pharming and its allies 1 7: "YES, IF", because: 
Non-
maleficence 
Beneficence Respect for 
autonomy / ' 
integrity 
Justice: equal 
/fair 
treatment 
Values: the 
good life 
Facts 
Animals The 
product 
will only 
end up in 
the milk: no 
health and 
welfare 
problems 
Birth 
defects are 
due to the 
process 
Treated like 
production 
animals 
Increased 
resistance 
against 
infections 
(mastitis 
prevention) 
A cow remains a 
cow 
No 'new' animals 
Working with and 
according to 
nature 
The gene has a 
similar structure 
and function as 
the natural gene 
Classic breeding 
also changes 
animals 
•Animals can also 
change by viruses 
Nothing 
morally new: 
transgenic 
mice and 
sheep already 
exist 
•Animals are 
also harmed 
in animal 
experiments 
for medical 
purposes 
•Laboratory 
animals should 
be treated 
differently from 
production 
animals 
The gene 
was not 
human, but 
synthesised 
•The genes 
have to be 
human-like, 
but do not 
create 
human-like 
animals 
Species •The species 
barrier is but a 
religious argument 
•Changing a few 
genes does not 
alter a species 
People have 
different 
relations with 
different species 
Consumers 
(and 
babies) 
Afo risks Improved 
food 
production 
and food 
quality 
Food for 
target groups 
Patients 
(and 
premature 
babies) 
Production of 
biomedical 
proteins and 
clinical food 
Effective, and 
fewer side-
effects 
Human 
interests 
should bear 
more weight 
in balancing 
the interests 
No serious 
alternatives 
Proteins 
survive the 
stomachs of 
patients 
Producers: 
Gene 
Pharming 
High 
quantities at 
low cost: 
commercially 
attractive 
•Productivity 
or the 
protection of 
nature can 
also be good 
reasons 
Earning money 
can be ethically 
sound 
Producers: 
farmers 
Less 
production 
losses 
*No impact 
on cattle 
breeding 
•Productivity 
or the 
protection of 
nature can 
also be good 
reasons 
Science •Young 
researchers 
are forced 
to go 
abroad 
Improving the 
technique and 
abetter 
regulation of 
the effects 
•Medical 
progress 
•Scientific 
autonomy 
should not be 
restricted 
•Science should 
not be slowed 
down 
Next to the arguments of Gene Pharming, the arguments of Nutricia, the NIABA, Dutch researchers using or 
creating transgenic animals, the KNAW and the patients' organizations are incorporated. Arguments 
introduced by the experts and the KNAW (an expert organization) have been given an •. 
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Figure 5.3: View of the Dierenbescherming and its allies 1 8: "NO", because: 
Non-
maleficence 
Beneficence Respect for 
autonomy / 
animal 
integrity 
Justice: equal 
/fair 
treatment 
Values: the 
good life 
Morally 
relevant facts 
Animals Animals are 
made with 
deliberate 
mistakes 
Birth 
defects 
They will 
live a 
controlled 
life Effects 
on mature 
animals 
unknown 
New 
diseases? 
No positive 
health effects 
expected 
Not in the 
interest of the 
animals 
Respect for 
intrinsic value 
and animal 
integrity 
No reduction 
to mere things 
'New 
animals' 
•Violating 
the integrity 
is a major 
harm 
No use as bio-
reactor, 
chemical 
factory, 
disposable 
Animals 
should be 
treated 
equally 
Fungi and 
animals 
should be 
treated 
differently 
No sacrificing 
of animals for 
profit 
•Slippery 
slope 
•The more is 
unclear the 
more seems to 
be allowed 
No mixing of 
humans and 
animals: 
monsters, 
'Frankenstein* 
No need to use 
animals 
(alternative 
methods) 
Species The natural 
variance of 
the 
livestock 
might 
diminish 
The new 
genes change 
the species 
Respect for 
evolutionary 
processes and 
for inherited 
characteristics 
Original breeds 
might disappear 
Consumers 
(babies) 
Their moral 
concerns 
are 
neglected 
No benefits 
for consumers 
They want 
animals to 
have a fairly 
natural life 
•They want 
animals to be 
respected 
They think it an 
immoral way of 
cattle breeding 
and playing 
God 
Patients 
(and 
premature 
babies) 
False hope 
They are 
being 
misused 
No vital 
medicine 
Traditional 
norms and 
values should 
not be sacrificed 
for progress in 
medicine 
Production in 
animals has not 
yet been proved 
and neither has 
the medicine 
•Still highly 
theoretical 
Producers: 
Gene 
Pharming 
Economic 
reasons and 
technological 
developments 
should not 
count 
Producers: 
farmers 
No benefits 
for breeders 
and farmers 
Economic 
reasons 
should not 
count 
Science •Irresponsible 
optimism 
Next to the views of The Dierenbescherming, the views are presented of the Christelijke Plattelands Jongeren, 
the Stichting Natuur en Milieu, Lekker Dier, the Nederlands Agrarisch Jongeren Kontakt, the Alternatieve 
Konsumentenbond, some ethicists and philosophical experts and some animal scientists who subscribe the 'no' 
of the Dierenbescherming. Experts opinions are marked with an •. 
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Figure 5.4: View of the Ministry of Agriculture and its allies 1 9: "NO, UNLESS", because: 
Non-
maleficence 
Beneficence Respect for 
autonomy/ 
integrity 
Justice: equal 
/fair 
treatment 
Values: the 
good life 
Morally 
relevant facts 
Animals Harm 
should be 
prevented 
*Hardly 
any harm 
should be 
allowed 
•Harm 
should be 
monitored 
• The many 
abortions 
and birth 
defects are 
not due to 
the gene, 
but to the 
process 
*No benefits 
expected, as 
mastitis is a 
multi-
factorial 
disease 
•Cows for 
medicine will 
be treated 
well 
Respect for 
the intrinsic 
value and 
for animal 
integrity 
•Patenting 
also is 
morally 
problematic 
•Less 
invasive 
alternatives 
should be 
preferred 
Experiments 
need to be 
ethically 
sound 
•Mastitis 
prevention is 
not a good 
reason 
•Very strong 
reasons are 
needed 
•The burden 
of proof 
should be 
inverted 
This is a new, 
morally 
problematic 
development 
•A public 
debate is needed 
•No mixing of 
humans and 
animals 
Alternatives do 
not seem to be 
useful and of 
sufficient 
quality 
The gene is 
human-identical 
•The origin of 
the gene is a 
minor question 
•Theories are 
not clear about 
animal 
transgenesis 
•Lack of 
knowledge 
•Alternatives 
are available 
Species Crossing 
the species 
barrier is 
morally 
problematic 
Consumers 
(babies) 
Safety 
precautions 
have to be 
taken 
There might 
be good uses, 
•e.g. 
humanised 
milk 
•Luxury 
products and 
cosmetics are 
not good 
reasons 
•Frightening 
perspective 
•People should 
know what is 
going on in the 
laboratories 
•The 
developments 
are far-reaching 
and unknown 
Patients 
(and 
premature 
babies) 
Vital 
medicine are 
an option 
•Balancing in 
case of 
human health 
and welfare 
•Only in case 
of vital 
diseases and 
medicine 
A public debate 
is needed 
•Lactoferrin 
produced in 
micro-
organisms may 
be as good 
Producers: 
Gene 
Pharming 
•Economic 
reasons 
should not 
count 
Regulation is 
needed 
Producers: 
farmers 
•Farmers did 
not ask for it 
•Economic 
reasons 
should not 
count 
Science Dutch 
researchers 
should not 
be hindered 
•A giant step 
forward 
•New 
scientific 
options 
•Experiments 
should be 
controlled 
•This cannot be 
left to scientists 
alone 
•A public 
debate is needed 
Next to the arguments put forward by the Ministry, the additional reasons given by its advisory committees and 
some experts are mentioned. Expert opinions are marked with an •. 
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The outcomes. 
A first impression of the matrices shows that Gene Pharming puts particular 
emphasis on the benefits for consumers, patients and producers, and that the 
Dierenbescherming emphasises the backlashes for the animals and species. The 
Ministry is reserved. It does not reject animal transgenesis, but acknowledges that 
it is morally problematic. It transpires from the schemes that most experts have 
argued in favour of a 'yes, if a certain set of conditions is fulfilled' or of a 'no, 
unless there are sufficient reasons for doing so' policy. Hardly any experts 2 0 have 
publicly supported the absolute 'no ' of the Dierenbescherming. 
Individual writers to the editor, editors writing an editorial, as well as the 
journalists who wrote an opinion page article did not bring about new arguments or 
insights. A few of these expressed quite elaborate opinions that were a 
recapitulation of the arguments put forward by either the Dierenbescherming, or 
Gene Pharming, or an expert. 
In this sub-section, I will analyse the different positions. In the next ones, I will go 
into the controversies that have become manifest from the schemes. 
The 'no' of the Dierenbescherming was initially supported by some public interest 
organisations. Later in the debate, the Dierenbescherming actively organised its 
support. As can be suspected, this did not produce any additional arguments, which 
means that the Dierenbescherming produced most of the arguments in favour of the 
'no ' position itself. It argued that the principles of non-maleficence, of respect for 
autonomy and for justice are at stake with respect to animals, and that the 
principles of non-maleficence and respect for autonomy are violated concerning 
species. This last point is interesting, since from the outset the Dierenbescherming 
has always been concerned with (the suffering of) individual animals only. Its 
concern does not extend to nature. In this debate, though, it has co-operated with a 
major nature-conservation organisation, namely the Stichting Natuur en Milieu. 
They could do so, because of a common interest in species. How can this new 
interest of the Dierenbescherming be explained? It does not seem to be a strategic 
consideration only, since arguments referring to the harming of species had been 
put forward from the very beginning of the debate. I suppose the subject of the 
debate itself has induced this new scope 2 1 . Regarding animal transgenesis, the 
Dierenbescherming could not limit itself to its traditional arguments of animal 
Thijs Visser, biologist and bio-ethicist, is such an exception. Jan Grommers, veterinarian and bio-
ethicist, seems to be balancing between an 'no', and a 'no, unless' position. 
Aside: the notion of a species had already entered the discourse of the Dierenbescherming with 
regard to the treatment of the individual animals. They advocate that animals must be able to 
exhibit their species-specific behavior. 
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suffering. Although there also was a discussion about harm being done (in 
particular harm done during the actual 'production' of the transgenic animals) the 
central issue regarding the mature animals was not a question of harming the 
animals, but of changing the genetic make-up of animals. The individual animals 
were changed on the level of the species as genes of other species were introduced 
into the genome. This is exactly what the Dierenbescherming means by not 
respecting the intrinsic value of the animal and by violating animal integrity: the 
nature of the animals (and so of the individual animals) is changed. 2 2 
The Dierenbescherming has also argued that the consumers are on its side. The 
Alternatieve Konsumentenbond indeed was one of its allies. Arguments referring to 
consumers, however, arose in a later stage of the debate. These arguments were a 
reaction to arguments of Gene Pharming in particular and its interpretation of some 
public opinion surveys. I assume that this means that these arguments were not 
central to the view of the Dierenbescherming. The same can be said about its 
remarks regarding the supposed benefits for patients and its statement that producer 
interests should not count if animals are at stake. 
Although the Dierenbescherming has argued in favour of a ban on animal 
biotechnology, it also has argued for what they regard as a correct interpretation of 
a 'no, unless' policy. In particular they have stressed the obligation to develop and 
use alternative production methods. Furthermore, they have tried to take the edge 
of the arguments in favour of animal biotechnology. In entering in these 
discussions, they apparently abandoned their unqualified 'no ' position, but in fact 
they did not. 
Central to the 'yes, if position of Gene Pharming were the beneficial effects for 
consumers, patients, and producers as well as for animals, without harming the 
wellbeing of the animals. It has even stressed that the animals will be well off, as 
they are valuable, and have to be kept in good condition. Another core argument 
was its denial of animal transgenesis being morally problematic, as it is not a moral 
novelty. In its view, animal transgenesis is in line with classic breeding. It has 
stressed that the animals remain, despite genetic modification, individuals of their 
species, because the inserted genes have a similar structure and function as the 
originals. It regards animal transgenesis as a natural way of changing animals that 
is compatible with traditional livestock breeding. They have also put forward that 
See also: Visser, M.B.H. and Verhoog, H. (1999) De aard van het beestje. De morele relevantie 
van natuurlijkheid. [The nature of the animal. The moral relevance of nature.] NWO Ethiek en 
Beleid. Den Haag. 
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transgenic animals already exist for over a decade (laboratory animals), and that 
nobody has ever complained about it. Furthermore, it points at a moral 
inconsistency; namely, animals are treated more badly in factory farming. 
It is obvious that the reasons mentioned by Nutricia, the NIABA, and Herman de 
Boer more or less agree with the views of Gene Pharming, since they have a 
common interest in animal biotechnology. 
The arguments of the experts were not directed at livestock breeding but at animal 
experimentation. Most experts are biomedical researchers, working with transgenic 
mice. Like Gene Pharming they have argued that animal transgenesis is nothing 
morally new. Their main argument is that species also change under the influence 
of viruses, which in their view means that the species barrier cannot really be an 
argument. Furthermore, they have argued that animals are sometimes badly harmed 
in animal experiments, which is permitted if the purpose is sound enough. Their 
arguments mostly refer to the benefits for science and in the end for patients. 
Researchers have also stressed another aspect, namely scientific autonomy. This 
argument was intensively discussed in the seventies during the debate on 
recombinant DNA, but it did not find much response in the underlying debate on 
animal transgenesis. Apparently, it has become common sense that scientific 
autonomy can be restricted when public support is lacking. From the schemes, it 
can also be concluded that economic autonomy can be restricted for the same 
reasons. This is not a novelty in the Netherlands either. In the Netherlands 
commerce, profit etcetera are not reckoned as serious arguments for harming 
animals. Only Rene von Schömberg suggested that productivity, and so the 
'wellbeing' of firms can be an argument in favour of animal transgenesis. He, 
however, did not give reasons for his point of view, and nobody has supported or 
even reacted to it either. 
The patients' organisations have argued in favour of patients only. They have 
pointed at the opportunities of creating effective medicine by means of this 
technology, and the advantages this technology might have compared to alternative 
production methods. They did not react to any other aspect of the case, which is 
predictable, as they are, like the Dierenbescherming, single-issue organisations. 
Herman de Boer has been a category of its own, since he was very explicit about 
his views on animals and animal biotechnology. Besides from being the main 
spokesperson of Gene Pharming for most of the time, he has repeatedly stressed the 
special relationship that Dutch people have with cattle, which in his view should 
result in a more careful treatment. This also is the reason why he is prepared to 
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differentiate among different species of animals, which the Dierenbescherming 
furiously rejects ('all animals are equal'). 
Researchers also stress these differences: they have asked for a special treatment of 
laboratory animals as these animals are used for medical purposes. Their position, 
however, differs from the position of Herman de Boer. De Boer has stressed that 
people prefer a better treatment of farm animals with which they have a special 
relationship. Researchers have stressed that laboratory animals always were treated 
differently from other animals and that therefore regulation should be less 
stringent. Their conclusions are the same, the argumentation, however, differs. 
The 'no, unless' position of the Ministry of Agriculture, Nature Conservation, and 
Fisheries was supported by advisory committees and by experts. These committees 
and experts have taken a more or less detached point of view, seeking for a way of 
handling animal biotechnology. Especially the experts have had a major input, 
stressing new, additional arguments. The scheme shows that the Ministry and its 
advisory committees have only used a few arguments that were mainly directed at 
the policy that had to be chosen 2 3. They have hardly addressed the case at hand, at 
least they did not argue for or against it. From this scheme it might even be 
concluded that although the Ministry has asked for a public debate, and has asked 
experts to write reports in order to stimulate the deliberations it only had a minor 
input itself. 
The additional input of the experts was mainly directed at the interpretation of the 
'no, unless' policy-principle, and in particular of the 'unless' part of it. They have 
argued about what might be sufficient and insufficient reasons for making an 
exception on the 'no ' (see the justice column). 
Acknowledging intrinsic value and animal integrity: the central issue 
Whether animal transgenesis as such is morally problematic or not has been 
considered a question of whether or not the intrinsic value of the animals is 
violated. The notion of the mtrinsic value of the animals was introduced in the 
debate as a broader concept than the general accepted concepts of animal health 
and welfare. Intrinsic value namely includes the idea of animal integrity. Animal 
integrity and therefore intrinsic value has been the core issue of the debate. These 
I would like to note that the reports written by the advisory committees did have a major input in 
the debate, but not by way of citation in the press. The media have preferred to interview 
individual members of the committees. These members have explained and commented on the 
recommendations given by the committee at hand. Most of these views expressed individual 
opinions and were therefore processed as expert opinions. 
87 
concepts were put forward by experts and by the Dierenbescherming and were 
soon acknowledged by all participants that took a 'no ' or a 'no, unless' position. 
People and organisations in favour of 'yes, i f policy have stressed that the intrinsic 
value was not at stake. And they react as if the concepts of intrinsic value and 
animal integrity are imposed upon them. And it is questionable whether they have 
acknowledged these concepts at all. For them only animal health and welfare are 
serious arguments. Herman de Boer, for instance, argues that it is allowable to 
genetically modify animals if no harm is done to animals. So, changing the genetic 
make up of the animals as such is not considered an issue, but the possible harm 
done to the animals is. In reaction to their opponents, they have stressed that animal 
integrity, and so the intrinsic value, will not be harmed. 
People and organisations that adhere to a 'no, unless' policy consider the intrinsic 
value of animals and animal integrity the main reason for this policy. The changing 
of the genetic make up of animals as such is morally problematic. This means that 
the questions whether or not animals have intrinsic value and whether or not their 
integrity is violated have been crucial in their view. 
The intrinsic value and animal integrity, however, have not been argued about in 
the newspapers. In the newspapers, people have only referred to the intrinsic value 
or to animal integrity, without an explanation. This does not mean that there has 
not been a debate on these subjects. On the contrary, there has been a serious 
expert debate, with articles in philosophical journals, conferences, workshops, 
expert seminars etcetera. It only means that the broader public has not been 
confronted with the arguments for and against these new concepts and therefore 
was not able to arrive at a considered opinion about a 'yes, i f or 'no, unless' 
policy. At the most they could arrive at the intuition that animal transgenesis is or 
is not morally problematic. This means that this opinion formation process might 
have been facilitated in a better way. 
Summarising, I conclude that the positions of the main actors in the debate are 
determined by their attitude towards animal integrity and intrinsic value. In the 
next section, I will discuss what this has meant for the structure of the debate. 
'Yes, i f or 'no, unless' 
Positions are always sustained by reasons. In this particular debate, the different 
positions in the debate that are determined by different attitudes regarding animal 
integrity and intrinsic value were related to different ways of reasoning. People 
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with a 'yes, i f position have stressed the benefits. These benefits are more or less 
evident. They will only be stressed if there are also reasons for not making 
transgenic animals, for instance if the animals will be harmed. If animals are 
harmed, the benefits will have to be balanced against the harm being done. 
These benefits come back as 'sufficient reasons' in the column of fair treatment if 
people adhere to a 'no, unless' position. Within a 'no, unless' reasoning the 
benefits will have to be strong enough to make an exception on the 'no ' . Harms 
will only come into play if the reasons are potentially strong enough for making an 
exception. In this view reasons have to be much stronger than in the 'yes, i f view. 
Exceptions will only be debatable if human health is at stake, or, even stronger, if 
human lives are at stake (vital medicine and lethal diseases). In figure 5.5, the 
differences between these two lines of argumentation are summarised. 
Figure 5.5: Summarising scheme of the two types of argumentation (yes, if, and no, unless) that are 
caused by a difference in perception of the moral impact of animal biotechnology. 
Intrinsic value / animal integrity is an argument 
No, unless policy 
No 
Is there an alternative? 
Is this alternative realistic? 
Are the animals treated fairly? 
-Is there a sufficient reason? 
-If the reason is sufficient; does it 
outweigh the harms? 
Yes, if policy 
Do the benefits outweigh the 
harms? 
Consequentially there were two levels in the discussion. One level refers to the 
most general issues of the debate namely 'Is animal transgenesis as such 
allowable?' 'Should we continue the experiment?' and 'How should animal 
transgenesis be regulated?' This discussion continues throughout the debate. Next 
to this general discussion a number of specific issues were raised. These issues 
were discussed in the light of the core issue(s). These issues, as we saw, refer to the 
other three principles, to notions of the good life, or were factual discussions. 
The main outcome of the debate on the core issue(s) has influenced the debates on 
the other issues. For instance, it is obvious that as soon as Parliament decided for a 
'no, unless' position as the point of departure for legislation (in May 1990), all 
participants started to argue about the 'unless' (for or against, about the conditions 
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for making exceptions et cetera). From this moment on the alternative production-
methods became subject of the discussion, as well as the reasons for making 
exceptions. In the view of the Dierenbescherming a 'no, unless' position implied 
that if an alternative is possible this should be investigated first. Only if such an 
alternative does not work out as expected there might be a good reason for making 
an exception. Gene Pharming has always stated that in vitro (non-animal) produced 
alternatives will not be of the same quality as the products from transgenic animals 
and that these alternatives will be very expensive. Whereas the last argument did 
not put any weight in the discussion (I will discuss this elsewhere), the first one 
did. The Ministry and its advisory committee on alternatives (Committee 
Kooreman) have interpreted the 'no, unless' principle quite differently from the 
Dierenbescherming. In their view, only feasible and effective alternatives should 
count as a realistic alternative. So, both paths should be developed. Only if the 
alternative proves to be a realistic alternative should the transgenic path be ended. 
Political parties and politics 
I did not process the reasoning of the political parties in the matrices. I did so 
because of the way this reasoning was handled in the media. Reports on political 
discussions in the newspapers always arrived mediated by journalists. Only once a 
politician has written an article on animal biotechnology. Politicians were never 
interviewed. The only reports on their views were the reports on the parliamentary 
discussions in the papers. These reports always had the character of an overview of 
the opinions in only a few lines. In practice this has meant that only positions were 
mentioned and hardly any arguments for or against these positions. So, I will 
restrict myself to a short analysis of their views 
The political parties had another interpretation of the 'yes, i f - 'no, unless' 
controversy. Therefore, it seemed as if some parties had changed their opinion 
during the debate. The PvdA (social democrats), for instance, started with the 
request for a moratorium on animal biotechnology, because it wanted to gain time 
for a public debate. Shortly thereafter, it has pleaded for the 'no, unless' policy as 
the basis of the Animal Health and Welfare Law. And later, it wanted to impose 
restrictions (which is the 'yes, i f way of thinking) on the ground of the harm 
imposed on the intrinsic value of the animals. The CDA (Christian democrats), too, 
was formally in favour of a 'no, unless' policy, but often has argued from a 'yes, i f 
point of view. It seems as if these parties did not really make a difference between 
a 'no, unless' and a 'yes, i f policy in the way I have analysed these concepts in the 
former section. This 'confusion' might be caused by their main argument for 
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adopting a 'no, unless' policy, namely the prevention of undesirable developments, 
or, in other words, the adoption of a precautionary principle and a preference for a 
proactive instead of a reactive regulation. It is not the intrinsic value or animal 
integrity that they were primarily worried about. They just wanted to be able to 
control scientific developments instead of being taken by surprise by these 
developments. And they did not yet know what the restrictions would have to be if 
they would decide for a 'yes, i f policy. Therefore, they preferred a case-by-case 
approach for defining the (ethical, social, and political) limits of this new 
technology. In evaluating these cases, arguments pro and con could be evaluated; 
and restrictions and exceptions formulated. They did not seem to be interested in 
the formulation of these phrases (whether it is a sufficient reason or a benefit for 
instance); they seemed to be only interested in the outcomes. My cautious 
conclusion is that the political parties did not really make a difference between a 
'yes, i f and a 'no, unless' policy. In a way they had a point, since in the end, if the 
'yes ' would be completed with a limited list of restrictions, and if it is clear in 
which cases an exception on the 'no ' should be made, there probably will not be 
much difference between the outcomes. The main differences between these two 
policies from this point of view are the starting points and the initial arguments, not 
the outcomes. 
So, politics decided about a framework for decision-making, but did not 
substantiate the conditions or exceptions. This was convenient as public debate was 
still going on and politics could not be sufficiently concrete about the many issues 
it had to deal with. 
This means that the substantiation of this framework (the Animal Health and 
Welfare Act and the Decree on Biotechnology) is left to public debate, to the 
Governmental Council for Animal Issues and in particular to the advisory 
committee installed by the Minister of Agriculture (i.e. the Committee on 
Biotechnology in Animals). In practice, this means that substantive politics is 
developed by way of a case-by-case approach (or, in other words, by way of 
jurisprudence). Van den Belt 2 4 calls this a form of legal insecurity. He argues that 
the 'biotechnological actions he [the applicant for a license, ET] is planning to do 
are subjected to an 'ethical test' of which the criteria are not laid down clearly. This 
clarity cannot be given, as this case-by-case approach is directed at initiating a 
Van den Belt, H. (1998) Hoe liberaal is 'nee, tenzij'? Bespreking van F.W.A. Brom: 
Onherstelbaar verbeterd. Biotechnologie bij dieren als een moreel probleem. (Van Gorkum, 
Assen, 1997) [How liberal is 'no, unless? Review of FJ.A. Brom: Irreparable improved. 
Biotechnology in animals as a moral problem.]. In: Kermis en Methode: Tijdschrifl voor 
Empirische Filosofie 22/4, 342-348 
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process of public opinion formation in which 'new morals' will be formed. The 
applicant, therefore, is made into a plaything of an obscure process of developing 
morals in stead of being efficiently subjected to a clear administrative procedure' 
[my translation, ET]. Van den Belt, therefore, is in favour of laying down 
conditions or exceptions. He does not seem to acknowledge the complexity and 
unpredictability of new and fast scientific and technological development 
politicians are worried about. It seems to be impossible to determine all the 
restrictions in advance. The alternative indeed is what politicians are afraid of 
namely running behind the developments, being continuously taken by surprise by 
unsuspected side effects of new technologies and by public reactions of distrust in 
science as well as in politics (if the regulation proves to be insufficient). I would 
say, that the development of a new technology with an unpredictable en uncertain 
outcome indeed should, for some time, be accompanied with a public debate and so 
with unpredictable and uncertain regulation. A case-by-case approach will in time 
lead to a set of restrictions or exceptions. Only then will uncertainty and 
unpredictability for applicants diminish as the uncertainty and unpredictability of 
the technology has diminished. 
The usefulness of the matrices 
Mepham prefers to incorporate all the arguments with respect to an issue in one 
single matrix. He argues that this will facilitate rational public decision making by 
providing a framework for rational analysis. Initially, I had chosen to separate the 
arguments of the different actors, in order to show the differences amongst them. 
This was mainly a pragmatic consideration. I expected that different actors would 
lay a different stress on the four principles and on the different affected parties. It 
turned out that an honest treatment of the lines of reasoning of the different actors 
means that the same arguments put forward by different actors have to be listed in a 
different column of the matrix. If I had followed Mepham's procedure, I would 
have had a problem in filling out the arguments in the scheme, because, I would 
not have known where to put the reasons in favour of animal transgenesis. These 
reasons could have been 'benefits' in the column of beneficence or they could have 
been 'sufficient reasons' in the column of justice as fairness. Since, for actors who 
are not acknowledging animal integrity and intrinsic value these are benefits, and 
for actors that are acknowledging animal integrity these can be good enough 
reasons or not. And, the real controversy, namely whether animal transgenesis as 
such is morally problematic or not, would not have become as clear as it has 
become now. In the different matrices I have made, this fundamental difference in 
perception has become visible. This means that Mepham's aim with the matrix, 
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namely to facilitate rational public policy decision-making, is in my case much 
better met if several matrices are made that together better articulate the ethical 
dimensions of the issue involved. Only by making several matrices for each main 
line of reasoning, the different ways of valuing an issue have become transparent. 
The matrices do not show the developments over time. This omission is inherent to 
this kind of analysis. I would like to lift out two aspects for which time has played 
a role. In the first two years, many arguments were put forward as a candidate for 
an adequate new norm for dealing with animal biotechnology and in particular with 
animal transgenesis. For instance naturalness, playing God, deliberate 'mistakes', 
the species barrier, respect for evolution were mentioned. Only in the course of the 
debate, it proved that these concepts were less adequate than the concepts of animal 
integrity and intrinsic value. It is sometimes said that all the arguments are put 
forward in the first few months of a debate and that nothing new is added later. In a 
way this is true, but what happened in the course of a debate is that the arguments 
that were put forward in the beginning were better articulated and got different 
weights. Some found more and more response; others faded away because of lack 
of response. And in the course of a debate some arguments got better articulated 
and better specified with respect to specific cases (see the next chapter). 
Another influence of time was that as soon as politics had decided in favour of a 
'no, unless' policy Gene Pharming and after some time the researchers have 
formally deferred to this policy. Their input in the deliberations from that moment 
on got a double message: 'this is what we stand for, but we defer to the formal 
policy'. Consequentially, the participants increasingly started to argue about the 
'unless'. In a way this can also be said about the Dierenbescherming although they 
have never formally deferred to the official policy. Part of their input in the 
discussion now concentrated on alternatives for animal transgenesis and on good 
reasons for making exceptions. 
Conclusion 
This chapter concerns the positions and lines of reasoning regarding the central 
issue of the debate. Arguments were classified according to an adapted matrix of 
Mepham which I have used as a heuristic device. These adaptations are mentioned 
in second section. Most important are the changes I have introduced in the 
interpretation of the bio-ethical principles of Beauchamp and Childress that are 
originally meant for humans and that are now 'translated' into principles regarding 
the treatment of animals. 
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The way I have used the matrix allows to reconstruct the different positions in the 
debate and the underlying lines of reasoning. Gene Pharming has argued in favour 
of a 'yes, if a certain set of conditions is fulfilled' policy and has put emphasis on 
the benefits for consumers, patients and producers. The Dierenbescherming has 
stressed the backlashes for the animals and for species; their 'no ' has not been 
central to the discussion, however. The Ministry of Agriculture and many experts 
were in favour of a 'no, unless there are good reasons for doing so' policy. 
It turns out that the stand that a participant takes originates from a different 
perception of the moral problem involved. Actors in favour of a 'yes, i f policy did 
not acknowledge the intrinsic value of the animals; and participants in favour of a 
'no, unless' position have stressed the intrinsic value of the animals as well as 
animal integrity. Both positions have resulted in different questions with respect to 
animal transgenesis. 
During this debate the meaning of 'caring for animals' has changed in content. It 
used to mean taking care of the health and welfare of animals; now it also means 
caring for animal integrity. 
In the next chapter, I will choose a different angle for analysing the content of the 
debate. I will focus on some specific applications of animal transgenesis. I will 
show that the context in which a debate takes place influences the outcome. 
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6. Which practice, what norms? 1, 2, 3 
Animals are not always treated equally. Rabbits for instance are differently treated 
depending on the context in which they are kept: a pet is differently treated from a 
laboratory rabbit and this rabbit will be differently treated from a store-rabbit. The 
norms and values for, in this case, rabbit keeping will depend on what the animals 
are kept for. Some animals, however, are associated with only one context. Cattle 
for instance are only associated with cattle farming. Therefore it did matter for the 
debate on animal transgenesis that Herman was a bull instead of another animal. 
Many Dutch people have special ties with dairy cattle; they value dairy cattle as an 
element of the Dutch cultural identity and they consider them as fully dependent on 
human care. This cultural background has undoubtedly caused the huge public 
involvement in the debate on animal transgenesis. Herman the bull, however, did 
not only open the eyes of the public for the developments in animal biotechnology, 
but, Herman, being a bull, also has shaped the content of the debate. As people 
have special ties with dairy cattle, they also have strong feelings and images about 
dairy cattle farming. In their eyes, Herman the bull could not be considered as just 
a laboratory animal. He remained a dairy farm animal all the time, that is to say an 
individual animal in the context of dairy farming. But he was not an ordinary farm 
animal either, because of the experiment he was involved in. So, Herman the bull 
1 Parts of this chapter were already published in: E.P. Theune (1997) De stier Herman en het 
ontstaan van een nieuwe praktijk. Een inhoudelijke reconstructie van het Nederlandse debat over 
dierlijke biotechnologie. [Herman the bull and the emergence of a new practice. A reconstruction 
of the content of the Dutch debate on animal biotechnology] In: L.P.F. Pijnenburg (ed.) 
Vijandbeelden in de filosofie. [Images of enemies in Philosophy] p. 149-156 Wageningen 
University, Wageningen. 
2 My ideas about practices were shaped by the discussions in the Group of Applied Philosophy at 
Wageningen University. See for instance: H. Koningsveld (1988) De kwaliteit van zocHechnologie 
[The quality of zofitechnology]. In: Kwaliteiten in de dierlijke productie, bijdragen aan het 3e 
Zodiac - symposium Wageningen [Qualities in animal production, contributions to the 3rd Zodiac 
- conference Wageningen] Pudoc.Wageningen; B. Gremmen (1993) The Mystery of the Practical 
Use of Scientific Knowledge. Dissertation Universiteit Twente; S. Lijmbach (1993) 'Het Konijn' 
[The Rabbit] unpublished paper about the different practices of rabbit keeping 
3 It is interesting that Collin Spedding (2000) has published a book recently in which he also 
distinguishes different practices of animal keeping and in which different practices have different 
standards with respect to the handling of animals. My practices are more specific however, as this 
is adequate for my research (see the first and second section). 
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did not fit in with the traditional categories of thinking about animals: he was 
neither an ordinary laboratory animal nor an ordinary farm animal. 
This inability to fit in with one of these contexts will be the content of this chapter. 
In the former chapter, I have taken the arguments at face value. In this chapter, I 
will show how the contexts from which the participants enter the debate influence 
the kind of reasons that are put forward and the stresses people put on some 
arguments and not on others. These contexts can only be detected and analysed 
when the researcher takes a step back and takes a perspective that is external to 
these practices. This is what is called an external or outside perspective. These 
contexts become the more important as specific applications are involved. The 
different contexts involved can be a source of dynamics next to the dynamics 
caused by the developing case we have witnessed in chapter 3. 
I will start with the introduction of the concept of a practice. Next, I will describe 
the four practices at stake. Subsequently, I will explain what has happened during 
the debate and what has been the outcome. And I will end with a concluding 
section. 
The concept of a practice 
It is common (but discussed) practice to appreciate animals differently if they 
belong to different practices of keeping animals. For instance, a rabbit is differently 
appreciated in the wild, in the fur-industry, and as a pet. The moral status of a 
rabbit may differ depending on the practice it belongs to. 
The concept of intrinsic value that I have introduced in Chapter 5 does not allow 
for degrees. Something has intrinsic value or it has not, and the intrinsic value is 
violated or it is not. Moral status, however, is a gradual concept4, which means that 
animals can have more or less moral status. This moral status will affect the 
treatment of that animal. It is a dynamic concept as well: how we value animals 
may rise (or fall). And this means that the moral status of an animal may depend on 
historically, culturally, and personally fixed differences among animals, and on our 
knowledge regarding these animals 5. So, for the understanding of what has 
happened in this particular debate, the context in which the animals were valued is 
of great importance. 
Many such contexts can be disseminated. In this chapter, a specific kind of context 
will be central, namely a practice. A practice can be defined as a social domain of 
4 Dr. Tjard de Cock Burring (2000) De status van het dier [The status of the animal]. Inaugural 
speech, Utrecht University 
5 Ibidem 
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action with its own norms and values about what is good or bad practice within the 
context of the practice. Such a practice will influence the interpretation of the more 
general norms and values with respect to the issue at hand as well as the 
interpretation of the norms and values that are related to notions of the good life 
within the culture 6. 
Alisdair Maclntyre has defined the concept of a practice more specific, namely as: 
any coherent and complex form of socially established co-operative human 
activity through which goods internal to that form of activity are realised in the 
course of trying to achieve those standards of excellence which are appropriate 
to, and partially definitive of, that form of activity, with the result that human 
powers to achieve excellence, and human conceptions of the ends and goods 
involved, are systematically extended' 7. 
This means that norms about justifiable actions and about adequate competence 
can be disseminated in every practice, and that these norms are developed 
continuously: 
'To enter into a practice is to accept the authority of those standards and the 
inadequacy of my own performance as judged by them. (....) Practices of 
course, as I have just noticed, have a history: games, sciences and arts all have 
histories. Thus the standards are not themselves immune from criticism, but 
nonetheless we cannot be initiated into a practice without accepting the 
authority of the best standards realized so far.' 8 
Such domains of action can be disseminated on several levels of analysis. One can, 
for instance, speak of the agrarian practice (or sector), but also of livestock 
breeding, or dairy farming as a practice. And within, for instance, the practice of 
dairy farming one can even distinguish different styles of farming. On each level, 
people have their collective notions about 'this is how we do it', 'this is what we 
stand for', 'these are our ideals', 'this is a good farmer', 'this is good practice' and 
6 See for instance: J. Rawls (1971) A Theory of Justice. Cambridge, Mass.: Harvard U. Press. J. 
Rawls (1993) Political Liberalism, New York: Columbia U. Press. J. Habermas (1993) On the 
Pragmatic, the Ethical, and the Moral Employments of Practical Reason, In: J. Habermas: 
Justification and Application. MIT. J. Habermas (1985) Moral und Sittlichkeit, In: Merkur 1985. 
p. 1041 - 1052. J. Habermas (1986) Life-forms, Morality and the task of the Philosopher. In: Peter 
Dews (Ed.) Habermas autonomy and solidarity: interviews with Jürgen Hbermas. London, New 
York: Verso New Left Books. J. Habermas (1984) Über Moralität und Sittlichkeit - Was macht 
eine Lebensform >rational<? In: H. Schnädelbach (Ed.) Rationalität Frankfurt am Main: 
Suhrkamp. M. Walzer (1983) Spheres of Justice. A Defence of Pluralism and Equality Oxford UK 
& Cambridge USA: Blackwell. 
7 A. Maclntyre (1981) After Virtue. A study in Moral Theory. Notre Dame, Indiana: U. of Notre 
Dame Press, p. 182. 
8 Maclntyre (1981) p. 190. 
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so on and so forth. These are aspects of notions of the good life that are not 
committed to a specific culture or subculture but to a specific practice within a 
culture. It should be noted that people usually belong to one culture, but can 
participate in several subcultures and practices, which might cause all kinds of 
conflicts between the norms and values that are specific to these different 
subcultures and practices or between these and the more general culture. And 
because of the internal dynamics of a practice, certain activities might meet a limit 
within the practice itself as well 9. 
There may be other reasons too for starting a discussion on norms and values. For 
instance, a new technology might create its own practice, or it might cause 
discussions about the practice this new technology belongs to. In both cases, a 
discussion may arrive on the norms and values that should be applied to the new 
technology. From these examples, a dynamic concept emerges of practices, and of 
the norms and values inherent to that practice. 
The practices at stake 
At the start of the project Gene Pharming has mentioned a very general aim, 
namely to change the genetic make up of cattle in order to produce specific 
proteins in the milk. The changing of the genetic make up of the animals has been 
discussed throughout the debate in general terms (see chapter 5). After the birth of 
the first calf, however, three specific reasons for making these animals were 
discussed subsequently, to wit: 
• The protection of the animals themselves against mastitis (issue 4); 
• The development of a technique for producing human medicine (issue 3); 
• And the production of specific proteins to be used in specialised infant and/or 
clinical food (issue 2). 
These reasons refer to three different practices, to wit the veterinary practice, the 
biomedical production practice, and the specialised food production practice. Each 
of these practices has a sub-practice in which research is done and animal 
experiments are performed. Next to these practices the dairy farming practice also 
played a part in the debate, as it was the genome of dairy cattle that would be 
changed to produce milk containing the proteins wanted. In figure 6.1, these 
practices are roughly put into a scheme. To better describe the practices at stake, I 
will use Maclntyre's terms. Maclntyre has characterised a practice as a specific 
Frans Brom (1997) Onherstelbaar verbeterd. Biotechnologie bij dieren als een moral probleem. 
[Irreversibly improved. Biotechnology in animal as a moral problem] Van Gorkum Assen. 
99 
human activity, that produces specific (material or non-material) goods, that has its 
own goals and aims, and its own standards (norms and values). And there are off 
course practitioners of the practice. In my discussion, I will also incorporate the 
consumers (users) of the good as well as the broader public that may have all kinds 
of views on and expectations of the practice. These additions reveal that in my 
view practices are no isles in the world but have all kinds of relationships with the 
broader social world. To become a practitioner means to adhere to the standards of 
the practice, but for an outsider who maintains relations with the practice or who 
has political views about the practice these standards are much less compelling. 
Figure 6.1: Rough scheme of the practices involved, each with an animal experimentation practice 
(aep). 
In the continuation of this section, I will concentrate on the ordinary activities of 
the practices. The debate on animal transgenesis will be the subject of the next 
section. I will not describe the practice in full, but I will concentrate on those 
aspects that will be relevant for the next sections. 
The veterinary practice is a human activity that is oriented at producing animal 
health and welfare (end), by preventing and curing animal diseases (goods). But 
this does not mean that veterinarians (practitioners) serve the interests of the 
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animals only. Bart Rutgers , for instance, has shown that the views of the owners 
(users) usually are dominant in the decisions that are made with respect to animals. 
So, differences in treatment may occur depending on the attitude of the owners 
towards their animals. This means that the purposes of the practice are dependent 
on the views of the owners. And so will the standards. For instance, economic 
standards will be applied to the veterinary treatment of production animals: the 
owner will make a cost-benefit analysis. Regarding pets, however, emotional ties 
will dominantly guide the decisions of the owners. Some owners will even apply 
standards that are almost equal to those for humans. The broader public sees a 
veterinarian as animal's doctor. Consequently, most people will share the views 
and standards of pet-owners. 
Animal experiments within this context will be directed at the care for the health 
and wellbeing of the animals (purpose) only. That is to say, they are oriented at a 
better insight in animal diseases, at the development and testing of medicine, and at 
the development of and training in (in case of students) veterinary treatment. A 
discussion inherent to this specific animal experimental practice always is whether 
animals may be used and hurt to find cures for the diseases of other animals. If the 
animals themselves may benefit from the experiments, people will tend to be rather 
tolerant with respect to the experiments. 
The biomedical production practice is a human activity oriented at the health and 
wellbeing of humans (end). Medicine, vaccines, and other biomedical products 
(goods) are developed, produced, and tested by means of biochemistry, micro-
organisms, tissue-culture, or animals. Patients and doctors (users) will use these 
products for preventing and curing diseases. For research and production purposes 
many laboratory animals, mostly mice and rats, are used. These animals are more 
or less anonymous, as they have no personal name, are bred for this purpose, lead a 
short life, and are easily replaced. Animals sometimes are severely harmed in the 
experiments 1 1. The last few years, researchers (practitioners) are increasingly using 
transgenic animals as a means for producing medicine. Within the practice, 
human health is the highest good (standard). Animals will be used for medical 
Rutgers, L.J.E. (1993) Het wel en wee der dieren. Ethiek en diergeneeskundig handelen. [The weal 
and woe of animals. Ethics of veterinary practice]. Dissertation Utrecht University. 
Vétérinaire Hoofdinspectie van de Volksgezondheid (1996) Registratie dierproeven en 
proefdieren. [Registration animal experiments and laboratory animals] Rijswijk. Ministerie van 
WVC. 
1 2 Van der Meer, M. (1994) Transgenese bij dieren. Inventarisatie technieken en toepassingen. 
Gezondheids- en welzijnsaspecten. [Transgenesis in animals. Review of techniques and 
applications. Health and welfare aspects.] Thesis. Group of Laboratory Animal Studies, 
Veterinary Faculty Utrecht University. 
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purposes if the research design is adequate and if respect is paid to the three R's of 
Russell and Burch 1 3 (standard). This means that animal interests have some weight, 
as their interests are the source of these restrictions. Most researchers are 
convinced that in the biomedical practice, human interests outweigh animal 
interests 1 4. The broader public adheres to this view. A minority wonders whether 
animals are sometimes too easily used, as they utter doubts to at least some of this 
research. They are primarily worried about fundamental research that has no direct 
relation with applications in the sense of an improvement of the care for human 
health and welfare and that cause severe pain to the animals. In short: in the context 
of this practice, animals are usually seen as 'just' laboratory animals that may be 
used for all kinds of biomedical research with some restrictions. 
The specialised food production practice of clinical or baby food production is 
considered another branch of human activities than ordinary food production or 
dairy production. Specialised food (goods) is produced for specific groups of users 
that cannot digest normal food or normal dairy products. One cannot speak of one 
group of users. For instance, standard infant formula is made to replace mother's 
milk. Other baby food products are made varying from cookies to canned carrots in 
order to facilitate parents with easy food. Specific infant formula is made for babies 
that cannot digest standard infant formula. And all kinds of food products are made 
for patients that cannot eat or digest normal food. The end of this activity is to 
produce better food-replacing products (end). It is an industrialised activity and the 
practitioners usually are (bio-) chemists and (food-) technologists. Standards are 
the production of safe, healthy, and appropriate food. 
Animal experiments will be executed for the testing and controlling of the 
effectiveness and safety of the products. 
Most activities in this branch are not very well known to ordinary people. They 
only know the cans of infant formula and the baby food products they can buy in 
supermarkets. They do not recognise most of these activities as paramedical 
activities. Therefore, they will see these as food business or as agribusiness. 
Consequently, people have a strong commercial connotation to this practice. And 
in the Netherlands there is a strong tendency not to allow animal experiments for 
commercial reasons. So, public support for performing animal experiments will be 
quite low and even lower the more impact the experiments will have on the 
1 3 Russell, W.M.S. and R.L. Burch (1959) The principles of Humane Experimental Technique. 
London. Methuan & Co Ltd. The three R's stand for Refinement of the research design as to inflict 
as little pain and distress as possible, Reduction of the number of animal as far as possible, and 
Replacement of animals by in vitro systems or by animals that will suffer less. 
1 4 Stafleu, F. (1994) The ethical acceptability of animal experiments as judged by researchers. 
Dissertation. Utrecht University. 
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animals. These public standards do not cohere with the standards inherent to the 
practice. 
The practice of dairy cattle farming is quite a different matter. This is a human 
activity directed at the production of milk (end) for dairy products (goods). A main 
standard will be the optimising of farming results and so a good income for farmers 
(practitioners). Another standard will be a safe and healthy product for the 
customer (user). Lately some additional standards are imposed on the practice from 
outside (that is to say from legislation and /or public opinion) concerning the health 
and welfare of the animals (as such, not as a means for enlarging the production) 
and concerning the care for the environment. Depending on the farming style, and 
so the attitude of the practitioner, these additional objectives will have different 
weights. For an outsider to the practice it seems as if dairy cattle have a good life. 
And it is obvious that the animals will be kept in good health, since if they were not 
kept in good health, they would produce less. On the other hand, most people do 
not know that a cow can live some 20 years, and that she is used up in less than 6 
years in contemporary cattle farming, because of the enormous production she has 
to deliver. Nevertheless, the image with the broader public is that dairy cattle live 
an easy life. And this is what they deserve in their eyes. 
Animal experiments for dairy cattle farming will for instance concern: feed 
conversion, the 'improvement' of the genetic heritage of the animals 1 5 , the care for 
the animals, the realisation of environmental demands, the operational management 
etcetera 1 6. In dairy farming the distinction between animal experiments and the 
farming practices is rather vague. A gradual transition occurs from laboratory 
experiments, via experimental farming, to farmers that are experimenting. Invasive 
research, including the making of genetically changed animals, usually will be 
restricted to a laboratory setting. Genetically changed herds, however, might in the 
end be found on ordinary farms. In this animal experimentation practice severe 
animal suffering and major health damage will not be easily accepted, as the results 
of these experiments will be directly implemented in regular animal keeping. Most 
research will therefore be done by non-invasive means. 
So, animals, and in particular laboratory animals, are differently valued in these 
practices. In the veterinary practice the animal experiments are directed at animal 
health and wellbeing and therefore rather easily accepted. In de biomedical 
1 5 I will come back to this 'breeding' sub-practice in the next section. 
1 6 Bijman, W.J. et al (1990) De rundveefokkerij. [Cattle-breeding] In: Biotechnologie in de 
zuivelproductieketen. Implicaties voor de melkveehouderij. [Biotechnology in the dairy production 
chain. Implications for cattle-breeding] NOTA-Werkdocument W19. Den Haag 
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production practice, laboratory animals are seen as a means to the much more 
important end of human health and wellbeing. In dairy cattle farming the norms 
and values of the wider public with respect to this practice are quite different from 
the norms and values of most practitioners, who are primarily interested in 
production. They agree, however, on the standards regarding animal experiments, 
namely that they should be in line with the treatment of animals in the production 
practice. Disagreement, however, exists regarding the treatment of the production 
animals. 
In the specialised food production practice practitioners and the wider public have 
a different view on the practice (paramedical practice versus agri- or food industry) 
and therefore have different standards with respect to animal experiments. 
The interaction of practices 1 7 
Characteristic of the discussions about the suggested applications of the newly 
developed technology was the reference to different practices by different 
participant of the debate. Apparently, it could not be taken for granted to which 
practice the new activity belonged. In this section, I will analyse the three sub-
debates about the making of transgenic animals. I will show how these sub-debates 
emerged, explain how they proceeded, and analyse what their outcomes have been. 
Three reasons for making transgenic animals were discussed during the debate, to 
wit: 
- The protection of the cattle against mastitis (issue 4); 
The development of a technique for producing human medicine via cow's milk 
(issue 3); 
The production of lactoferrin via cow's milk to be used in infant formula or 
clinical food (issue 2). 
I will first go into the first and the last sub-debate, as the origins, progress, and 
outcomes are rather easy to explain. After that, I will discuss the second sub-debate 
that has a less clear outcome. 
. The use of animal transgenesis for the protection of the cattle against mastitis 
The first discussion was about the use of animal transgenesis for the protection of 
the cattle against mastitis, an infection of the udders (issue 4). At first sight, 
Bart Gremmen's dissertation and a few discussions with him have shaped my ideas about what 
happens at the interface of two (or more) practices. See: H.G.J. Gremmen (1993) The mystery of 
the practical use of scientific knowledge. Dissertation Enschede. 
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mastitis prevention is a veterinary purpose and so a good reason for intervening in 
the animals. There has been a discussion, though, about: 
The effectiveness of lactoferrin as a means for preventing mastitis; 
The desirability of the creation of herds of transgenic animals; 
The possibility of alternative ways of preventing mastitis; 
The relation of the incidence of mastitis to high productivity farming, and the 
stimulation of such high productivity farming by controlling mastitis. 
We can see that the first and the third question are questions primarily posed within 
the context of the veterinary practice. The second and the last, however, exceed the 
limits of this practice, as these primarily refer to the dairy farming practice. 
The veterinary practice and the dairy farming practice partly overlap. The 
veterinary practice is facilitating the dairy farming practice (next to other animal 
keeping practices) by performing a specific task, namely disease prevention, health 
control, and the cure of cattle diseases. It was not, however, the research branch of 
the veterinary practice that initiated the idea of preventing mastitis by way of 
animal transgenesis. The research-firm Gene Pharming originated from 
biochemistry and from molecular biology and therefore was more related to 
pharmaceutics than to veterinary science. Since Gene Pharming wanted cattle to 
produce its products, it sought contact with the research institution of the Ministry 
of Agriculture to stable its animals. Mastitis prevention was just one of the 
possibilities disclosed by animal transgenesis. Gene Pharming was not familiar 
with veterinary diseases or with the veterinary practice; it only knew that 
lactoferrin would have an antibacterial effect and it knew that bacteria were a cause 
of mastitis. Of course, there is a relation between pharmaceutics and the veterinary 
practice, but there was no relation between Gene Pharming and the veterinary 
practice. The critiques from people out of or related to the veterinary faculty of 
Utrecht University (the scientific branch of the veterinary practice) could therefore 
not be easily refuted. Gene Pharming did not know the norms and values inherent 
to the veterinary practice and so could not adhere to these. It was an outsider and 
remained an outsider. 
The project of Gene Pharming would lead to a breed of cattle that would be 
mastitis resistant. So, one might also consider a relation with cattle breeding and in 
particular the branch within cattle breeding that produces new, better, or healthier 
breeds. Gene Pharming's kind of objective is familiar to cattle breeding, as 
breeders will for instance breed for better legs, for better udders, for a better build 
and so on. The technique of animal transgenesis is in line with other 
biotechnological techniques used for better and quicker breeding, such as artificial 
insemination, in vitro vertilisation, and embryo transplantation. 
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In this branch, however, farmers have a big say. And at present farmers do not 
want transgenic cattle, for one reason because they are afraid of not being able to 
sell their meat and milk to the German market that has high purity standards. 
Therefore, animal transgenesis is not being done in cattle breeding. Therefore, the 
desirability of the creation of a whole stock (herds) of transgenic cattle is being 
questioned. So, the objectives of Gene Pharming did not strike with the 
contemporary norms and values of the cattle breeding practice either. 
A third practice, however, is at stake, namely the pharmaceutical practice, a 
specific branch of the biomedical practice. This practice normally produces 
medicine (also by means of animals) but does not produce resistant animals. So, 
linking up to this practice does not seem an obvious possibility either. 
To conclude: animal transgenesis for the production of mastitis resistant animals 
could not hook on to an existing practice, but was measured to the norms and 
values of the two existing practices it mostly related to. And it failed to meet the 
standards of these practices. 
. The production of lactoferrin via cow's milk to be used in infant formula or 
clinical food 
The production of lactoferrin via cow's milk to be used in infant formula has 
caused many reactions. Most people who reacted were upset about the use of 
transgenic cattle to produce a 'commercial' product. Nutricia responded that it will 
be better for babies if infant formula resembles mother's milk as good as possible. 
The Dierenbescherming characterised this activity as a billion-dollar market for 
which the genetic modification of animals should not be allowed. Herewith, it 
implicitly referred to the Law on Animal Experiments, which does not allow 
animal experiments for commercial reasons. According to this law only serious 
biomedical reasons are acceptable for performing animal experiments. Such serious 
reasons did not seem to be at stake here. As soon as this discussion emerged, Gene 
Pharming interfered by stressing that the human lactoferrin 'obtained from the 
transgenic cows will only be used in clinical food, that is to say in food for 
premature babies and for patients. Consequentially the production of lactoferrin via 
cow's milk should be considered as a paramedical activity instead of as a food-
production activity. So, it hoped to shift the discourse from milk (food) production 
to biomedical purposes, as experiments within this context may reckon on more 
support. But it failed. It probably failed because of a combination of reasons, to 
wit: the motives of Nutricia (namely that the lactoferrin may also be used in infant 
formula) were already broadly known; the heavy campaign of the 
Dierenbescherming that stressed that Nutricia was up to making 'mother's milk 
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from cows'; and the wider public that was hardly familiar with the specialised food 
production practice to which Gene Pharming referred. 
For Nutricia and Gene Pharming, the production of humanised infant formula was 
in line with the production of clinical food, as these were, in their view, both part 
of the paramedical practice of specialised food production. The 
Dierenbescherming, the broader public and the farmers (the practitioners) 
obviously had a different view. They regarded the production of baby food as in 
line with the dairy production practice, which has quite different standards for the 
treatment of laboratory animals than the paramedical practice. People are reluctant 
in doing invasive animal experiments within the dairy production practice, and so 
in doing such experiments with the intention of producing humanised infant 
formula. Within a food production practice, invasive animal experiments are 
allowed for testing products or diets and hardly for making new products. Products 
made by way of transgenic animals or plants may not reckon on much support. 
So, for the time being, the dairy production practice has prevailed over the 
specialised food production practice, and the norms and values of the dairy farming 
practice were applied to the production of proteins to be used in any kind of food 
including infant formula and even clinical food. Consequentially animal 
transgenesis for these reasons was not allowed. 
. The production of human medicine by way of cows' milk 
The most interesting discussion, however, was about the second reason for making 
transgenic cattle, namely (the development of a technique for) producing human 
medicine by way of cows' milk. This was an interesting discussion because people 
usually hardly object to the use of animals for biomedical reasons, including the 
production of human medicine. But, in these normal cases rats, mice, and other 
laboratory animals are used for examining biomedical questions or for producing 
valuable proteins. Now a piece of cattle is used. Herman de Boer, the main 
spokesperson of Gene Pharming, has always said that the [mature] transgenic cattle 
should resemble ordinary cattle and that harm is not acceptable. So, in his view 
cattle should not be treated as ordinary laboratory animals, whereas the purpose of 
the treatment of these animals very much resembles the purposes for which 
laboratory animals are used. He grants cattle a special place. He, for instance, 
refers to a hierarchy among animals: 'it is common sense not to use cattle as a 
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model for human sicknesses' [my translation, ET] 1 8 . And he was consistent in what 
he said, as he has objected the production of 'EPO'-cattle 1 9 . 
Herman de Boer was not the only one who wanted to apply different standards for 
cattle and for normal laboratory animals. The KNAW [Royal Dutch Academy for 
the Sciences] tried to prevent laboratory animals to fall under the Decree on 
Animal Biotechnology. This Decree should, in its view, apply to production 
animals only 2 0 . Its spokesperson Dr. A. van der Eb stated 'why should not we 
differentiate among animals, since in daily practice people discriminate among 
animals, and there seems to be an unarticulated hierarchy in what we think we can 
do with animals' [my translation, ET] 2 1 . This view is also held by the Committee 
Biotechnology in Animals that has to assess all Dutch animal experiments. This 
Committee has advised positively about the making of transgenic mice and 
negatively about the making of transgenic cattle attributing this distinction to the 
higher moral status cattle have in the Dutch culture 2 2. 
So, it seems as if a double standard is applied: a difference is made between the 
treatment of laboratory animals and the treatment of production animals (cattle) 
even if they are made transgenic for the same reason. For an explanation of this 
double standard, one should turn to a difference in moral status among animals, 
that is related to the practices to which the animals 'belong'. Some animals may 
belong to more than one practice, but most animals belong to only one practice. 
Whether an animal belongs to the one or the other practice need not be caused by 
the species it is, but is mainly caused by how the animals are used or seen. 
Especially domesticated animals may function in different practices. But even wild 
animals can be part of different practices e.g. of hunting (as game), of specific 
practices of nature management (as functioning in a specific ecosystem) and so can 
be differently valued depending on the context. Animals that have always belonged 
to one practice may after some time also become part of another practice. 
1 8 NRC 24 June 1992 
1 9 EPO (erythropoietine) regulates the production of red corpuscles. Bicycle racers sometimes 
illegally use it for better performance. At first side the production of EPO via the milk of cows 
does not seem problematic, as the EPO is excreted. It turned out, however, that the EPO also leaks 
back into the blood of the cattle themselves which may give rise to the same problems as bicycle 
racers may experience. (Aside: De Boer does not apply the same standards to the animals that were 
used for making transgenic cattle.) 
2 0 KNAW et al (1995) Volksgezondheid en biotechnology [National health care and biotechnology]. 
KNAW. DenHaag. 
2 1 Volkskrant 2 February 1996 
2 2 Tj. de Cock Buning (2000) De status van het dier. [The status of the animal.] Inaugural speech. 
Utrecht University. Utrecht 
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Nowadays rats, for instance, are kept as pets, which was unthinkable only a few 
decades ago. 
So, the question arises how Herman the bull was conceived. Let us first start with 
some observations. 
First, the Minister did not want to differentiate among animals in the Decree on 
Animal Biotechnology, so the arguments in favour of cultural or practical 
differences were not granted. The Decree makes no difference among animals; it 
does not even differentiate between worms and mammals. And it sets higher 
standards for the making of transgenic animals than the existing legislation does for 
ordinary animal experiments. 
Second, from the start of the debate, biomedical research (with or without 
transgenic animals) and the making of Herman the bull were seen as two different 
things. Biomedical reasons other than the production of specific proteins by means 
of animals have not been part of the core debate. This means that most people saw 
the production of pharmaceuticals by means of transgenic cattle as something 
different from biomedical research. And, which is more surprising, they regarded 
this as different from the production of sera or vaccines by means of laboratory 
animals as well. Transgenic laboratory animals have not been part of the discourse 
at all. 
Third, in the discussion on the insertion of human genes into animal genomes, Dr. 
P. Borst has argued in favour of such an integration for human health's sake, but 
his arguments did not have impact on the debate about transgenic animals as if his 
arguments have skipped the debate. It seems as if the biomedical research practice 
did not even come to mind in people at the time. 
How should this be interpreted? In my view, practices have put a mark on the 
discourse on animal transgenesis because Herman being a bull did not simply fit 
into one of the traditional practices. He did not fit in with the practice of dairy 
farming, for he was not just a production animal. He was not made by ordinary 
breeding, but in a laboratory. He was not meant to have his daughters producing 
milk for consumption but milk for the extraction of human medicine. He would not 
be part of the livestock of dairy cattle, since he was not aimed to mingle with other 
cattle. 
But he did not fit in with the practice of biomedical research either. Cattle do not 
'belong' to this practice, only laboratory animals do. Herman's offspring will not 
live in laboratories, but on farms. The mature animals will lead an ordinary life as 
ordinary cattle will. They will for instance be fed and milked as ordinary cattle 
will. 
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As Herman the bull did not simply fit in into one of these practices there are 
several possibilities: 
one of the practices is extended or changed as to make Herman the bull fit in; 
or a niche is created in one of the practices in which the new activity may 
develop; this niche may in time even develop into a new (sub-)practice; 
or both practices merge as to make an overlapping area for these new activities; 
or a new practice is created that fits with this new activity and that creates a 
new perspective for valuing the new activity. 
So, what were the participants aiming at with their inputs in the debate? Let's have 
a closer look at the reasoning of the main participants (see also Chapter 5). 
Especially the reasoning of the participants that were in favour of the incorporation 
of a 'yes, i f principle in the law is very interesting. Gene Pharming, most of the 
time by mouth of Herman de Boer, has stressed that the animals will be treated like 
production animals, that a cow remains a cow, and that classic breeding changes 
animals too. This is summarised in the expression that there is nothing morally 
new, or that the animals are just like ordinary farm animals. Gene Pharming sees a 
future in which transgenic herds are at pasture. This means that it has opted for the 
farming practice, with the norms and values inherent to this practice. Farmers and 
their organisations, however, do not agree with this view. They prefer to the keep 
milk production practice as it is and consider the activities of Gene Pharming as 
foreign to their practice. 
The experts who are also in favour of a 'yes, i f policy (most of them are 
biomedical experts) do not share this argumentation, however. They stress that 
animals also change induced by viruses, that animals are also harmed in animal 
experiments for medical purposes, and that other arguments against the genetic 
modification do not hold. In their view, the animals are just like ordinary 
laboratory animals and the interventions do not differ from other interventions in 
laboratory animals. So, they explain that the use of transgenic laboratory animals is 
in line with the laboratory animal practice, with its norms and values. This does 
not encompass the production of medicine by way of milk in cattle, but only 
medical research in general. Therefore, they prefer different legislation for 
production animals and laboratory animals. 
The Dierenbescherming (who says 'no' against animal biotechnology) has stressed 
the (moral) novelty of animal transgenesis. It has argued that the lives of the 
animals will differ from the lives of normal farm animals, as the animals will live 
under controlled conditions. In its view, animal transgenesis is not in line with the 
dairy farming practice. The Dierenbescherming has most of the time directed its 
comments at Gene Pharming and not at the experts. In reaction to the experts they 
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have stressed that all animals should be treated equally. In its view, mice and rats 
should not be genetically engineered either, as this reduces animals to mere things 
and does not pay respect to evolutionary processes and inherited characteristics as 
new genes are introduced into a species. It is in fact saying that transgenic 
laboratory animals should not be made either and in the end that the laboratory 
animal practice should not be continued at all. This means that they do not want to 
differentiate among animals and that a context dependent valuing of animals is 
rejected. It strives at an equal treatment of all animals, which is consistent with the 
acknowledgement of the intrinsic value of animals: all animal should be paid equal 
respect. 
The Minister of Agriculture ('no, unless') acknowledges that animal transgenesis 
as such is morally problematic and stresses that harm should be prevented. He does 
not differentiate between transgenic cattle and other transgenic animals. He does 
not compare transgenic animals with other animals, but prefers to treat them as a 
specific category. In fact, he is saying for the making of transgenic animals specific 
norms and values regarding the treatment of animals should be developed. In the 
Decree on Animal Biotechnology, the standards are set higher than in the existing 
legislation for animal experiments. These standards are imposed on the making of 
transgenic animals. This can be seen as the opting for a new practice, but also as 
opting for an overlapping sub-practice of the existing practices. In both cases the 
practitioners are subjected to more stringent norms and values for the treatment of 
the animals. 
The experts in favour of a 'no, unless' policy (mostly animal ethicists) argue that 
hardly any harm should be allowed, that very strong reasons are needed for 
changing the genome of animals, and that the burden of proof should be inverted. 
Just like the Minister, they do not differentiate between transgenic cattle and other 
transgenic animals. So, in the view of the Minister and the experts transgenic 
animals are a specific category of animals for which higher standards regarding 
harms and the reasons for changing the animals should be applied. This means that 
they do not regard the making of transgenic animals in line with any existing 
practice, but regard it a (overlapping sub-) practice of its own, for which higher 
standards should be applied than to both reference practices. This accords with the 
advice of the Advisory Committee Ethical and Biotechnology in Animals that has 
stressed that animal transgenesis should be regarded a break in trend with the 
familiar (scientific) handling of animals and that therefore the traditional standards 
do not apply to this new technique 2 3. 
Advisory Committee Ethics and Biotechnology in Animals (1990) Ethics and Biotechnology in 
Animals. Wageningen. NRLO 
I l l 
All in all three dominant views on animal transgenesis for biomedical reasons were 
developed. Gene Pharming and the biomedical experts have opted for an 
assimilation to the existing practices of subsequently cattle farming and biomedical 
production; according to the Dierenbescherming all animals should treated equally 
which means that it rejects any context-depending norms and values for the 
treatment of animals; the Minister and the animal ethicists prefer to develop 
specific norms regarding all transgenic animals, which should be more stringent 
than the norms regarding each of the reference practices. This last view, that 
animal transgenesis is neither just a continuation of one of the existing practices 
nor should lead to the overruling of all contextual norms and values regarding the 
treatment of animals has dominated as the content of the Decree on Animal 
Biotechnology shows. 
Conclusion 
The huge public involvement was, as we saw in the Introduction, largely due to the 
emotional proximity of cattle in the Dutch culture. The assimilation to the animal 
ethical debate, which was discussed in the former chapter, explains the 
differentiation that people make between animals in general on the one hand and 
plants and micro-organisms on the other. Consequently, arguments that refer to the 
animal-as-an-animal have carried much more weight than other arguments. Animal 
transgenesis has been considered as a moral novelty, a break in trend. New 
concepts were developed (intrinsic value, animal integrity) as well as new 
legislation that lays down these new concepts (the Animal Health and Welfare Act 
and the Decree on Animal Biotechnology). 
This chapter has considered the discussion about several specific applications of 
the new technology and the bull that was central to the experiments. 
We saw that animal transgenesis for the production of mastitis-resistant animals 
could not hook on to an existing practice, but was measured to the norms and 
values of the two existing practices it mostly related to. And it failed to meet the 
standards of these practices. And a new practice with its own norms and values did 
not develop. 
In the case of the production of lactoferrin via cow's milk to be used in infant 
formula or clinical food, the norms and values of the dairy practice prevailed over 
the norms and values of the specialised food production practice. Therefore animal 
transgenesis was not allowed for this purpose. 
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In the case of the production of human medicine by way of cow's milk, the case 
was not closed at the moment Herman the bull did not fit in with one of the 
existing practices. The reason for making transgenic animals therefore was 
apparently so forceful that rejection would have been too simple an outcome. At 
the same time the norms and values of either related practice were insufficient. 
Gene Pharming has argued in favour of an assimilation to and adaptation of the 
dairy farming practice. It has reasoned that the project still is in the experimental 
stage of breeding adequate animals, but the production animals will live on 
ordinary farms and will be treated as ordinary farm animals. Only their milk will be 
treated differently. 
For the Dierenbescherming as well as the Minister of Agriculture an assimilation to 
an existing practice was out of the question. The Dierenbescherming has argued 
that all animals should be treated equally which seems to result in a valuation that 
is practice-independent. The Minister of Agriculture wants to have all transgenic 
animals treated equally, but makes them into a category of its own with its own 
legislation. This outcome might, however, also be interpreted as that it considers 
animal transgenesis a practice of its own, or as an overlapping practice of the 
existing practices of cattle farming and the biomedical production of medicine. In 
the 'Besluit Biotechnologie' the new norms and values are set higher than in either 
former practice. The high standards regarding the purposes of the biomedical 
animal experimentation practice as well as the high standards regarding the health 
and wellbeing of the dairy farming practice are applied to the production of 
medicine by way of transgenic animals. And respect for animal integrity is a 
serious candidate for being a major standard in this practice. This standard is 
become central to this case as we saw in the Chapter 5, for enabling to cope with 
this specific treatment of animals that cannot be valued by the traditional standards. 
Will this practice hold, or will it just be a transitional stage? Many futures are 
possible. It is thinkable that transgenic cattle will in time be seen and treated as 
ordinary farm animals. It is also thinkable that within a few years cattle will be 
regarded as ordinary laboratory production animals and treated correspondingly. 
But, it is also possible that the high standards regarding transgenic cattle and the 
background norm of respect for animal integrity will in time be applied to all 
laboratory animals, that is to all animals that are subjected to invasive experiments. 
Over the last hundred years, we have seen a tendency to set the standards higher all 
the time, and this debate on animal transgenesis might have been an acceleration of 
this process. Even more, the introduction of the concepts of intrinsic value and of 
animal integrity have brought to mind a new way of thinking about animals. This, 
however, would imply that practice-bound standards have had their day and that 
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more general, practice-exceeding, standards regarding animals have the future. 
Time will learn. 
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7. Debating in public: the process 
In the debate on animal transgenesis, participants have not only criticised each 
other's points of view and reasons, but also each other's behaviour. Accusations 
like using sophisms, not revealing true motives, and withholding relevant 
information were uttered at several occasions. The main participants, to wit the 
Minister of Agriculture, the Dierenbescherming, and Gene Pharming, have each 
been criticised. The criticised have replied to these criticisms, thereby taking such 
criticism seriously. Apparently, the debaters have a set of rules in mind regarding 
the process of debating to which they will refer if they assume that these rules are 
violated. And they do not like being accused of violating these rules. These rules 
and so an evaluation of the kinds of input in the debate by the main participants 
will be central to this chapter. 
Several philosophers have tried to reconstruct these rules for evaluating 
deliberations. These standards will hardly ever be met fully, if applied to public 
debates. One may wonder whether these reconstructed rules are adequate for the 
evaluation of a public debate, or, in other words, whether a public debate can be 
equated with a deliberation. To my opinion, it can only be partially. This implies 
that the rules for deliberations cannot be applied directly to public debates. They 
might, however, be an assistance in finding the rules that are adequate for the 
evaluation of public debates. 
This insight and the adapted set of rules will also be helpful in replying much 
critique on public debates, as much critique emerges from an equation of public 
debates and deliberations. 
In the first section of this chapter, I will discuss the discursive quality of 
deliberations. In the next section, I will argue why a public debate cannot be 
equated to a deliberation. The third section1 will be used to develop the rules for 
A concept for the third section was presented at the workshop 'The social management of 
Biotechnology' at Tilburg University in 1995. This lecture was transformed into a paper with M. 
Korthals as a co-author: (1996) From animal welfare to intrinsic value: reconstructing public 
debate on animal biotechnology. In: R. von Schömberg and P. Wheale. The social management of 
biotechnology: workshop proceedings. Tilburg University. A slightly different version was 
published with the authors names reversed in P. Wheale, R. von Schömberg and P. Glasner (1998) 
The social management of genetic engineering. Ashgate. Aldershot etc. 
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public debates that are equivalent (not equal!) to the rules for the discursive quality 
of deliberations. In the fourth section, I will reconstruct some additional rules from 
the public debate at hand. In the fifth section, I will reply the critics of public 
debates in general and this one in particular. In the last section, I summarise the 
results of this chapter. 
The discursive quality of (public) deliberation 
When critical theorists like Jürgen Habermas 2, and other authors from this tradition 
such as Gutmann and Thompson 3, Manin, and, Munnichs, speak about 
deliberations, deliberative democracy, and discourses, they refer to discussions 
with a very specific discursive quality. Deliberation is seen as 'a procedure of 
becoming informed and of reflection on own and other opinions, prejudices, and 
inconsistencies' 4. In deliberations, 'individuals acquire new perspectives not only 
with respect to possible solutions, but also with respect to their own preferences' 5. 
Munnichs describes a deliberation as 'a conscientious process of exchanging and 
valuing reasons' 6 (my translation and my italicisation, ET). In his view, the 
discursive quality of deliberations has to do with the conscientiousness in which 
the participants exchange and value reasons. What then is a conscientious process 
of exchanging and valuing reasons? An answer to this question is given by 
Habermas and some other authors in the critical tradition7 who have reconstructed 
a set of normative parameters (requirements, criteria) to which deliberations are 
measured. The outcome of a deliberation will be considered rational (well-
considered, conscientious), if these procedural criteria are at least to a certain 
2 J. Habermas (1962/1984) Strukturwandel der Öffentlichkeit. Untersuchungen zu einer Kategorie 
der bürgerlichen Gesellschaft [Structural change of the public sphere. Research into a category of 
civil society.] Herman Luchterhand Verlag. Darmstad und Neuwied, and J. Habermas (1992) 
Faktizität und Geltung. Beitrage zur Diskurstheorie des Rechts und des demokratischen 
Rechtstaats. [Between facts and norms. Contributions to a discourse theory of law and 
democracy.] Suhrkamp Verlag. Frankfurt am Main. 
3 A. Gutmann and D.F. Thompsom (1996) Democracy and disagreement. Harvard U. Press. 
Cambridge and London. 
4 B. Manin (1987) On legitimacy and political deliberation In: Political theory 15/3, p. 338-368, 
p.350 
5 Ibidem 
6 G.M. Munnichs (2000) Publiek ongenoegen en politieke geloofwaardigheid. Democratische 
legitimiteit in een ontzuilde samenleving. [Public discontent and political credibility. Democratic 
legitimacy in a post-traditional society]. Van Gorcum, Assen, p.77 
7 J. Cohen (1989) Deliberation and democratic legitimacy. In A. Hamlin and B. Pettit (Eds.) The 
good Polity. Oxford,). Peters, see note 8 Several articles by M. Kettner, see note 12. 
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extent m e t . In this view this means that deliberations should first and foremost be 
directed at mutual understanding, since that is what these conditions are 
guaranteeing. 
Jürgen Habermas has reintroduced9 the notion of the discursive quality of public 
debates in the sixties. In his first work on the topic 1 0 , he has reconstructed three 
characteristics of the discussions in the 'Tischgesellschaften, Salons und 
Kaffeehäuser' in the 18th century: 
'Die Parität, auf deren Basis allein die Autorität des Arguments gegen die der 
sozialen Hierarchie sich behaupten und am Ende auch durchsetzen kann, meint 
im Selbsverständnis der Zeit die Parität des "bloss Menschlichen". ... Die 
Diskussion in einem solchen Publikum setzt zweitens die Problematisierung 
von Bereichen voraus, die bislang nicht als fragwürdig galten. ...führt drittens 
zur prinzipiellen Unabgeschlossenkeit des Publikums.' 1 1 
These characteristics return in different words and further specified in his later 
work and in the work of the other authors mentioned. Since the ideas of these 
authors are very much alike and since Matthias Kettner has done much work on 
better articulating these criteria over a period of some ten years, I will concentrate 
on the criteria which Kettner has reconstructed. 
In Kettner's 1 2 view, a deliberation is an argumentation about reasons ('gute 
Gründe') in which the participants are only oriented at the argumentation itself. 
This means that the participants will value conflicting reasons by referring to other 
reasons with the intention of finding or improving a common background of values 
and so in the end consensus. Each discussion contains reasoning, but this reasoning 
will not always be a deliberation in the sense described. So, a discussion will not 
always be a discourse. Kettner has constructed a set of five normative parameters 
8 B. Peters (1994) Der Sinn von Öffentlichkeit. Köllner Zeitschrift fir Soziologie und 
Sozialpsychology, Sonderschrift 34 42 - 76. 
9 In the second decade of the twentieth century this also was a major issue, especially in the USA. 
1 0 J. Habermas (1962/1984) Strukturwandel der Öffentlichkeit. Untersuchungen zu einer Kategorie 
der bürgerlichen Gesellschaft [Structural change of the public sphere. Research into a category of 
civil society.] Herman Luchterhand Verlag. Darmstad und Neuwied. 
1 1 Ibidem pages 52 and 53. 
1 2 For the justification of these parameters see Kettner's article from 1999a named Neue 
Perspektiven der Diskursethik. In: A. Grunwald and S. Saupe (Eds.) Ethik in der 
Technikgestaltung. Praktische Relevanz und Legitimation . Springer. Berlin etc. These parameters 
were first introduced in an article called: Scientific knowledge, discourse ethics, and consensus 
formation on public policy issues. This article was published in R. von Schömberg (1993) Science, 
politics and morality. Scientific uncertainty and decision making. Kluwer. Dordrecht. 
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that he regards arguably necessary for a reasonable (rational) discussion (discourse) 
on moral issues: 
'Parameter 1: Reasonable Articulation of Need-Claims: All participants in a 
discourse should be capable of reasonably articulating rationally any need-claim 
they take to be morally relevant. 
Parameter 2: Bracketing of Power Differentials: Differences in (all sorts of) 
power which exist between participants (both within and outside argumentation) 
should not be any participant's good reason in discourse for endorsing any 
moral judgment. 
Parameter 3: Non-strategic Transparency: All participants should be able to 
convey their articulations of morally significant need-claims truthfully, without 
strategical reservations. 
Parameter 4: Fusion of Moral Horizons: All participants should be able to 
sufficiently understand need-claims in the corresponding moral horizons of 
whoever articulates them. 
Parameter 5: Comprehensive Inclusion: Participants make the following 
constraint on what their community of discourse can accept as good reasons: 
that participants must anticipate whether their reasons can be rehearsed by all 
nonparticipant others who figure specifically in the content of any moral 
judgment determined by the participants to be taken seriously by everyone.' 1 3 
Most authors have applied these or comparable criteria to all kinds of discussions. 
Kettner, however, regards these five criteria as a prerequisite for a discussion to be 
a moral discourse. So, a moral discourse is a discourse on moral issues that fulfils 
the procedural standards that Kettner has reconstructed. To my opinion, equivalent 
sets of procedural standards can be developed for other deliberations as well. 
In the next section, I will argue that a public debate cannot be equated with a 
deliberation. In the third section, I will trace to which extent each of the criteria 
expounded above is applicable to the particular public debate at stake, and whether 
criteria can be reconstructed that are adequate for public debates. Each sub-section 
of the third section will start with an explanation of what Kettner has meant with 
the criterion in question. 
M. Kettner (1999) New ethics, new genetics (see above) p. 143 and 144. NB. A 'need-claim' is 
what in ordinary language is meant with an 'interest'. I will use the term 'interest'. 
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The nature of public debates 
A public debate cannot be equated with a deliberation, since a public debate is not 
primarily oriented at mutual understanding or consensus. A public debate should 
rather be seen as a process in which views and reasons are tested. In the course of a 
debate, it will become clear which views and reasons may reckon on public support 
and which will not. A debate is a support - seeking activity. 
It is obvious that public reasoning will be central in a public debate. Views will be 
put forward and will be argued for and against. The weight and impact of these 
reasons will be discussed. Reasons will be articulated, and specified, and so on. In 
the meantime, information will be clarified and preferences will be sharpened. But 
this reasoning will not necessarily be the conscientious exchange of reasons that is 
characteristic for a deliberation. And this will be so because the debaters are first 
and foremost trying to obtain public support instead of mutual understanding. As 
people are arguing in front of the larger public they will try to convince this public 
of their views and reasons, and they will try to convince them that other views and 
reasons are less adequate. They will try to put forward their views as lucid and 
sharp as possible instead of seeking common ground in a discussion oriented at 
finding consensus. To summarise: 
Deliberation -> oriented at mutual understanding and in the long run consensus 
-> conscientious reasoning; seeking common ground; 
-> convincing each other 
Public debate -> oriented at gaining public support and impact 
-> lucid reasoning; articulating points of view 
-> convincing the public 
This does not mean that a public debate will not have any discursive quality at all. 
It does, however, mean that the standards will not always be applied as stringent as 
in the case of a deliberation. Some deviations of the standards will be accepted as 
normal, but others will not. 
Until now, I have spoken about the discursive quality of a public debate, but there 
will be more than just reasoning in a public debate. Of course, there will be 
reasoning. But, as the debaters want their reasons to have as much impact as 
possible, they will time the moment at which they put forward these reasons, and 
they will be strategic in the information they supply (which may include 
For the views expressed in this section, I have to pay much credit to Matthias Kettner, with whom 
I have discussed the nature of public debates extensively. 
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withholding information). And these ways of doing will be discussed themselves, 
as a public debate will be self-reflexive in this respect. 
The debaters will also strengthen the views and reasons of themselves and weaken 
those of others by referring to the source of these arguments. They will do so by 
telling stories (narratives). For instance, they will try to show that self-interest has 
influenced the views. Or they will refer to motives for having certain views and 
they will in particular do so if these motives have not been made public. Or they 
will discuss the integrity of themselves and of others. Or they will reveal 
background information that sheds another light on reasons that were put forward 
by themselves or by others. This still might be considered an argumentation in the 
sense of a discussion about reasons, as it helps to assess reasons as good or bad 
reasons, but it no longer is a conscientious discussion about reasons. 
But this extension still does not fully capture the nature of public debates, as a 
debate is about getting people somewhere, namely to get them in a position that 
they will give support to a particular view, while discussions and deliberations are 
about assessing reasons only. Therefore, expressive elements will be explicitly 1 5 
brought in as a means to influence people. Photos, drawings, posters, and 
documentaries, for instance, will refer to feelings, pathos, and emotions. Such 
images are not arguments by themselves, but can be regarded as a message within 
the context of an argumentation and so have an argumentative intention. An image 
shows a reality and raises the question whether this reality makes a difference to 
the audience. So, an image is by itself not a reason for doing something, but it 
wants to give reasons for changing your mind. A public debate will also be self-
reflexive concerning such images. People will differentiate among types of images 
and in particular with respect to the intention of these images. For instance, they 
will make a difference between an advertisement in which some horrible image is 
used and an equally horrible abortion photo shown by the anti-abortion movement. 
People have a sensibility for these different uses and draw therefore lines between 
commercial advertisements belonging to the economic sphere and contributions to 
a public debate belonging to the public sphere. And they might value the images 
differently for this reason only. Both types of images are meant to get people 
somewhere, but are appreciated differently. The first type will be valued as a 
strategically used sophism, while the second type will be valued as a 
communicatively used sophism, that is, as a contribution to the debate. But not 
every use of an image put forward in a public debate will be seen as a contribution 
to the debate. It might be considered a strategically used image; it may be too much 
Of course, expressive elements will play a role in any conversation, but the difference is that in 
public debates these will be actively put in as a means to get people somewhere. 
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exaggerated and so be too harsh; but it may be too covert and suggestive as well; 
and it may be too much an advertisement. So, here too the self-reflexivity of the 
debate will be directed at the protection of the public sphere. This is done by 
evaluating the limits of this sphere and by criticising when these are crossed. 
In the next section, I will reconstruct a set of criteria that are derived from the 
criteria of Kettner and that are adequate for valuing a public debate. In the third 
section of this chapter (called theatre), I will add some extra rules that are specific 
for public debates. 
Kettner's parameters and the public debate about Herman the bull 
Matthias Kettner has discerned five normative parameters for evaluating the 
discursive quality of deliberations. I questioned whether and how these normative 
requirements should be interpreted for the evaluation of a public debate. This will 
be the topic of this section. The first question to be answered will be to what extent 
did this debate fulfil Kettner's requirements. In other words: to what extent did this 
debate have discursive quality? And the second question will be whether it will be 
possible to reconstruct a set of equivalent criteria that is adequate for the evaluation 
of a public debate. I will discuss each parameter with these questions in mind I 
will not follow Kettner's order, though. I will follow a more obvious order from 
pure reasoning to more procedural aspects. 
- Reasonable articulation of interests. 
It is, according to Kettner, necessary that all participants are capable of interpreting 
and articulating their interests rationally. This means that the participants must be 
capable of giving reasons to substantiate their views and opinions, and to clarify 
how their interests connect to other interests. This allows other participants to 
criticise these views and opinions, and the supporting reasons. Because of this 
criticism, interpretations of interests might change, but this is up to the criticised. 
I want to go one step further than Kettner. In my view, each participant should also 
respond to criticism as good as possible. A reasonable participant cannot ignore 
criticism. He or she has to answer criticism seriously by providing additional or 
better-articulated reasons, or by denouncing the criticism. 
So, reasoning does not concern reason - giving only, it also concerns listening to 
and responding to reasons given by others. And this may result in some 
development in the reasoning over time. This last aspect, however, bridges the gap 
between reasoning and the fusion of (moral) horizons and will be discussed in the 
next sub-section. 
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Reason - giving 
It is obvious that the participants of this debate have reasoned to substantiate their 
views and they have elaborated on their reasons as well. There will be no public 
debate without reason giving. A fine example is the very first article published on 
the matter, namely an interview by Jan Bonjer 1 6 with Dr. Herman de Boer of Gene 
Pharming. In this interview, Herman de Boer explains why he considers the 
making of genetically modified cattle a good thing. He mentions five reasons for 
doing so and two restrictions he puts upon himself1 7. 
People elaborate on their reasons as well. For instance, after the first calf was born 
the reasons presented by Gene Pharming were further specified with respect to the 
positive effects of the newly inserted gene on lactoferrin production in the udders 
and so on mastitis prevention in adult cows. And each time as there was a 
development in the research project, reasons were given specific for this 
development. It should be noted that de Boer also mentioned some restrictions in 
the interview, which means that he is fully aware that there might be objections to 
this project and he claims that these objections will be met in the project. So, he is 
anticipating criticism and therefore already explaining that he himself also imposes 
restrictions upon himself. So, he was explicitly entering a debate. The same can be 
said about all other actors that have participated in the debate. 
Responding to reasons 
The second question, namely whether people also have responded to reasons given 
by others, is less easy to answer, since at first sight it seems as if people have 
hardly reacted to one another. People seem to only have stressed their own points 
of view. This is true for most contributions to the debate, but not for all of them. 
From a cautious reading of the articles and interviews in the newspapers, it shows 
that people and organisations have very conscientiously read each other's 
contributions to the debate. And they have used these contributions to elaborate on 
their own views. And sometimes they have responded to statements or reasons put 
forward by others as well, and at some other times they have even reacted 
straightforwardly to an opponent. 
NRC 9 March 1989 
His reasons were: it will enable to make valuable medicine and to produce proteins that can hardly 
be produced in another way. It might enhance the resistance of cattle against mastitis. And it might 
improve the effectiveness and quality of food-production. Furthermore it will be economically 
attractive. The restrictions were: one should not do strange things to cows and one should take 
care. 
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A more detailed analysis of the first two years of the debate, in which 44 articles 
were published, is not very impressive though. It is obvious that people were more 
interested in putting forward their own views and reasons than in discussing other 
views. It seems as if they were quite reluctant to get involved in a discussion. 
Instead, the actors have put forward their own views in front of the broader public, 
which is their audience. By being as clear as possible, they were hoping to win the 
favour of the public. And they have tried to weaken the views of their opponents 
not by directly attacking them, but by anticipating their views and criticisms. A 
good example is Herman de Boer of Gene Pharming who from the very beginning 
stressed that the firm cared about its animals, that it did not want to harm them or 
do strange things to them, and that actually the animals were not harmed in either 
way. This combination of reasons is very convincing as it comes through as an 
authentic view, and as it refers to the common way of thinking about animals. But, 
until that time there had not even been the suggestion that the animals might be 
harmed in their health or wellbeing. The point of the critics, namely, was not that 
the animals were harmed in their health or welfare, but that they were harmed in 
their intrinsic value, claiming that the making of a transgenic animal is a moral 
problem as such. Only later in the debate would conventional harm done to the 
animals become an item. 
This means that it is possible to reconstruct the 'statements' in the newspapers of 
the first two years as if it were a discussion. But, in fact, it has hardly been a 
discussion. And from the point of view of the public, it could hardly have been a 
discussion, as the public was probably not able to grasp the indirect references that 
were made. 
Later in the debate, however, this will change. In November 1992, the debate 
accelerates: the Dierenbescherming starts its campaign against animal 
biotechnology. Next to lucid inputs in the debate, it was also play to the gallery. 
From this time on, also the number of reactions increased. People got angry or 
annoyed about the input of the Dierenbescherming. Some accused the 
Dierenbescherming of polarising the debate or using slogans 1 8, but it answered that 
it first and foremost wanted to induce a public debate as the developments were 
going very fast and most people hardly knew what was going on 1 9 . From this 
moment on, every article attacking the Dierenbescherming or its view was replied 
within a few days in the same newspaper. In these replies the Dierenbescherming 
aimed to dismantle each argument and put forward its own view on the matter. If 
E.g. Wim. P, Zeijlemaker, biochemist and editor of the journal 'Bionieuws' (De Volkskrant 22 
December 1992) and Bas van Kleef, editor of De Volkskrant, (De Volkskrant 20 November 1993) 
Antoinette Hertsenberg of the Dierenbescherming in De Volkskrant of 31 December 1992 
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any part of the debate had the outer form of a discussion, it was this; but there was 
not much movement in points of view. Everybody has taken his stand and has 
stuck to it. The participants have only exposed their views in reaction to other 
views. For an outsider, however, this probably has been very informative as the 
reasons pro and contra became very clear. 
At the end of the debate (1995) as the Decree on Animal Biotechnology (the 
specific regulation for animal biotechnology) was discussed, many reasons were 
put forward by biomedical researchers and their organisations to make an 
exception for laboratory animals like rats and mice in the legislation. The 
Dierenbescherming, backed by the Nature en Environment Foundation and the 
Alternative Consumer Foundation, tried to neutralise these reasons and in 
particular the reasons for differentiating among species, which gave rise to some 
interesting discussion. 
To conclude: Kettner's first parameter was that all participants should reason to 
substantiate their views (that is to say their interpretation of the interests at stake), 
which means that they have to try to articulate their views as good as possible. And 
this is what the participants have done: they have given reasons for their views, 
have articulated and specified these reasons, and have given additional reasons. 
And they have listened to reasons put forward by others, sometimes responded to 
reasons, they have anticipated criticism or developments, and they have elaborated 
on their reasons in order to meet criticism. There has hardly been reflective 
criticism on the participants of the debate in this regard. Only the 
Dierenbescherming has been criticised for being too harsh sometimes, for instance 
for its accusations, insinuations, and more generally for unnecessary polarising the 
debate. Here one may find a specific standard for a public debate. One should 
reason lucidly, even sharply, in order to substantiate one's views; one should listen 
to and respond to criticism; one should criticise the views and reasons of an 
opponent as long as this will illuminate the issue at stake. But needlessly attacking 
an opponent, polarising the debate, or rousing public sentiment is considered one 
step too far 2 0. Where the line has to be drawn will probably depend upon the 
situation. I will come back to this point in the next section. 
At least in this specific debate. This might be a feature that is more prominent in Dutch public 
debates than in others. The Dutch 'polder model' is based on the continuation of the discourse and 
is oriented at consensus, which implies that attacking an opponent too fiercely might lead to being 
disqualified as a serious discussion partner or might scare of discussion partners that are 
appreciated for the sake of the debate. 
125 
- Fusion of moral horizons 
Kettner's fourth parameter has to do with mutual understanding. In a conscientious 
process of exchanging and valuing reasons people have to look for common 
ground. People should not just reason in favour of their own views, but they will 
have to explain their views in a way that others will be able to understand them, 
and they have to try to understand what others mean within their own moral 
horizon. Kettner considers such a fusion a prerequisite for exploring the space for 
consent and dissent. 
People develop their opinions and views against the background of a moral 
horizon, that is to say a notion of the good life that contains the moral norms and 
values they adhere to. Under normal circumstances, such a moral horizon is hardly 
articulated. Only when a moral conflict arises do people explicitly fall back on this 
moral background. A moral conflict may arise out of the confrontation of different 
moral backgrounds (an external moral conflict) or out of conflicting parts within a 
particular moral background (internal moral conflict). People draw on their moral 
background for reasons and views to solve a moral conflict. So, both in internal and 
in external moral conflicts people refer to their moral horizons. In the case under 
discussion, there is an external moral conflict. Matthias Kettner has argued that to 
have a discussion oriented at a moral solution for such a conflict, one needs to 
sufficiently understand each other's arguments and this is only possible if moral 
horizons sufficiently fuse with each other. That is to say: in a discussion, people are 
searching for common ground by formulating and reformulating aspects out of 
their moral background. 
This means that external moral conflicts arise out of different moral backgrounds; 
such conflicts can only be discussed if these horizons fuse sufficiently; and they 
can only be solved if these horizons fuse at exactly the point what the conflict was 
about. 
As moral horizons have to do with deeply rooted and hardly articulated moral 
values, such horizons only slowly change by way of many smaller and larger 
changes. In such a change, parts of the horizon are articulated (although not 
necessarily the parts that will change, but it will always be parts that have to do 
with the change). But it will only be possible to discuss these parts from a shared 
background of other values. 
For a fruitful discussion it is necessary that sufficient overlapping consensus of the 
moral horizons of the discussants will be found or created. These overlapping parts 
form a basis from which the colliding parts can be discussed in order to try to make 
them fuse too. 
126 
In the case of animal biotechnology, there was a commonly shared care for the 
animals. Nobody has argued or even suggested that animals can be used at one's 
convenience. But a point of discussion was how far-reaching this care has to go. 
All parties in this dispute agreed that the animals that were to produce the 
lactoferrin should be in good health and welfare. But the views diverged regarding 
the animals that had to be used in order to produce these transgenic animals, and 
regarding animal transgenesis as such. With respect to the use of animals to 
produce a transgenic animal, the concepts and lines of argumentation of opponents 
and proponents are within the same spectrum, as they have to do with animal 
health and welfare. The discussants only differed about how much harm should be 
allowed. 
With respect to the second issue of the making of transgenic animals as such, 
however, the opponents had a very different view from the proponents. The 
opponents considered the changing of the genetic make up of an animal a harm of 
the integrity of the animals. This concept of animal integrity is foreign to the 
proponents. It does not fit within their moral horizon. A paradigmatic change in 
view is needed to grasp the concept. Fusion of moral horizons with respect to this 
conflict seems to be hardly possible. Herman de Boer, however, had a notion of 
what is meant by animal integrity. He has stated several times and in different 
words that a cow has to remain a cow. But in his view, this has mainly to do with 
how a cow looks like (in the eyes of an innocent passer-by) instead of what you 
know about it (how it is made for instance). Still, this seems to be a beginning of 
understanding, since in his view it is not animal health and welfare only that is 
important. 
A fusion of moral horizons is necessary for understanding each others views and is 
a prerequisite for solving a moral conflict. Until a common concept, a common 
view is found the controversy will continue. In this case, the kernel of the 
controversy is the acknowledgement or not of animal integrity (authenticity, 
wholeness). A part of the participants does not recognise this concept while it is 
crucial for others and there does not seem to be a common ground to discuss this 
concept as it is more far-reaching than the more traditional concepts of animal 
welfare, animal health, or animal care. The conflict can be considered a conflict 
about notions of the good life that are profoundly different with respect to the 
general attitude towards animals. It is like a paradigmatic difference. Therefore, the 
conflict seems, for the time being, insoluble. The opponents talk at cross-purposes. 
And no one is criticising this. People (the audience) will only wonder which 
position they will take themselves and which will prevail in the end, as this is what 
will happen in time. 
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One may wonder now whether this is all that can be said about this parameter. I 
would say no, as people (the audience) still will have expectations in this regard. 
They can understand that there are opposing positions that do not converge and 
they can even understand a lack of willingness to grow towards each other's point 
of view. They probably do not even expect this in a public debate. They expect the 
parties to inform them (the public) by positioning themselves, by clarifying 
positions, and thereby persuading the public and seeking for public support. They 
expect them to listen to each other and to respond to each other. They expect them 
to use the reasoning of others to sharpen their own views and to elaborate on their 
reasons in order to make their position more clear. They expect lucid reasoning and 
they expect progress (new and additional reasons) being made. They want to be 
enabled to choose position in this paradigmatic dispute. This gives rise to another 
rule for public debates: the participants should develop and better articulate their 
points of view during the debate. When progress stops and nobody can add 
something new, the debate will be closed as it has no use anymore. 
- Comprehensive inclusion 
The fifth criterion of Kettner puts a restraint on what are considered good 
(legitimate) reasons. According to Kettner, reasons will be good reasons if they 
take into account the people that will be affected by the outcomes of the debate but 
that did not participate in it. Therefore the participants have to justify their views 
and the effects of the outcomes of these views on relevant others that did not speak 
up. 
These relevant others were explicitly present in the debate. Patients organisations, 
biomedical experts, and Gene Pharming have pleaded in favour of the patients; the 
Dierenbescherming has stated that animals too should be considered as relevant 
others. Several discussants have referred to the feelings and notions of the broader 
public concerning the handling of animals and their reserves about the new 
biotechnology. And the parties have criticised each other for having too less an eye 
for other interests. Margreet van Bladeren of the Rheumatics Patients Association, 
for instance, has expressed her disapproval of the one-sidedness of the 
Dierenbescherming. She has accused the Dierenbescherming of neglecting the 
interests of the chronically diseased people in our society and of oversimplifying 
what was going on 2 1 . But on an average, there was only mild criticism in this 
respect. I suppose that most people thought it obvious that for instance the 
Dierenbescherming addresses the interests of the animals and that a patients 
Algemeen Dagblad 15 December 1992 
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organisation will put forward the interests of the patients. The Dierenbescherming, 
however, has reacted to the criticism that it, of course, cared about patients, but that 
it preferred to look for other means to help them. Gene Pharming has stated that 
making medicine by way of cow's milk will result in cheaper medicine for patients, 
but that animal health and welfare should be a condition for the production of these 
medicine. Only the patients organisations did not publicly care about animals, but 
this was not carried after them. 
So, there seems to be mild pressure on the participants in a public debate to address 
the interests of relevant others thereby showing that they have taken notice of them. 
And it seems to be accepted practice that some organisations stand up for the 
interests of a single group or a single issue, as long as they also acknowledge that 
this is but a specific view. 
- Bracketing of power differentials 
Kettner's second criterion has to do with the distribution of discursive power, that 
is to say the power to express one's views. This distribution influences the 
possibilities of people to articulate their views in public. It is obvious that 
discursive power is not evenly distributed in a public debate. Some will have easy 
access to the media, others will not. The relevant question, however, is, whether 
this has influenced the possibilities for people to articulate their views. It is obvious 
that individual people are merely an audience and will hardly have access to the 
media. More essential is the question whether this has caused that some views were 
not heard. No one in the debate has referred to this point. Apparently, an unequal 
distribution of access to the media is generally accepted. What probably would not 
have been accepted is that some relevant views did not get access to the media. 
Editors may sort out letters to the editor and opinion page articles, and select letters 
and articles of known experts or other people, and they may interview only some 
people and not others, but this should not result in the loss of views. It is my 
impression that the relevant views were heard, although some religious views were 
only heard at the start of the debate and did not come back later. Nobody, however, 
has complained about suppressing certain views, not in the media, not at public 
meetings, and not at conferences, which suggests (but does not guarantee) that 
relevant views or voices were not silenced. 
- Non-strategic transparency 
This last criterion has been a main item in the debate. People have strategically 
supplied information. They have withheld relevant information. And they were not 
always open about their motives. As soon as one party got hold on information 
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about the other they timed the moment to make use of it in order to damage the 
image of the other party. For some of these moves, the discussants were heavily 
criticised, for others, however, not. 
Timing information is what most participants did. For instance, both patients 
organisations wrote their opinion page article just before an important 
parliamentary discussion and before a court trial of the Dierenbescherming, so 
trying to influence the political parties and the court. And the Dierenbescherming 
only started to use the information it had acquired about Gene Pharming planning 
to produce 'mother's milk from cows', as it knew that Gene Pharming had to admit 
it, that is to say at the time it had a strong case. I can imagine that discussants did 
not like this timing of information by their opponents, but they did not criticise it 
either. This seems to be accepted practice. 
The Dierenbescherming most of the time was the party in the offence, while Gene 
Pharming and the Minister of Agriculture were the defending parties. 
The Dierenbescherming only got some fierce criticism on its, sometimes, harsh 
campaign, which was called polarising, using bad rhetorics, and misleading. It was 
not criticised for timing its information (planning its campaign), nor for changing 
its position from 'no, unless' to an absolute ' n o ' 2 2 which might have been only 
changed for the sake of the debate. If it had not changed its position, the debate 
would probably have ended at that moment. Only a change in opinion did 
guarantee the continuation of the debate. Nobody felt publicly irritated about it. 
Nor was it criticised for concentrating on animal welfare issues when it could 
corner Gene Pharming. 
The Dierenbescherming has entered the debate with a new moral issue, namely that 
the changing of the genome of animals should be seen as a violation of the animals 
as such. Gene Pharming, however, had said from the start of the debate that it cared 
about animal health and welfare, that it did not expect any harm for the animals, 
and that if there were harm they would stop the experiments. At a certain moment 
it turned out that harm was done to the animals. Then the Dierenbescherming 
changed its strategy and concentrated on this harm. For the Dierenbescherming, 
this was in fact a side issue, which subtracted the attention from its main point. 
Animal integrity shifted to the background of the debate. The Dierenbescherming 
used this in its own eyes less central issue to corner Gene Pharming. This change of 
strategy was not discussed during the debate. It is possible that nobody has grasped 
So, from this moment on one cannot be sure about the true position of the Dierenbescherming as 
they used the same reasons to sustain their former position. 
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this point. It is more probable, however, that any animal issue is considered a just 
issue to be handled by the Dierenbescherming. 
One might conclude that there was a high tolerance for the actions of the 
Dierenbescherming. Only one strategic action was severely criticised next to the 
much discussed poster, namely its threat to start a boycott against Nutricia. This 
was considered one step too far by many. Nobody, however, has argued why it was 
one step too far. I suppose it was because of the breaking off of communication. 
The Dierenbescherming stopped reasoning and this seems to be 'not done'. 
The tolerance for Gene Pharming was much lower. Gene Pharming was a quite 
open firm, which was probably due to its close ties to the academic world. It 
expressed more an expert culture than a market culture. It, however, also was a 
commercial firm that had to find market partners. These market partners (in 
particular Nutricia) were not as open as Gene Pharming due to competition and 
they demanded Gene Pharming to reduce its openness. So, Gene Pharming was 
open about its general objectives and was willing to enter the debate, but it was not 
open about its investors and about its short-term objectives. This has been the cause 
of much criticism of Gene Pharming: several people, and of course the 
Dierenbescherming, have accused Gene Pharming of not being open about its 
objectives, of shifting goals, and of hiding its 'real' goal, namely the intention to 
produce 'mother's milk from cows'. 
It is obvious that Gene Pharming was not prepared for criticism. And it certainly 
was not prepared for the fierce criticism of the Dierenbescherming. 
Only after four years of debating, did it transpire that Gene Pharming was up to 
produce lactoferrin for use in baby-food. Several people, among whom Henk 
Verhoog, member of the ethical committee that had to evaluate research proposals 
of Gene Pharming 2 3, had already earlier expressed their annoyance about Gene 
Pharming not being clear about its objectives. These people wondered what was 
really going on. Such statements anticipated the heavy criticism on Gene Pharming 
and already gnawed at its image. As it became known that Gene Pharming had 
withheld relevant information from publicity, from the ethical committee and from 
government, the company was heavily criticised and lost much of its credibility. 
The Minister even thought of ending the contract with Gene Pharming. This means 
that, withholding this kind of information was not considered admissible. 
The till then invisible financier in the background (Nutricia, later called Numico) 
had an even bigger problem as its role got known, as this firm is very dependent of 
Het Parool 28 November 1992 
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the trust of its consumers. It was, however, not the secrecy of Nutricia that caused 
most upheaval, but the intention of producing 'mother's milk from cows'. Artificial 
baby food already was a touchy issue. Only two decades before, was Nestle (a 
Swiss baby milk producer) attacked by consumer organisations for the large-scale 
introduction of artificial infant formula in third world countries, because mother's 
milk is evidently best in these countries for hygienic reasons. As the 
Dierenbescherming 2 4 threatened with a boycott 2 5, Nutricia withdrew from the 
project 2 6. Interesting were some other reactions of Nutricia. It asked for a new 
ethical assessment by the advisory committee and it announced to start a discussion 
within the company about the use of transgenic products and it promised to use 
alternatives if there were any. So, it turned out to be very sensitive to the 
substantive criticism. 
At the time that one of the most important decisions had to be taken, namely 
breeding with Herman the bull (1992), Gene Pharming made an overt strategic 
move. It organised the support of the patients organisations. Now, Gene Pharming 
was accused by, for instance, the Dierenbescherming of creating false hope for 
patients and of using the patients organisations. Later, Herman de Boer of Gene 
Pharming explained that this may seem populism, but he thought it necessary to 
resist the campaign of the Dierenbescherming. In his view, it was obvious that 
patients would be 'a victim too of a threatening moratorium'. Therefore, he 
claimed that the patients organisations did not feel used, but knew what they did 2 7 . 
So, De Boer took serious notice of this criticism and defended himself as being 
criticised unjustly in this case. 
The Minister of Agriculture has been subject to severe criticism for withholding 
information about the involvement of Nutricia to Parliament and the public. 
According to Nutricia, the Ministry of Agriculture knew about the sponsoring since 
1991 2 8 . The Minister had a severe problem as Parliament might have decided 
differently about the project, if this information would have been available at the 
time. The Minister admits that the Secretary of State handling this issue indeed 
knew about the co-operation and did not inform Parliament. The contract namely 
contained touchy information from the point of view of competition, but did not 
seem relevant for the Herman project, as the advisory committee and Parliament 
Together with the Stichting Natuur en Milieu and the Alternatieve Konsumentenbond 
Algemeen Dagblad 11 March 1994 (first warning), Algemeen Dagblad and Volkskrant 4 June 
1994 (actual threat) 
NRC, Trouw, Algemeen Dagblad 10 June 1994, Volkskrant 11 June 
NRC 15 June 1995 
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had to decide about the production of human lactoferrin for veterinary and later 
medical purposes 2 9. Misleading Parliament is a heavy accusation. The Secretary of 
State, however, acknowledges to have known about the contract, but claims that he 
was not fully informed about its content. He was not aware of the primary purpose 
of the co-operation with Nutricia, namely the enrichment of infant food with 
human proteins obtained from transgenic cattle. In the contract of Gene Pharming 
and the ministerial research institution ID-DLO, only bio-medical purposes were 
formulated. He suggested that this contract now should be terminated 3 0. The 
Minister admits that he did not inform himself well enough, because he assumed 
that both firms would adhere to the political agreement. Then parliament calls the 
Minister naive and frivolous, and that is it 3 1 . 
Michiel Linskens of the Dierenbescherming concludes several times that both 
Government and Gene Pharming have neglected an important ethical principle 
namely that of openness 3 2. A differentiation should be made, however, as the 
Minister has a legal obligation to inform at least Parliament whereas Gene 
Pharming only has a civil duty to inform the public. This is reflected in the reaction 
in the press. The lack of transparency of the Ministry was a very heavy issue, 
whereas the behaviour of Gene Pharming was only disapproved. Still, the civil duty 
of companies to be open about controversial issues more and more becomes an 
issue, as companies will be judged about how they fulfil this social duty. 
Early 1995, it transpires that at least one member of the CDA party knew about the 
involvement of Nutricia. The Dierenbescherming accuses the CDA of misleading 
the public. Mechteld de Jong of the CDA answers that she had to respect 
2 8 Algemeen Dagblad 11 June 1994 
2 9 Algemeen Dagblad 15 June 1994 
3 0 NRC 16 June 1994, Volkskrant 16 June, Algemeen Dagblad 16 June, Trouw 16 June. NB: The 
Minister wants the contract of Nutricia and Gene Pharming to be changed in coherence with the 
contract of the Ministry and Gene Pharming (Volkskrant, Algemeen Dagblad, Trouw, Telegraaf 29 
June). At the end of the year the Ministry and Gene Pharming end the contract voluntarily under 
the condition that the research into the health and wellbeing of the animals in the experiment will 
go on (Trouw, Algemeen Dagblad, Telegraaf 9 November). 
3 1 Telegraaf 17 June, Volkskrant 17 June, NRC 17 June. Later Gene Pharming explained why 
mastitis prevention was mentioned as the primary goal. It wanted to produce biomedical proteins 
without a specific objective as the technique was still in an experimental stage. The Minister, 
however, wanted to have a specific objective in order to approve of the project. In consultation 
with the Ministry, mastitis prevention was chosen as a preliminary objective. On the long run, 
however, the firm still is primarily interested in human medicine. Next Nutricia came in as it was 
interested in the lactoferrin that would be produced. It did not want publicity due to considerations 
of competition. 
3 2 E.g. Volkskrant 29 June 
133 
confidential information, as a lot of money was involved. This affair, however, did 
not cause as much upheaval as the lack of openness of Gene Pharming or of the 
Ministry. So, it seems to be less worse than the lack of openness of the firm itself. 
Theatre 
It is obvious that major failures with respect to the five rules I have discussed 
above will result in comments and criticism and in damage to the image of the 
criticised. And we have seen that there are implicit rules for comments and 
criticisms as well. In this section, I will reconstruct some more rules for debating in 
public. I have restricted myself to the aspects, and so rules, that emerge from this 
particular debate. I have called this section theatre, as the elements I have gathered 
under this heading have to do with the selective presentation of oneself and others. 
Theatre always will be an element in a public debate. It enlivens the debate and 
helps to keep people attentive. We will see, however, that there are social 
conventions that the participants are supposed to respect. In three sub-sections, I 
will reconstruct three more rules. These rules can be regarded as a substantiation of 
the rule that people should reason, although this will be 'reasoning with other 
means'. 
- Regarding story telling 
Several times an issue was discussed that was beside the main theme of the debate. 
For instance, a discussion arose in Parliament on whether the inserted gene was of 
human origin (1991). Shortly thereafter, a point was made out of the request of 
Gene Pharming to sell the non-transgenic animals. It might be questioned whether 
these were important issues. Tjard de Cock Buning 3 3 had a point when he stated 
that whether the inserted gene is of human origin is not important. In his view, 
what should be at stake is the transfer of genes from one species to another 3 4. The 
other issue, about what to do with the non-transgenic animals, also was a side 
issue. Of course, it had to be decided whether the cattle might be sold or whether 
the cattle was necessary for the experiment, but it does not seem worth public 
NR.C 7 May 1991 
Aside: If everybody would have agreed that the gene was of human origin, than there would have 
been two main issues in this debate, an animal ethical one, about animal transgenesis and a 
medical-ethical one, about the mixing of human and animals. As everybody accepted the 
explanation of the Minister this last issue is not further discussed in the debate, but it has come 
back in the debate on xenotransplantation. Peter Vermij (Het Parool 2 December 1992), however, 
argued that the Minister had used bad rhetorics in distinguishing human and human-identical 
genes. For the debate on animal transgenesis this has been a good thing, since as soon as medical 
ethical issues arise, animal ethical issues slide into the background (see Stalleu 1994). 
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upheaval. But, both issues discussed together created an image of Gene Pharming, 
namely the image of a firm dealing in an unethical way with animals by handling 
them as sees fit. The use of human genes gives rise to the idea that legal rules are 
broken and the selling of the remaining animals gives rise to an image of an 
unscrupulous commercial firm. It is not sure whether it was the intention to damage 
the image of Gene Pharming at this stage in the debate. It had, however, this effect. 
By telling stories, one might damage the image of an opponent. A comparable case 
is at hand in 1993 with the mosaic 3 5 cow Ineke that gave birth 'illegally'. And later 
another side issue, about twenty embryos that were 'bred' in a single cow, has also 
drawn attention. 
In a way, these issues are side issues, in another way, however, these issues all 
have to do with a general attitude towards animals. The way the 
Dierenbescherming has handled these issues, thereby damaging the image of an 
opponent, has not been criticised during the debate. It seems to be accepted 
practice as a kind of circumstantial evidence. The condition, however, seems to be 
that the stories told are true stories, that is to say they have to be evidence. So, the 
rule seems to be: the participants may use circumstantial evidence as long as this is 
true evidence. 
- Regarding suggestive reasoning 
There were, however, also actions that were deliberately meant for creating a 
negative image of Gene Pharming. Several opponents of animal biotechnology and 
in particular the Dierenbescherming accused Gene Pharming of having commercial 
intentions. This was a true story, but it was not the whole story. Of course, Gene 
Pharming was a firm operating in the market. Although it was at the time still 
heavily subsidised by the Ministry of Economic Affairs, it also had been and still 
was searching for market partners. The transgenic animals were up to producing 
marketable products for these market partners. But, it may be questioned whether a 
marketable product is a bad thing just because it is marketable? Or as Postma 3 6 , a 
spokesperson of Gene Pharming, states: 'It is possible to earn money in an ethically 
sound way' (my translation, ET). Still, the suggestion that arises from the 
accusations is a different one. But, our society is also in need of market parties for 
efficiently producing all kinds of products and this is not considered unethical as 
such. Only certain attitudes of commercial firms and certain ways of producing 
things are considered unethical. This implies that establishing that a firm has a 
A cow is called mosaic if only parts of the animal are transgenic. In this case only the placenta 
was. As a placenta will be destroyed after birth, this will be a border case. But, as the cow was in 
the experiment, she should not deliver without permission, was the opinion of the Minister. 
NRC 5 January 1991 
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commercial character is not enough. One has to look further. One of the reasons for 
naming Gene Pharming commercial might be the content of the Law on Animal 
Experiments 3 7. This law forbids animal experiments for commercial reasons. But, 
this law only roughly indicates what should and should not be considered a 
commercial reason. The production of pharmaceuticals for humans and animals is 
not considered a commercial reason, food production is a border area, and the 
making of other products is considered a commercial reason. So, the activities of 
Gene Pharming were either non-commercial or border activities, while the 
suggestion raised in the newspapers was that their only intention was commerce. 
This means that the intentions of Gene Pharming were put in a bad light by calling 
them purely commercial. Only insiders will see the difference and only insiders 
have complained about this suggestive reasoning. Criticism on this point of the 
Dierenbescherming in particular has been expressed several times in the 
newspapers (see also my discussion of the first parameterin the former section). 
Mid 1993, the Dierenbescherming raised its first accusations that Gene Pharming 
was up to produce infant feeding milk containing the transgenetically produced 
lactoferrin. Gene Pharming responded that it was a possibility they had mentioned 
before but did not confirm or refute the accusation. At the end of the year the 
accusations became stronger. Antoinette Hertsenberg of the Dierenbescherming 3 8 
called Gene Pharming a liar, for not revealing the true objectives of its research, 
namely the production of mother's milk from cows, a million-dollar market: 'It 
wants to feed genetically modified milk to our babies' (my translation, ET). The 
way in which the Dierenbescherming, in this case, formulated its accusations 
appeals to feelings of fear among the public. It has a demagogic element in it which 
annoys a number of people (see also my discussion of the first parameter of Kettner 
in the former section). 
Piet Borst 3 9, biochemist and contributor to the NRC, was the first to reflect upon 
the negative effects of the polarising attitude of the Dierenbescherming. He 
suggested that denouncing 'Herman the bull' and Gene Pharming by the 
Dierenbescherming will result in the avoidance of publicity by Gene Pharming that 
first was enthusiastic about publicity. He suggests that too much polarisation and 
too suggestive reasoning might scare of some participants, whose participation is 
appreciated for the sake of the debate 
37 
38 
39 
This reason is not mentioned in the newspapers 
Trouw 24 November 1993 
NRC probably summer 1991 (exact date unknown to me, E.T.) 
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There seems to have been an implicit rule in the debate: the participants should not 
unnecessary reason suggestively, polarise the debate, or rouse public sentiment. 
- Regarding expressive elements 
The Dierenbescherming started the year 1994 with a harsh and confronting poster-
campaign. It showed the image of a 'Madonna and Child', but the woman is naked 
and has cow's udders instead of breasts, which you will only see at second sight. 
The poster in AO size is exposed in waiting cabins at bus stops and at train-stations. 
The text was 'NEW - MOTHER'S MILK FROM COWS'. People were offended 
by the exposition of a woman with animal traits and by the suggestion that 
scientists were changing the genetic make up of humans 4 0 . They called the poster 
disgusting, insulting, or misleading. Apparently, the Dierenbescherming has gone 
too far in the eyes of quite a lot of people. The Dierenbescherming responded that 
this poster was meant to stimulate discussion. It claimed that it was not the poster 
that was shocking, but the developments in animal biotechnology and hence the 
message of the poster. It also claimed to have revealed the true aims of Gene 
Pharming, namely the production of mother's milk from cows 4 1 . Several letters to 
the editor supported the view of the Dierenbescherming 4 2. Some of the opponents 
of the poster, however, even have appealed to the Advertising Code Foundation, 
who, however, decided that the poster was not misleading, as its message was 
clear, namely a warning against genetic engineering. So, the poster did not violate 
the formal standards for advertisements, but it still was confronting in the eyes of 
many people. The Dierenbescherming never used such a harsh poster again. 
The Dierenbescherming, however, has used other posters and poster-like 
advertisements in the newspapers in its further campaign, but these did not trigger 
any reactions by the public. Probably these were not considered as confronting. It 
seems as if the criticised poster has triggered another message than was meant. The 
image was so strong that many people draw a conclusion from the poster that was 
not intended. 
Since this subsection is about the impact of images, another image has to be 
mentioned, although it did not appear in the newspapers, namely an image in a 
VPRO documentary (1992). If people have seen this documentary they will hardly 
remember what is said, but they will remember the last scene in which a cat 
cuddles with the still young bull Herman. Whatever Gene Pharming has said about 
Volkskrant 22 January 1994, NRC 22 January, Trouw 25 January, Volkskrant 29 January, 
Telegraaf 27 January, Parool 3 February, NRC 10 February 
E.g. Algemeen Dagblad 18 January, Trouw 18 January, Volkskrant 18 January, Parool 16 
February, NRC 17 February 
E.g. NRC 22 January, Volkskrant 29 January, NRC 10 February. 
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'a normal animal, with just one extra gene' cannot have had the impact of this 
single image. 
So, expressive elements are explicitly put in as a means to influence the public by 
showing a reality that challenges people to rethink their views. Such a message 
should be clear and not be very offensive. Otherwise expressive elements may give 
rise to criticism. So, the implicit rule has been: expressive elements may be used as 
a means to influence the public, but the message should be clear and the images 
should not be too offensive. 
Doubts about the fruitfulness and sense of this debate 
During the debate some participants have uttered doubts about the fruitfulness and 
sense of debates in general and this debate in particular. Some have asked for a 
public debate on animal transgenesis even after several years of debating 4 3. Others 
have criticised the debate for not discussing the important issues 4 4 or for being too 
emotional 4 5. People have complained that the debate was only on procedures 
instead of on the genetic engineering itself46. And more in general, it has been said 
that public debates do not have any impact or even have no use, because such 
debates always are irrational 4 7 or because ethical limits always will be readjusted 4 8. 
It is suggested that it is impossible for the larger public to be involved in public 
debates. And there were many complaints about the quality of the debate 4 9. 
E.g. the ethicists G. van Thiel, F. Brom and A. Huibers in De Staatscourant of 29 March 1995. 
Such a statement also was one of the outcomes of the consensus conference that was organised by 
the Dutch Organisation of Technology Assessment in 1993. The Dierenbescherming, the 
philosopher Henk Verhoog, and Wim Zeijlemaker, writer of a letter to the editor, have asked for a 
debate in 1992 (in subsequently De Telegraaf of 7 November, Het Parool of 28 November and De 
Volkskrant of 22 December). And it was the main reason for the Dierenbescherming to start a 
campaign on animal biotechnology in 1993. 
E.g. the philosopher Tjard de Cock Buning (NRC, 7 May 1991) and the patient's organisations 
(Algemeen Dagblad, 15 December 1992 and De Volkskrant, 7 April 1993). 
E.g. Andries Dijkstra (Telegraaf, 14 May 1991). 
E.g. Mr Drs. J. Staman of the Ministry of Agriculture, Nature Management and Fisheries (De 
Volkskrant, 20 November 1993) 
E.g. the philosopher Hans Achterhuis in De Volkskrant of 24 December 1994 
E.g. the philosopher Rene von Schömberg in Trouw of 8 January 1993. In his view ethical limits 
are just changing, and the outcome will always be arbitrary. In my view ethical limits are changing 
because of a learning process, and so will not be arbitrary. See also my criticism on Von 
Schombergs's view in NVBe - nieuwsbrief, 6 (1), 4-8 
During the debate on animal transgenesis most complaints were about a general lack of 
transparency; the slogans and one-sided information put forward by the Dierenbescherming; the 
withholding of information and therefore misleading of the other participants in the debate by the 
Minister of Agriculture and Gene Pharming. These kinds of complaints started at the end of 1992 
and were generally uttered in 1993 en 1994. 
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After having written this book, I can reply most of these critics. I will start with 
what can be reconstructed as the expectations of the critics of public debates in the 
media; then I will put forward a more realistic view on public debates; and I will 
end with a reply to the critics. It is my hypothesis that these critics have too high 
expectations of public debates, which explains their disappointment in the process 
and in the outcomes. 
A reconstruction of the expectations 
One may wonder what people are expecting of a public debate if they come to the 
kinds of criticism that I have summarised above. From the criticism that was 
uttered, I deduce that these critics expect first and foremost that people will be 
seriously discussing with each other, that is to say that they will reason 
conscientiously, that they are seeking common ground and that they are oriented at 
mutual understanding and in the long run consensus. They want a rational debate, 
that is to say a discussion about reasons. They expect that is only spoken about the 
important issues, and not about side-issues and procedures. And they want impact. 
And they do not expect impact if people are quarrelling instead of trying to meet 
each others point of view. And they do not see impact because they think that 
politics will only listen if many people are involved and if their opinions are more 
or less convergent. What they observe is only limited involvement and are divided 
opinions. So, they conclude that this public debate, if any public debate, will not 
have impact. 
A more realistic view 
Let us start with the last point. If this image of a public debate is compared to what 
actually happens in any public debate, the judgement cannot be but negative. Even 
a broad public debate will not reach everybody let alone involve huge numbers of 
people. But, in my view, it will be enough if it reaches everybody who is interested 
in the topic and if it is open for people who want to have a say. The last condition 
is harder to meet than the first one. In this particular public debate, all news media 
have very well covered the issue at hand. One can also detect that there were 
individuals who have participated by writing a letter to the editor, but one cannot 
know how many people wanted to participate but that were denied entrance for 
whatever reason. What can concluded, however, is that the letters that were printed 
did not add new reasons to the debate. And one may assume that newspapers have 
printed the most interesting letters, which would mean that the letters that were not 
printed would not have added to the debate 5 0. 
It would be interesting though to examine how papers deal with letters to the editor. 
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In my view, the public in a public debate in the media is first and foremost an 
audience. The participants (the actors) do not primarily want to influence each 
other, but they perform before the public as an audience in order to convince this 
public, that is to say to influence public opinion and to gain public support for then-
views. And they do so by lucid reasoning, by articulating differences, and by 
campaigning. I assume that they want to influence public opinion in order to have 
an impact on politics. This is exactly what many critics observe and this is what 
they criticise. 
But is it a bad thing if the discussants are mainly performing before the audience of 
the broader public? Is not the forming of a well-informed, and therefore critical, 
public opinion, even if it is divided, a good thing as a result of a public debate? Is 
not listening to both sides an effective way of forming a considered opinion about 
an issue? And should not the reasons pro and contra be as clear as possible? And 
are not people capable of evaluating the quality of these reasons? And should not 
politicians be influenced by reasons in the first place in stead of by listening to 
broad majorities? 
Public debates are not only about reasons. As I have stated in the former section, 
suggestive reasoning and campaigning are also part of public debates. Herewith, 
feelings and the playing on these feelings become more explicit an aspect of public 
debates. Here we arrive at the criticism that there is much irrationality in public 
debates. But, one may argue that if these feelings cannot be countered by the other 
party, there will be something in these feelings that cannot be voiced (yet) but that 
still has to be taken seriously. This means that there are elements in the formation 
of an (public) opinion that cannot be made rational (yet), but still are there and are 
powerfully there. 
For instance, the notion that you cannot just do everything with animals has been a 
powerful notion from the start of the debate onwards. At first, this was almost the 
only thing that could be said about a very powerful feeling concerning the 
treatment of animals. After nine years of debating and a lot of philosophising, 
which has led to the implementation of new concepts like the intrinsic value of 
animals and animal integrity, this view is broadly accepted as a respectful view, but 
it still is only a bit more substantial than the expression of the powerful feeling the 
debate started with. 
This reveals my idea of rationality. I agree with J. Habermas' pragmatic concept of 
rationality. According to Habermas, the rationality of an expression or an act 
depends upon the criticisability of the knowledge that is incorporated in this 
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expression or act 5 1 . This means that, in order to be rational, it has to be possible to 
defend or criticise an expression or act. So, a reference to a feeling that other 
people cannot understand and that cannot be made understandable is (for the time 
being) irrational. But if it can, with circumstantial reasoning, be made better 
understandable, it will also grow to be more rational. And this is what has 
happened during this debate with for instance the feeling that animals have to be 
treated respectfully and that animal transgenesis might be disrespectful to animals. 
People have tried to find words and they did find words that can communicate a 
feeling that could at first hardly be put into words 
This points at an important element of what debates are about: namely trials to 
articulated the notions that are important to people, such as values, first 
impressions and emotions. In a debate, the unvoiceable will get articulated! 
Therefore, a lot of reasoning, a lot of trials, and a lot of repetitions are necessary to 
find the words that will make these notions understandable and so criticisable. So, 
the introduction of feelings and emotions should not be considered a degradation of 
a debate but a challenge for all debaters to examine, to phrase, and to criticise the 
source of these feelings. 
And in my view, there has been this kind of rationality in the debate on Herman the 
bull. In particular, the trial to put vague notions considering animals into words has 
made this debate a fruitful one (see also chapter 5), and this has even led to the 
introduction of the concept of the intrinsic value into the Animal Health and 
Welfare Act. 
But it is not the introduction of feelings and emotions only that may cause people 
to think that a debate is quite irrational, this might also be caused by the relatively 
small scope of some of the participants. In chapter 6, we have seen that many of the 
participants have argued from the scope of a particular practice, such as the 
veterinary practice, the biomedical production practice, the specialised food 
production practice, and the dairy farming practice. For a fruitful debate about an 
issue like animal transgenesis that has to do with all these practices, the participants 
have to be able to exceed the limits of their practice. This, however, is a great thing 
to be asked from participants as they will sincerely consider the scope of their 
practice the best one. But, because of the public character of a debate, the 
participants are forced to deal with reasons that are foreign to their practice. And 
this is what they have done. The result, however, has not crystallised yet, as I have 
reasoned in the last section of chapter 6. One may conclude that a new practice is 
Habermas, J. Theorie des kommunikativen Handelns. Band 1. Handlungsrationalität und 
gesellschaftliche Rationalisierung. Suhrkamp Verlag. Frankfurth aM p. 13-24 
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emerging, but one may also conclude that one of the traditional practices will 
incorporate this new technology or that the classic practices will dissolve in certain 
aspects as general norms and values will prevail. In all these cases, however, the 
case is dealt with and it could only been dealt with by discussing reasons pro and 
contra. So, in this respect too the debate has resulted in more rationality. 
A reply to the critics 
By now, I am able to reply most of the critics: 
- If people have the idealistic conception of a public debate that I have sketched 
above, many doubts and criticisms are understandable, but they are not to the point. 
The fruitfulness and sense of a public debate should not to be measured to the 
convergence of views and opinions but to the sophistication and rationality of the 
opinions of the participants and of the broader public at the end of the debate. And 
this is what we see: all participants have elaborated on their views and reasons and 
have listened to and responded to other reasons and views (see chapter 6 and this 
chapter). 
- And if one expects that everybody has to be involved in a debate in order to make 
it a genuine public debate, than there will hardly be any public debates. In my 
view, however, it will be enough if everybody who is interested in the issue is able 
to follow the debate (as a spectator), that each voice will be heard, and preferably 
that everyone who wants to participate can do so. There is no reason to believe that 
people could not follow the debates or that some voices were not heard. My 
material does not provide information about the non-participation of people who 
have wanted to participate. 
- If critics are asking for a public debate after several years of debating than what is 
this book than about? 
- The same can be replied to the criticism that the debate was only about 
procedures. This book shows that there was more than a debate about procedures 
only. 
- If impact has to do with a convergence of opinions only, than indeed an average 
public debate will not have much impact as a debate will seldomly result in a more 
or less unified opinion. But, I do not think that this is what public debates are 
about. In my view public debates are about public opinion formation in the first 
place and therefore about reasoning and about the rationalisation of at first only 
partially articulated notions. And public debates have impact because people, and 
politicians, cannot but deal with the reasons that are put forward (see also chapter 1 
and the first part of this chapter). 
- 1 sense a rather sceptical attitude in the criticisms of Hans Achterhuis and René 
von Schömberg. These two philosophers advance an intriguing counter-position to 
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mine. The controversy between such a sceptical and my democratic position is 
extremely difficult to solve conceptually. My book, however, is one piece of 
evidence in favour of a democratic position. And it shows the importance of 
empirical work as well! 
- That leaves me with the criticism that the participants have 'misbehaved' and 
therefore distorted the debate. Especially the lack of transparency by Gene 
Pharming and the Ministry of Agriculture, as well as the suggestive campaigning 
of the Dierenbescherming have been an item in the debate. It is obvious that these 
participants sometimes went one step too far in their public performance, but it 
should be stated as well that they have taken the criticisms on their performance 
seriously and have replied to them and also have adjusted their behaviour. 
Transparency has become a serious item in public organisations as well as in firms 
during the last decade. And the Dierenbescherming has learned that too harsh a 
campaign may turn against itself (see the first part of this chapter). 
Conclusion: criteria for the evaluation of public debates 
In the second section, I have made a rough differentiation between deliberations 
and public debates before an audience. A deliberation is oriented at mutual 
understanding and at convincing each other. Therefore conscientious reasoning and 
seeking common ground is essential. A public debate before an audience, however, 
is primarily oriented at gaining public support and therefore at convincing the 
public. The reasoning will be lucid and differences will be articulated. If people do 
not recognise this difference they will not be able to judge a public debate 
adequately, as we saw in the former section. 
The criteria Matthias Kettner has developed for evaluating a deliberation will 
therefore not be immediately applicable for the evaluation of a public debate as 
well. As we have seen in the third section, these criteria do play a role in the 
evaluation of a public debate, but have to be adapted to the specific characteristics 
of public debates. From the debate at hand, it transpires, that people apply specific 
criteria for evaluating public debates that are consistent with the nature of public 
debates. So, people seem to be implicitly aware of the differences between a 
deliberation and a public debate and will therefore not be as strict in their 
judgement in case of a public debate. People tackle each other for their conduct 
while (implicitly) referring to these criteria. The criticised feel called to account, 
and will defend themselves. An explication of these implicit debating rules might 
help people to better understand and express what they are doing and what 
sometimes is going wrong. 
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I will summarise the criteria that I have reconstructed from the debate at hand: 
A. Reasoning 
• all participants should reason to substantiate their views 
• all participants should listen and respond to criticism 
• all participants should criticise the views and reasons of others if this will 
illuminate the issue at stake 
And some extra rules regarding 'reasoning with other means' 
• the participants may use circumstantial evidence as long as this is true evidence 
• the participants should not unnecessary reason suggestively, polarise the 
debate, or rouse public sentiment. 
• expressive elements may be used as a means to influence the public, but the 
message should be clear and the images should not be too offensive. 
B. Fusion of moral horizons 
• the participants do not need to strive after a fusion of moral horizons, but they 
have to show understanding for other points of view 
• the participants should strive after progress in their points of view 
C. Comprehensive inclusion 
• the participants should acknowledge the interests of relevant others, although 
they are allowed to argue in favour of a specific interest 
D. Bracketing of power differentials 
• all views should be heard, which does not imply that everybody should be 
heard 
E. Non-strategic transparency 
• the participants may time information 
• the participants should not break off communication 
• nowadays even market parties should be open about their objectives 
• people may seek/use allies, but these should be treated respectfully 
• political administrators should fully inform the chosen politicians to whom 
they are accountable. 
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8. Conclusion. 
In the introduction, I indicated that my motivation for writing this book was to 
better understand public debates. My guiding intuitions were that debating in 
public makes sense; that debates may pass off well; that they can have impact; and 
so be successful. I have chosen to investigate a single, but interesting debate. I had 
the strong impression that the debate on animal transgenesis, with Herman the bull 
as its central case, has been a successful debate. It has had continuity. The debate 
was imbedded in a more comprehensive debate on animal health and welfare to 
which it has added new substantiations of recently developed concepts. The various 
aspects of the case were discussed over a period of time which has resulted in a 
development in argumentation. During this time span the participants have reacted 
to each other's points of view, reasons, and lines of reasoning. All relevant aspects 
and considerations seem to have been discussed. The inputs of the various 
participants were also discussed with respect to the communicative quality of these 
inputs (that is to say there has been a meta-discussion as well). And the debate has 
had impact on public opinion formation, on the development of ethical standards, 
and on policy formation. 
In this book, I have substantiated these intuitions by way of reconstructing the 
debate at hand. In this way, I have gained insight into what has made this particular 
debate a successful debate. By analysing the characteristics of this debate, I have 
also got hold of some traits of successful public debates in general. 
It may be questioned what the use is of arriving at a better understanding of public 
debates. It is my conviction that insight in what you are actually doing and what the 
implicit rules are that guide these actions, will lead to more adequate and better 
considered actions. This applies at least to myself. 
My book started with a number of questions about how to understand public 
debates in general and the debate on animal transgenesis in particular. I have 
restricted myself to the debate in the written media as this debate facilitates a broad 
public opinion and will formation. And I have taken the debate itself as a point of 
departure. This means that my work is empirically based and that I have adopted an 
inductive approach. I have tried to let the material speak while having theories and 
heuristic devices in mind. 
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My guiding questions in analysing the debate on animal transgenesis were directed 
at the substantiation of the claims I have made above: 
- what has kept this debate going? 
. what has been the internal dynamics of the debate? 
. what were the external influences that have kept the debate going? 
. what has been the role of the participants? 
- what has been the development regarding the content of the debate? 
. have any new concepts been suggested and substantiated? 
. has there been progress in the positions and the lines of argumentation of 
the participants? 
. what has been the influence of the participants on each other? 
- what has been the impact of the debate? 
. have the members of the broader public been enabled to form a 
considered opinion? 
. has it had any impact on the development of ethical standards? 
. has it had any impact on political decision making? 
- has the debate passed off well? 
. were participants receptive to critiques of their behaviour? 
. have the participants taken the debate and the audience of the broader 
public seriously? 
. have all relevant views been heard? 
In reconstructing the debate on animal transgenesis, I did not only get a hold on 
what has actually happened, but also on what has made this debate a successful 
debate. From this reconstruction, I have derived a number of characteristics of a 
successful debate. The five chapters that build up the results of my research are 
aimed at answering one or several aspects of these questions. Chapters 3, 4, and 6 
are aimed at answering aspects of the first question (what has kept the debate 
going). Chapters 5 and 6, and partly chapter 7 are aimed at answering the second 
question regarding the content of the debate. The impact of the debate is discussed 
in chapter 5 and 6. Aspects of a reflective attitude are the subject of chapter 7. 
Main findings 
The internal dynamics (chapter 3) 
A media debate differs from other debates, as for the media topicality is a major 
motivation to publish about an issue. In particular a media debate like the one on 
animal transgenesis, which has lasted for some nine years, is more complex than 
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one would assume beforehand. Eleven episodes could be distinguished that were 
almost all caused by specific events. In almost each round a new issue has popped 
up for discussion, although many issues came back in later rounds. Most rounds 
had a well demarcated closure too. Only two round just ended. The Herman project 
(as a case) has been a necessary focal point of the debate and has incited the 
participants to develop their opinions and lines of reasoning. Immediate causes 
seem to be necessary to make the debate urgent. The debate has been an ongoing 
comment on the developments in the project of Gene Pharming ('the urges'). The 
continuation of the Herman project has been a cause of internal dynamics in the 
debate. Such a public urge seems to be needed for stimulating a public debate and 
for the development of a public debate. 
The roles of the participants (chapter 4) 
A public debate can be made, or not, by its participants. They bear the 
responsibility of bringing forward the relevant reasons in order to arrive at a well-
informed and thus a well-considered public opinion. First and foremost, a good and 
open flow of information is needed to inform the public, which requires that: 
the actors that dispose of the information (in our case Gene Pharming and the 
Ministry of Agriculture) have to provide the information to the public 
(openness, transparency); 
- politicians, interest groups, journalists, experts, et cetera have to point out the 
issues in dispute; 
the media have to spread the information and the contested issues. 
In this debate, the Dierenbescherming had a major role in pointing out the 
contested issues. Compared to individual citizens or individual experts, an 
organisation like the Dierenbescherming will be better able to hold out long enough 
to keep a debate going. The duration of the debate as well as the number of aspects 
discussed reveals that the information flow in this debate has been adequately 
provided. 
Other debates have influenced this pubic debate in the media. Political debate in 
Parliament has structured part of the debate in the media, as some rounds of the 
discussion were initiated by the process of legislation and were explicitly directed 
at influencing parliamentary discussions. The media reports of these parliamentary 
discussions hardly contained reasoning, unfortunately. 
Many expert-meetings have taken place about many aspects of the issue. The 
results of these expert debates have been communicated to the public by way of 
interviews and by opinion page articles. The reports of expert committees advising 
the Minister of Agriculture have had an input in the public debate in the media the 
same way and also by way of expert comments on these reports. The second 
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Schroten committee explicitly turned itself to the media for stimulating public 
debate. 
The underlying controversies (chapter 5) 
In chapter 5, I have reconstructed three different positions with respect to the 
evaluation of animal biotechnology in general. The most dominant positions were 
the 'yes, if a limited set of conditions is fulfilled' position of Gene Pharming and 
its allies and the 'no, unless there are good reasons to do so' position of the 
Ministry of Agriculture and its allies. The 'no ' of the Dierenbescherming and its 
allies has not been central to the discussion, but has played a role in the continuity 
of the debate. The two major positions originated from different perceptions of the 
moral impact of animal biotechnology, namely the recognition or denial of the 
intrinsic value of animals and more specifically of animal integrity as a relevant 
consideration for the appraisal of animal biotechnology. These positions resulted in 
different questions to be raised with respect to this new technology. 
The concepts of the intrinsic value of animals and animal integrity were put 
forward quite soon after the start of the debate and were further articulated during 
the debate. These concepts still are integral to the bio-ethical framework regarding 
animals. The intrinsic value of animals and in particular the 'no, unless' principle 
are incorporated in the Animal Health and Welfare Act and are basic to the Decree 
on Animal Biotechnology. 
So, the influence of the discussions on the development, articulation, and 
substantiation of ethical standards regarding the treatment of animals and the 
impact of these standards on policy formation have become clear. To have such an 
impact, a development regarding content of the debate is necessary. During this 
debate, a change in the way of thinking about treating animals has occurred by way 
of a discussion about the intrinsic value of animals and about animal integrity. The 
notion of caring for animals has changed in meaning. This change cannot but have 
wider impact as well. 
Interacting practices analysed from an external point of view, (chapter 6) 
In chapter 6, I have concentrated on the discussions about some specific 
applications of animal transgenesis in cattle. These discussions have to do with 
possible contents of the ' i f and the 'unless' discussed in the former chapter. The 
way in which animals are conceived and treated does not only depend on general 
norms and values regarding animals, but also on the inherent norms and values of 
the practices in which they are kept and thus to which they 'belong'. Animal 
transgenesis as a new technology did not easily fit in with one of the existing 
practices of animal keeping. Animal transgenesis for the production of mastitis 
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resistant cattle could not hook on to the existing practice of cattle-breeding nor to 
the veterinary practice and so could not find approval. Nor was the production of 
lactoferrin via cow's milk to be used in infant formula or clinical food able to hook 
on to the practice of dairy cattle-breeding or the biomedical production practice of 
medicine. In both cases a new practice did not develop either. 
The production of human medicine via cow's milk did not fit in with an existing 
practice as well. Here, however, the discussion went on, as the production of 
human medicine was broadly considered a valid reason for making transgenic 
animals. This discussion has resulted in a way of handling the production of human 
medicine in cattle, but has not (yet) given rise to the subsumption of animal 
transgenesis under a specific practice. There still are three options: an existing 
practice might be extended so as to include these transgenic animals; or a new 
practice may emerge. But it is also possible that these new standards will be 
incorporated in some general standards concerning animals and that the idea of 
practices is passed. At the end of the debate (1997) this had not been settled yet. 
The attempt to subsume this new technology under an existing practice and the 
tensions and discussions this has evoked have been a source of dynamics in the 
debate. The case-by-case discussions about the different applications have set a 
number of limits regarding these (kinds of) applications. 
The process of debating (chapter 7) 
Although a public debate is first and foremost oriented towards convincing the 
broader public, it will have many characteristics of a deliberation as well. To be 
taken seriously by the public as an audience, the actors have to reason, have to 
respond to reasons, have to show that they acknowledge other interests, that they 
understand what others put forward, that they do not exclude other actors and 
views from the debate, that they are as open as possible, that they are neither 
making things up nor unnecessarily rousing public sentiment, and that their 
messages are clear and not too offensive. And this is roughly what we could 
witness in the debate on animal transgenesis. Therefore, it can be concluded that 
the participants have been enabled to form a considered opinion. 
Most debating rules were respected. But there has been critique as well on the 
major participants. At several occasions the participants have violated the implicit 
rules of proper debating. Gene Pharming and the Ministry of Agriculture were 
criticised for not having fully informed parliament and the public. The 
Dierenbescherming was criticised for a poster that was considered too confronting. 
In addition to criticism of the behaviour of the participants, doubts were uttered 
about the fraitfulness and sense of debates in general and this debate in particular. 
In my discussion of these doubts, I have stressed that public debates should not be 
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mistaken for deliberations. Public debates are first and foremost directed at 
convincing the public. Mutual understanding and in the long run consensus reached 
by way of careful reasoning and seeking common ground may be a result of such a 
debate, but it is not its primary objective. The participants of a public debate are 
aimed at gaining public support and at impact by way of lucid reasoning, 
articulating differences and seeking coalitions. Nevertheless, there will be many 
deliberative elements in a public debate and the inherent rules of deliberations can 
be applied to public debates, but not too strictly. I have proposed some 
modifications in chapter 7. 
Conclusions 
My central claim in this book was that, although this debate has not been perfect, it 
still is an example of how a debate can be. We have seen that for a debate in the 
media to have continuity four elements are necessary, to wit: an issue (an urge); a 
flow of information (and transparency); the pointing out of relevant issues (mostly 
by an organisation that takes this responsibility); and good coverage by the media. 
For a development regarding the content, substance for discussion is needed. In this 
case new concepts have been developed for this new situation in which the genome 
of animals is changed. These changes of the genome do not always affect the 
health and wellbeing of these animals, but many people still feel uneasy about 
them. A discussion has arisen about how this new technology fits in with 
traditional ways of handling animals. By criticising each other and by putting 
forward alternative views, the participants have stimulated each other to better 
articulate their views in front of the public. The debate also has had impact: ethical 
standards and legislation have been adjusted. A debate can pass off quite well, as 
we have seen in chapter 7. Violations of the inherent debating rules have been 
criticised and it is observable that the participants have realised that it is necessary 
(sometimes they have even promised so) to behave according to these rules. 
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Supplement 1. List of abbreviations1 
A H W A = Animal Health and Welfare Act (Gezondheid en Welzijnswet voor Dieren) 
A K B = Alternatieve Konsumenten Bond (Alternative Consumers Association) 
C B D = Commissie Biotechnologie bij Dieren (Committee Biotechnology in Animals) 
C D A = Christen Democratisch Appel (Christian democrats) 
C E B D = Commissie Ethiek en Biotechnologie bij Dieren (Committee Ethics and 
Biotechnology in Animals) (the Schroten Committee) 
D 6 6 = Democraten 66 (liberals) 
GPV = Gereformeerd Politiek Verbond (small Christian party) 
GrL = GroenLinks (left wing environmentalists) 
ID-DLO = Instituut voor Dierhouderij en Diergezondheid van de Dienst Landbouwkundig 
Onderzoek van het Ministerie van Landbouw (Institute o f Animal Science and 
Health o f the Agricultural Research Department o f the Ministry o f Agriculture) 
rVO-DLO = Instituut voor Veeteeltkundig Onderzoek van de Dienst Landbouwkundig 
Onderzoek (Institute o f Animal Husbandry Research o f the Agricultural Research 
Department)) 
K N A W = Koninklijke Nederlandse Academie voor de Wetenschappen (Royal Dutch 
Academy for the Sciences) 
N I A B A = Nederlands Industriele en Agrarische Biotechnologie Associatie (Dutch 
Industrial and Agrarian Biotechnology Association) 
NIBI = Nederlands Instituut voor Biologen (Dutch Institute for Biologists) 
NIPO = Nederlands Instituut voor Psychologisch Onderzoek (Dutch Institute for 
Psychological Research) 
N O T A = Nederlandse Organisatie voor Technologisch Aspectenonderzoek (Dutch 
Organisation for Technology Assessment) later: Rathenau Inistute 
N R C = Nieuwe Rotterdamse Courant (New Rotterdam Newspaper) 
N W O = Nederlands Wetenschappelijk Onderzoek (Dutch Research Organisation) 
PPR = Politieke Partij Radicalen (environmentalists) 
PvdA = Partij van de Arbeid (social democrats) 
RPF = Reformatorisch Politieke Federatie (small Christian party) 
SGP = Staatkundig Gereformeerde Partij (Christian fundamentalists) 
v C E E G M D = voorlopige Commissie Ethische Evaluatie van Genetische Modificatie bij 
Dieren (provisional Committee Ethical Evaluation o f Genetic Modification o f 
Animals) (Schroten 2 Committee) 
vCOGEM = voorlopige Commissie Genetische Modificatie (provisional Committee 
Genetic Modification) 
W D = Volkspartij voor Vrijheid en Democratic (conservatives) 
1 M y translations, ET. 
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Supplement 2. Example 
D24: N R C 051290 - news item 
18 
I: a genetically engineered calf is born p j 
P: this is a good thing to do ^ a ^ 
R: since it wil l have an inherited enhanced resistance against mastitis A23a 
A: IVO-DLO - Dr.ir. P. Booman, and GPE - Dr. H. D e Boer 
R: since mastitis is a general cattle disease 
R: since mastitis diminishes milk yield 
R: since mastitis affects the tenability o f milk 
R: since mastitis affects the taste o f milk 
R: since mastitis affects the productivity o f farms 
D 2 5 : Het Parool 071290 - background article by Hans van Maanen 
II 
I: a genetically engineered calf is born pg 
P: this is morally problematic ^ 2 4 
R: since this is like making Frankenstein 
A: Lekker Dier 
P: this should be forbidden 
P28 
A 3 
A: Dierenbescherming P2 
P: there are no moral objections 
R: since this is in line with traditional breeding technology 
A: no actor mentioned 
R: since this is only faster and more secure than traditional breeding techniques ^ 
I: a transgenic calf is born that will produce extra lactoferrin in its milk as to be p ^ 
protected against mastitis ^ 
P: this is a good thing to do 
R: since this is a prominent cow's disease 
R: since cows produce too little lactoferrin 
R: since it is possible that c o w s have lost their ability to produce sufficient 
lactoferrin 
R: since this might restore the 'natural' level of the production 
I: a calf is born 
P: it is morally problematic 
R: since this is perhaps one step too far 
A: no actor mentioned 
R: since it is unknown how God has meant the cow to be 
R: since this should be discussed first 
R: since it might harm the health and well-being o f the animals 
P: a public debate is needed 
R: since the pros and cons should be evaluated 
II 
P6 
AO 
P7 
AO 
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Supplement 3. The actors in order of appearance 
AO no actor mentioned, 'opinions', 
'critics', 'insiders' 
Al Gene Pharming (GP, fist called 
Gene Pharming Europe and later 
called Pharming) 
Ala GP - Herman de Boer (scientific 
manager) 
Alb GP - drs. O. Postma (business 
manager) 
Ale GP - Dr R. Strijker (project 
manager) 
Aid GP - PR-buro (R. Praaning) 
Ale GP - ir. G. Hersbach 
Alf GP-DrD. VanBeynum 
(scientific manager) 
A1 g GP - Jan Nuyens (researcher) 
A2 Ministerie van Landbouw, 
Natuurbeheer en Visserij (LNV) 
[Ministry of Agriculture, Nature 
Management and Fisheries] 
A2a LNV - Minister Braks 
A2b LNV - State Secretary Gabor 
A2c LNV - Minister Bukman 
A2d LNV - mr. P. Ritsema 
A2e LNV - mr. Drs. J. Staman 
A2f LNV - lawyers of LNV 
A2g LNV - Minister van Aartsen 
A3 Dierenbescherming (DB) [the 
Dutch Association for the 
Protection of Animals] 
A3a DB - drs AJ. (Ton) Dekker 
(secretary) 
A3b DB - Reilingh (president) 
A3c DB - Antoinette Hersenberg (staff 
member) 
A3d DB - drs. Michiel Linskens (staff 
member) 
A3e DB-inspection - mr. D. Th. Van 
Oers 
A4 Christelijke Plattelands Jongeren 
(CPJ) [Christian Rural 
Youngsters] 
A5 St. Natuur en Milieu (SNM) 
[Foundation Nature and 
Environment] 
A5a SNM - Lucas Reynders 
(president) 
A6a some researchers at the PAN 
conference 
A6b medical researchers 
A7 — (combined) 
A8 the Second House of Parliament 
A8a a majority in Parliament 
A8b a minority in Parliament 
A9 D66 (liberals) 
A9a D66 - Tommel 
A9b D66-TerVeer 
A9c D66 - Tiesinga 
A10 RPF (small Christian party) 
A l l PPR (environmentalists) > GrL 
Al ia PPR - RiaBeckers 
A12 CD A (Christian Democratic 
Party) 
A12a CDA-vanNoord 
A 12b CD A - minority 
A 12c CDA - Laning-Boersema 
A12d CDA-Reitsma 
A12e CDA-de Jong 
A13 PvdA (social democrats) 
A13a PvdA - Swildens-Rozendaal 
A13b PvdA-Huys 
A14 W D (conservatives) 
A14a WD-Blaauw 
A15 a letter to Parliament by some 
biotechnology firms 
A16 Wageningen Agricultural 
University (WAU, later called 
Wageningen University) 
A16a ir. E. Kanis (WAU) 
A16b Dr. J. Noordhuizen (WAU) 
A16c Dr. R.R. Wiepkema (WAU, and 
member of the pCEEGMA) 
A16d Dr. Ir. E.W. Brascamp (WAU) 
A16e Dr. Jaap Visser (WAU) 
A17 Dr. V. Pursel 
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A18 Dr. Wagner 
AI 9 Michael Fox of the Humane 
Society (USA) 
A20 Commissie Ethiek en 
Biotechnologie bij Dieren 
(CEBD) [Committee Ethics and 
Biotechnology in animals] (also 
called the Schroten Committee) 
A20a CEBD - Dr Schroten (president) 
A20b CEBD - Dr Tj. De Cock Buning 
(also vCEEGMD member) 
A21 GroenLinks (GrL) (left wing 
environmentalists) 
A21a GrL-Beckers 
A21b GrL-Ojik 
A21c GrL-Vos 
A22 Michiel Linskens (researcher for 
the NOTA, i.e. the Dutch 
Organisation for Technology 
Assessment, later called the 
Rathenau Institute) 
A23 IVO-DLO (Institute for Animal 
Husbandry Research of the 
Agricultural Research Department 
of the Ministry of Agriculture; 
later called ID-DLO) 
A23a IVO-DLO - Dr. Ir. P. Booman 
A24 Lekker Dier [Tasty Animal} 
A25 Utrecht University, veterinary 
department (UU) 
A25a Dr. A. Brand (UU) 
A25b Drs. Bart Rutgers (UU) 
A25c Drs. F. Grommers (UU) 
A25d Dr. R.A.H. Willemsen (UU) 
A25e Dr. L.F.M. van Zutphen (UU) 
A26 Nederlands Agrarisch Jongeren 
Kontakt (NAJK) [Dutch Agrarian 
Youngsters] 
A27 Den Hollander (interviewer) 
A28 Werry Crone 
A29 Queen Beatrix 
A30 Centrum voor Bioethiek en 
Gezondheidsrecht (CBG) [Centre 
for Bio-ethics and Health Law] 
A30a CBG - Dr. J. Vorstenbosch 
A30b CBG - G. Van Thiel, F. Brom and 
A. Huibers 
A31 SGP (Christian fundamentalists) 
A3 la SGP - Bas van der Vlies 
A32 voorlopige Commissie Genetische 
Manipulatie/modificatie 
(vCOGEM)[temporary 
Committee Genetic Engineering] 
A32a vCOGEM - Dr. J.E.N. Bergmans 
(president) 
A33 Nederlandse Industriele en 
Agrarische Biotechnologie 
Associatie (NIABA) 
A33a NIABA - J. Veldhuyzen 
A33b NIABA-Dr. G.M.A. van 
Beynum 
A34 voorlopige Commissie Ethische 
Evaluatie van Genetische 
Modificatie bij Dieren 
(vCEEGMD) [provisional 
Committee Ethical Evaluation of 
Genetic Modification in Animals] 
(also called Committee Schroten 
2] 
A34a vCEEGMD - a majority (5 
members) 
A34b vCEEGMD - a minority (3 
members) 
A34c Dr. Henk Verhoog (member of 
vCEEGMD, also CEBA member, 
also RUL) 
A34d Dr. L. Layendecker (member of 
vCEEGMD) 
A34e Dr Schroten (president of 
vCEEGMD) 
A35 HetParool 
A35a Het Parool - chief-editor 
A35b Peter Vermij (journalist of Het 
Parool) 
A36 Andries Dijkstra - columnist 
Telegraaf 
A37 Piet Borst - columnist NRC and 
biochemist 
A3 8 Trouw - chief editor 
A39 J. van de Zwan 
A40 RoelofVennik 
A41 Nico Baaijens 
A4 la Marcel Kuiper 
A42 Thijs Visser - bioethicist 
A43 patients organisation 
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A43a Margreet van Bladeren of the 
Rheumatics Patients Organisation 
A43b Cees Smit of the Nederlandse 
Vereniging voor Hemofilie 
Patienten (NVHP) [Dutch 
Association of Haemophiliacs] 
A44 Erica Poot 
A45 Jacqueline Schuurmans 
A46 GPV (small Christian party) 
A47 'Herman the bull' as the 
hypothetical writer of a poem 
A48 Wim Zeijlemaker 
A49 Rene von Schömberg, 
philosopher 
A50 P. Van Duyn, former professor in 
cellular biology 
A50a Jos Kooten, physician in training 
A51 J. Ten Lindert, ethicist 
A52 Dirk van den Brink, ethicist 
A53 Mtg. E. Sgreccia, bio-ethicist and 
prelate of the Roman Catholic 
Church 
A54 » 4 3 b 
A55 the First House of Parliament 
A56 A.C. van Goederen 
A57 Gonnie Koot, editor of the AD 
A58a judge van Delden (court) 
A59 Dutch public opinion 
A60 a lay panel at a consensus 
conference 
A60a a majority (15) of the lay panel 
A60b a minority (6) of the lay panel 
(former A61) 
A62 Wim van Gelder, president of a 
parliamentary committee 
A63 children in an essay contest (four 
cited) 
A64 Johan Geveke (member of the lay 
panel) 
A65 Nederlandse Organisatie voor 
Technologisch aspecten 
onderzoek (NOTA) [Dutch 
Organisation for Technology 
Assessment] later called Rathenau 
Institute 
A65a Jose van Eijndhoven, manager of 
the NOTA 
A66 Bas van Kleef, editor of the Vk 
A67 Dr. R. Furth 
A68 Marian Enderink 
A69 two Calvinists heard on the radio 
A70 Youpvan'tHek 
A71 A.E. Buteyn and M.J. Buteyn 
A72 Drs. D.J. van der Graaf 
A73 Willem Kuipers 
A74 Kees Koopman (n.b. manager of 
theNIBI) 
A75 Irene Jansen 
A76 Herman Eetgerink 
A77 Ministry of Economic Affairs 
A78 Hajo Canter Cremers 
A79 Dr. F.L. Meijler 
A80 Nutricia 
A80a Nutricia - Muntjewerf 
A80b Nutricia - J.C.T. van der Wielen 
(president) 
A81 Wim Köhler (journalist of NRC) 
A82 Anja Hazekamp 
A83 Reclame Code Commissie 
[Advertisement Code Committee] 
A84 Leiden University (RUL) 
A84a Dr. Herman de Boer (RUL) 
A85 SP (Socialist Party) 
A85a SP-Poppe 
A86 Alternatieve Konsumenten Bond 
(AKB) [Alternative Consumer's 
Organisation] 
A87 NRC-chief editor 
A88 W. Th. Hermans 
A89 Telegraaf - chief editor 
A90 Dilian Hos 
A91 De Volkskrant (Vk) 
A91a Vk-chief editor 
A91b Vk-RikNijland (journalist) 
A92 Algemeen Dagblad (AD) 
A92a AD - chief editor 
A94 Wim Mey (journalist) 
A95 Committtee Kooreman 
(provisionally advisory committee 
of the Ministry of Agriculture on 
alternatives for animal 
transgenesis) 
A96 Campina Melkume (dairy firm) 
and other Dutch dairy firms 
A97 Bas van Kleef (journalist) 
A98 immunologists 
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A99 K. Glastra van Loon and K. 
Kuiper authors of a book on 
Herman the bull 
A100 Dr. Hans Achterhuis 
A101 CorrieVisser 
A102 FinnGene 
A102a Janne of FinnGene 
A103 Dr. Paul Krimpenfort - former 
researcher of Gene Pharming 
A104 Komnklijke Nederlandse 
Academie voor Wetenschappen 
(KNAW) [Royal Dutch Academy 
for the Sciences] 
A104aDr. A. Van der Eb (president of 
the Committee Transgenic 
Animals of the KNAW) 
A105 Elly von Jessen 
A106 Ministerie van Volksgezondheid, 
Welzijn en Sport [Ministry of 
Health, Welfare, and Sports] 
(VWS) 
A106aDrs. P. De Greeve of the section 
animal experiments of the 
Ministry of VWS 
A107 Ministerie van Volkshuisvesting, 
Ruimtelijke Ordening en Milieu 
(VROM) [Ministry of Housing, 
Rural Planning, and Environment] 
A108 Stichting voor Nederlands 
Wetenschappelijk Onderzoek 
(NWO) [Organisation for Dutch 
Scientific Research] 
A109 medical funds 
A110 Erasmus Universiteit Rotterdam 
(EUR) 
Al 10a Dr. Bootsma (EUR) 
A111 Katholieke Universiteit Nijmegen 
(KUN) 
Al 1 la Dr. B. Wieringa (KUN) 
A11 lbDr. H. Zwart - manager of the 
Centre for Ethics of the KUN 
(CEKUN) 
A112 Nederlands Kanker Instituut 
(NKI) [Dutch Cancer Institute] 
A113 'cattle breeders' 
A114 heard on the radio (a rumor) 
A115 Marije Gaell, care-taker of 
Herman the bull 
A116 Gist Brocades and Agennix 
A117 Organon 
Al 17a Organon - Dr Joop de Graaf 
A118 Collagen 
A118 Collagen - D. Forster 
AI 19 Tijdsein of the EO (radio 
programme) 
A120 Dutch government / the Council 
of Ministers 
A121 Commissie Biotechnologie bij 
Dieren (CBD) [Committee 
Biotechnology in Animals] 
A121aDr. Plasterk (member of the 
CBD) 
A121b Dr. Schroten (president of the 
CBD) 
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Experimenten met stier Herman gaan door 
11 June, De Volkskrant, Maarten van Calmthout, Nutricia verbreekt relatie met stier 
Herman 
11 June, Trouw, anonymous, Nutricia maakt knieval voor milieubeweging 
11 June, Trouw, anonymous, Experimenten Herman gaan gewoon door 
11 June, NRC Handelsblad, editoral, Herman voor het blok 
15 June, Algemeen Dagblad, anonymous, Gabor onthield Kamer informatie. Betrokkenheid 
Nutricia bij stier Herman verzwegen 
16 June, NRC Handelsblad, W.Th. Hermans, Stier Herman 
16 June, NRC Handelsblad, Antoinette Hersenberg, Stier Herman 
16 June, NRC Handelsblad, anonymous, Gabor: Gene Pharming onvolledig over proef met 
stier Herman 
16 June, De Volkskrant, anonymous, Gabor overweegt opzeggen contract voor stier 
Herman 
16 June, Algemeen Dagblad, anonymous, Gabor voelt zieh bedrogen door Gene Pharming 
16 June, Trouw, anonymous, Landbouw onthield informatie over stier Herman 
16 June, Trouw, anonymous, Bukman ter verantwoording. Kamer wist nooit van 
commerciele proeven met Herman 
17 June, Telegraaf, editorial, Herman 
17 June, Algemeen Dagblad, anonymous, Toekomst van stier Herman onzeker. Bukman 
laat contract met Gene Pharming doorlichten 
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17 June, Algemeen Dagblad, anonymous, Staat wil van stier Herman af. Juristen: Contract 
met Gene Pharming ontbinden 
17 June, Trouw, Dillian Hos, Bukman komt makkelijk weg in fokstier - debat 
17 June, De Volkskrant, anonymous, Landsadvocaat bekijkt contract Gene Pharming 
17 June, De Volkskrant, editorial, Gene Pharming 
17 June, NRC Handelsblad, anonymous, Bukman laat onderzoek naar contract - stier 
Herman doen 
18 June, De Volkskrant, Frans Eggermont, 'Zegen voor mensheid waarmee we nuttige 
dingen kunnen doen' 
18 June, Algemeen Dagblad, editorial, Zorgen om Herman 
18 June, Trouw, editorial, De manipulatie van Herman 
20 June, Algemeen Dagblad, anonymous, Ministeries werken längs elkaar in zaak -
Herman. Naam Nutricia was onleesbaar in contract 
21 June, Algemeen Dagblad, anonymous, Vragen over Herman 
23 June, Algemeen Dagblad, Wim Meij, Gene Pharming was onvolledig over Herman -
project 
24 June, Algemeen Dagblad, Wim Meij, Nutricia getergd door golf van kritiek 
25 June, De Volkskrant, anonymous, Commissie bepleit voortzetting met stier Herman 
25 June, De Volkskrant, Frans Eggermont, De race tussen koe en schimmel 
25 June, De Volkskrant, Frans Eggermont and Broer Scholtens, Herman treft geen blaam 
28 June, NRC Handelsblad, Wim Köhler, Argumenten tegen genetisch manipulatie snijden 
geen hout 
29 June, NRC Handelsblad, anonymous, Gene Pharming mag experiment met stier Herman 
voortzetten 
29 June, De Volkskrant, Michiel Linskens, Voor stier Herman is het nog te vroeg 
29 June, De Volkskrant, anonymous, Bukman tegen verbond op proeven met stier Herman 
29 June, Algemeen Dagblad, Gonnie Koot, Experiment met stier Herman wordt niet 
verboden 
29 June, Telegraaf, anonymous, Herman gaat door 
30 June, Trouw, anonymous, Proef met Herman mag doorgaan, mits voor medische 
doeleinden 
30 June, De Volkskrant, anonymous, Proef met Herman voor medisch doel mag van Kamer 
14 July, Telegraaf, Monique Harmsen, Biotechnologie vreest afhaken investeerders. Kleine 
groep actievoerders schept vijandig klimaat 
30 July, De Volkskrant, anonymous, Gene Pharming zoekt verbeterde 'Herman' 
23 August, NRC Handelsblad, anonymous, Campina in produktie van lactoferrine 
23 August, De Volkskrant, anonymous, Campina gaat melkeiwit produceren. Zuivelbedrijf 
heeft voor produktie lactoferrine geen genetische manipulatie nodig 
24 August, Algemeen Dagblad, anonymous, Ook Campina gaat lactoferrine maken 
24 August, De Volkskrant, Bas van Kleef, Melkindustrie ontdekt de wonderen van 
lactoferrine 
15 September, Algemeen Dagblad, anonymous, Conflict over nakomelingen stier Herman 
15 September, Telegraaf, anonymous, Gene Pharming eist geld van ministerie LNV 
15 September, Trouw, anonymous, Eigenaar van stier Herman wil contract met landbouw 
kwijt 
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15 September, NRC Handelsblad, anonymous, Biobedrijf dreigt contract stier Herman op 
te zeggen 
15 September, De Volkskrant, Bas van Kleef, Gene Pharming wi l af van instituut overheid. 
Verzorging Herman leidt tot onvrede 
17 September, De Volkskrant, anonymous, Resultaten dochter vallen tegen 
17 September, De Volkskrant, Bas van Kleef, Partijen ruzien over stier Herman. Verzorging 
nakomelingen zou siecht zijn. Conflict stier Herman. 
17 September, Algemeen Dagblad, Gonnie Koot, Ruzie o m stier Herman loopt op 
Ol October, NRC Handelsblad, anonymous, Vergunning nodig voor genetisch 
experimenten 
Ol October, De Volkskrant, anonymous, Genetische proef met dieren vereist vergunning 
31 October, Staatscourant, anonymous, Biotechnologie bij dieren vereist straks vergunning 
09 November, Trouw, anonymous, Rijk niet meer samen met Gene Pharming in proef met 
Herman 
09 November, Algemeen Dagblad, anonymous, Landbouw en Gene Pharming verbreken 
contract stier Herman 
09 November, Telegraaf, anonymous, Stier Herman moet door ruzie verhuizen 
03 December, NRC Handelsblad, anonymous, Gene Pharming neemt belang in Fins Bedrijf 
07 December, Algemeen Dagblad, Gonnie Koot, Stier Herman naar Polsbroek 
15 December, Algemeen Dagblad, anonymous, Molifantjes in het lespakket 
2 4 December, De Volkskrant, Hans Achterhuis, Het hedendaagse heil ige 
1995 
19 January, De Volkskrant, anonymous, CDA'ers wisten van stier Herman en Nutricia 
29 March, Staatscourant, G. van Thiel, F. Brom and A. Huibers, Genetische manipulate 
moet op politieke agenda 
08 April, De Volkskrant, Bas van Kleef, Oprichter neemt afstand van beleid Gene 
Pharming. Ruzie Gene Pharming 
14 April, De Volkskrant, Herman A. de Boer, Koeien mögen geen chemische fabriek 
worden 
22 April, De Volkskrant, Corrie Visser, Zielige dieren 
22 April, De Volkskrant, Michiel Linskens, Wat is het verschil hissen een muis en een koe? 
23 May, Algemeen Dagblad, anonymous, Stier Herman wordt opa 
27 May, De Volkskrant, Kees Fens en Michael Zeeman, D e zee klotst voort 
15 June, NRC Handelsblad, Frank Westerman, 'Spijt is een onproductief gevoel ' 
21 June, De Volkskrant, anonymous, Gene Pharming sluit collageen - contract 
30 November, De Volkskrant, anonymous, Organisaties tegen strenger toetsen genproeven 
op dier 
28 December, NRC Handelsblad, (missing) 
1996 
11 January, NRC Handelsblad, Elly von Jessen, Manipulate 
11 January, De Volkskrant, anonymous, Pharming staakt experiment met Finse proefkoe 
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17 January, NRC Handelsblad, Jan Libbenga, Bij biotechbedrijf Genzyme zijn twaalf 
geiten goed voor één fabriek 
27 January, De Volkskrant, Maarten Evenblij, Herman moet naar de slacht levé Dee 
02 February, De Volkskrant, anonymous, Kabinet wil tests op proefdieren ethisch toetsen 
02 February, Trouw, anonymous, PvdA: Proeven met ratten zonder ethische toetsing 
07 March, NRC Handelsblad, Koos van Zomeren, De onbereikbare koe 
04 April, NRC Handelsblad, Wim Köhler, De mtrinsieke waarden van een knock out -
proefdier 
03 May, Telegraaf, anonymous, Nutricia gedwongen tot stop proeven met lactoferrine 
25 May, De Volkskrant, Maarten Evenblij, Als het dier - zijn maar beleefd kan worden 
24 May, NRC Handelsblad, anonymous, Nutricia onthoudt zieh een jaar van genetische 
manipulate 
22 June, NRC Handelsblad, Marije Gaell, Hollands Dagboek 
18 July, NRC Handelsblad, Marcel aan de Brugh, Schimmel slaat koe 
30 August, Intermediair, anonymous, Pretpark wil stier Herman ovememen 
05 September, NRC Handelsblad, Ben van der Velden, Actiegroepen als nieuw 
bedrijfsrisico 
14 September, De Volkskrant, Rik Nijland, Menselijk collageen is nog lang geen 
koeienproduct 
17 September, NRC Handelsblad, anonymous, Veel extra, jonge hoogleraren in de 
scheikunde (nb over sturing technologie, ET) 
30 November, NRC Handelsblad, anonymous, Vergunning nodig voor genetisch 
modificeren dier 
1997 
08 February, De Volkskrant, anonymous, Castrate van ster Herman ditmaal gelukt 
28 March, Telegraaf, Rob Huisman, Nutricia verändert naam uit angst voor 'recalls' 
10 April, De Volkskrant, Rik Nijland, Pharming begint met fokken van gemanipuleerde 
koeien 
12 April, De Volkskrant, Rik Nijland, Genetsche toetsing 
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Samenvatting 
(Summary in Dutch) 
Een spraakmakend kalf 
Een reconstructie van het debat over dierlijke biotechnologie 
AI jaren wordt er veel gesproken over publieke debatten, over het belang en over 
de wenselijkheid ervan. Er wordt ook veel onderzoek naar gedaan. Dat onderzoek 
rieht zieh met name op het analyseren van de inhoud, dwz de argumenten, de 
argumentatie lijnen en de ontwikkeling in de argumentatie, van die debatten. 
Daarmee is nog niet expliciet geworden, echter, hoe debatten nu eigenlijk begrepen 
moeten worden. Wat zijn publieke debatten eigenlijk? Wat gebeurt erin? Waar zijn 
ze op gericht? Hoe worden ze beoordeeld? Dat soort vragen heeft centraal gestaan 
in dit onderzoek. 
Ik heb me daarbij gericht op een bepaald type publiek debat, namelijk het debat in 
de media. Via dit debat is in potentie de gehele bevolking bij het onderwerp 
betrokken. Het is dus het breedst mogelijke publieke debat. Het is ook een heel 
speeifiek soort publiek debat, omdat het niet primair gericht is op consensus, maar 
op het overtuigen van het bredere publiek en het verwerven van publiek draagvlak 
voor de eigen opvattingen en daarmee invloed op de politiek. Dat heeft 
consequenties voor de wijze waarop gedebatteerd wordt. Het gaat om aansprekend 
redeneren, om uitleggen, articuleren, onderscheiden enzovoort. Het bredere publiek 
is in de eerste plaats een publiek van toeschouwers: zij luisteren, voelen zieh al dan 
niet betrokken, en vormen zieh een beter overwogen mening over de kwestie. 
Bovendien heb ik me gericht op een speeifiek geval, namelijk het debat over de 
transgene stier Herman. Deze door Gene Pharming ontwikkelde stier heeft een 
nieuw gen waardoor zijn dochters menselijk lactoferrine uitscheiden via de melk. 
Ik heb niet nagegaan of dit debat exemplarisch is voor andere debatten. Wat ik wel 
heb gedaan is dit debat zover mogelijk uiteenrafelen om daarmee voor anderen 
zichtbaar te maken wat er in dit debat is gebeurd en hoe het begrepen zou kunnen 
worden. Daarmee geeft mijn werk handvatten om andere debatten toegankelijk te 
maken en te begrijpen. 
Voor mijn onderzoek heb ik me beperkt tot de ongeveer 300 artikelen die over 
transgenese bij dieren zijn versehenen in zes nationale dagbladen, te weten het 
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Parool, Trouw, de Volkskrant, het Algemeen Dagblad, de Telegraaf en het NRC 
Handelsblad. Enkele keren heb ik, ora het verhaal compleet te maken, ook artikelen 
uit de Staatscourant en Intermediair (een weekblad) erbij betrokken. Uit deze 
artikelen heb ik de argumentaties gelicht. Daarbij heb ik mij niet alleen op 
uitspraken gericht die betrekking hebben op het onderwerp, maar ook op uitspraken 
die de deelnemers over elkaars gedrag doen (metakritiek en metaopmerkingen). 
Daardoor kon ik naast de inhoudelijke argumentaties ook het proces van 
debatteren-in-het-openbaar in mijn onderzoek betrekken. 
Het tweede hoofdstuk van mijn proefschrift is een enigszins gestructureerde 
samenvatting van wat er in de 9 j aar die het debat duurde is voorgevallen. Voor 
degenen die niet bekend zijn met het debat vormt het een introductie ertoe en voor 
alle anderen is het een opfrisser. 
In hoofdstuk drie maak ik zichtbaar hoe het debat zieh ontwikkeld heeft. Allereerst 
blijkt het debat eigenlijk uit twee subdebatten te bestaan, namelijk een debat over 
transgenese bij dieren (het veranderen van het genoom van dieren) en een ander, 
meer algemeen debat, over de Gezondheid- en Welzijnwet voor Dieren 
(Dierenwelzijnwet) in voorbereiding. Voor beide debatten vormde de stier Herman 
een belangrijke impuls. Zeker het publieke debat in de media ontwikkelde zieh aan 
de hand van de ontwikkelingen in het project van Gene Pharming. Na de geboorte 
van het eerste kalf en na iedere nieuwe ontwikkeling in het project barstte een 
discussie los. De casus (de stier Herman) zorgde voor levendigheid; er was 
blijkbaar iets materieeis nodig om de gedachten en dus argumentaties aan te 
scherpen. Zulk soort directe aanleidingen zijn kennelijk nodig om een debat urgent 
te maken. Een debat in de media heeft daarbij nog een specifieke dynamiek doordat 
de belangrijkste motivatie voor de media om iets te publiceren de nieuwswaarde 
ervan is. Dat betekent dat het debat zieh ontwikkelde als een commentaar op de 
ontwikkelingen van het project van Gene Pharming. Zo'n zieh ontwikkelende 
casus zorgt keer op keer voor nieuwe aanleidingen om meningen en argumenten 
aan te scherpen, te herwaarderen en verder te ontwikkelen. De casus, en natuurlijk 
de commentaren van mensen en organisaties erop, zorgde zo zowel voor dynamiek 
als voor structuur in het debat over dierlijke transgenese. Het debat over de 
Dierenwelzijnwet had echter een eigen dynamiek, namelijk die van het proces van 
wetgeving. In dit subdebat zorgde de casus vooral voor extra stof voor discussie. 
In het vierde hoofdstuk staan de deelnemers aan het debat centraal. In het vorige 
hoofdstuk zagen we de ontwikkelingen in het project van Gene Pharming ( de 
casus) steeds voor nieuwe aanleidingen voor discussie zorgden. Maar een publiek 
debat wordt gemaakt, of niet, door de mensen, organisaties, deskundigen, 
177 
bedrijven, enzovoort die de problematische elementen uit de casus onderkennen en 
publiekelijk aan de orde stellen. Verder zijn er media nodig om hun zorgen, 
commentaren, enzovoort te publiceren. 
Gene Pharming was zelf een belangrijke deelnemer in het debat. Zij stond voor 
haar project en was vrijwel steeds bereid haar project publiekelijk te verdedigen als 
maatschappelijk van groot belang. De Dierenbescherming was haar belangrijkste 
tegenspeler, namelijk die van verdediger van de belangen van de dieren. Zij greep 
iedere aanleiding aan om publiciteit te zoeken, kritiek te uiten, kamervragen te 
laten stellen, enzovoort. Daarmee was zij een drijvende kracht achter het debat. 
Centraal in haar reacties standen steeds vragen als: mögen wij dieren dit wel 
aandoen? Heeft het dier dan geen eigenwaarde die we moeten respecteren? Is dit 
geen aantasting van de integriteit van dieren? Het Ministerie zat in een lastig 
parket. Enerzijds was zij belanghebbende, omdat zij de dieren van Gene Pharming 
huisvestte op een van haar instituten (ID-DLO), anderzijds was zij ook 
verantwoordelijk voor de voorbereiding en uitvoering van wetgeving ten aanzien 
de behandeling van dieren. 
Het ligt voor de hand dat kritische burgers of individuele experts een debat niet 
gaande kunnen houden; in de regel is hun adem daarvoor niet lang genoeg. Het zijn 
vooral de kritische maatschappelijke organisaties die dat wel kunnen. In dit geval 
was dat de Dierenbescherming. 
De inbreng van experts blijkt afhankelijk van hun respectievelijke vakgebieden. 
Dierethici, filosofen en dierenwelzijnexperts zetten overwegend kritische 
kanttekeningen bij ingrepen in dieren; bio-medici en andere onderzoekers die 
transgene dieren maken of gebruiken trachten juist het belang van transgene dieren 
aan te tonen. De opinies van deskundigen zijn daarom zeker niet belangeloos. Via 
hun beroepsgroep zijn ze reeds verbonden met bepaalde maatschappelijke 
belangen. Hun inbreng verliep via interviews en via ingezonden stukken op de 
publieke opinie pagina's van de kranten. Het publieke debat in de media werd 
mede gestructureerd door de debatten in het parlement, omdat sommige 
discussierondes gericht waren op het beinvloeden van de politiek. 
In het vijfde hoofdstuk analyseer ik de controverse die ten grondslag lag aan het 
debat. Met behulp van een aangepaste matrix van Mepham classificeer ik de 
argumenten van de drie belangrijkste deelnemers aan het debat als versterking of 
afzwakking van een van de vier door Beauchamp en Childress uit de dagelijkse 
praktijk gereconstrueerde ethische principes van 'geen kwaad doen', 'goed doen', 
'respect voor autonomie of eigenheid', en 'rechtvaardige behandeling'. 
Argumenten die niet onder een van deze vier principes geclassificeerd konden 
worden heb ik benoemd als waarde (d.w.z. een aspect van het goede leven 
benadrukkend) of als moreel relevant feit. 
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Gene Pharming neemt een 'ja, mite' positie in; zij vindt dat transgenese in principe 
moet worden toegestaan, maar dat aan een aantal randvoorwaarden moet worden 
voldaan. Zij legt de nadruk op de voordelen ('goed doen') voor consumenten, 
patienten en producenten, terwijl de Dierenbescherming die absoluut tegen is 
('nee') vooral de nadelen ('geen kwaad doen') voor de dieren en voor soorten 
benadrukt. Het Ministerie dat transgenese in principe wil verbieden tenzij er goede 
redenen zijn om specifieke toepassingen toch toe te staan ('nee, tenzij' - positie) 
stelt zieh terughoudend en afwachtend op, maar onderkent de morele problematiek. 
De positie die de partieipanten innemen blijkt samen te hangen met het al dan niet 
erkennen van de intrinsieke (eigenwaarde) waarde van dieren en ook de integriteit 
van de dieren. Een 'nee' of 'nee, tenzij' positie wordt alleen ingenomen als de 
intrinsieke waarde en de integriteit erkend worden. Wordt deze niet erkend dan 
neemt men ook een 'ja, mite' positie in. Het blijkt dat afhankelijk van of een 
deelnemer een 'ja, mite' of een 'nee, tenzij' beleidsprincipe hanteert argumenten 
anders geclassificeerd moeten worden. Deelnemers die een 'ja, mite' positie 
innemen, onderstrepen de voordelen van transgenese bij dieren en wegen deze 
voordelen af tegen de mogelijke nadelen. De voordelen verschijnen echter als 
goede redenen om een uitzondering te maken in de context van 'een rechtvaardige 
behandeling' bij deelnemers die een ' nee, tenzij' positie innemen. Bovendien 
worden dan ook nog andere vragen gesteld (zie figuur 8.1). 
Figuur 8.1: Samenvattend overzicht van twee typen van argumentatie ('ja, mite' en 'nee, tenzij') die 
samenhangen met een verschil in pereeptie van het morele belang van dierlijke 
biotechnologie. 
Intrinsic value / animal integrity is an argument 
No, unless policy Yes, if policy 
Is there an alternative? 
Is this alternative realistic? 
Do the benefits outweigh the 
harms? 
Are the animals treated fairly? 
-Is there a sufficient reason? 
-If the reason is sufficient; does it 
outweigh the harms? 
In hoofdstuk zes kies ik een andere invalshoek om naar de argumentaties van de 
deelnemers te kijken. Ging het in hoofdstuk vijf om de vraag hoe en onder welke 
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voorwaarden biotechnologie, of meer specifiek transgenese, bij dieren zou mögen 
worden toegestaan. In hoofdstuk zes gaat het om de verschillende toepassingen van 
transgenese bij dieren. De vraag naar wat eventueel goede redenen zijn Staat nu 
centraal. En dan blijkt dat transgenese bij dieren in verschillende praktijken van 
diergebruik anders wordt beoordeeld. Het is (nog steeds) staande praktijk dat de 
beoordeling van dieren, en dus ook wat met dieren mag worden gedaan, 
afhankelijk is van de context waarin het oordeel wordt geveld. Konijnen worden 
anders behandeld afhankelijk van of zij als huisdier, als productiedier of als wild 
worden opgevat. Zo zijn er ook verschillende praktijken in het spei als het gaat om 
het maken van transgene koeien die lactoferrine via de melk uitscheiden, namelijk 
de melkveehouderij, de biomedische productiepraktijk, de gespecialiseerde 
voedselproductiepraktijk, en de vétérinaire praktijk. Echter, transgene koeien horen 
niet vanzelfsprekend bij een van deze praktijken. Als ze worden gemaakt vanwege 
hun resistentie tegen mastitis (uierontsteking) dan horen ze noch vanzelfsprekend 
bij de melkveehouderijpraktijk noch bij de vétérinaire praktijk, maar worden 
tegelijk wel beoordeeld naar de maatstaven van deze beide relevante praktijken. 
Een oordeel dat vanuit beide perspectieven negatief uitvalt. 
Het maken van zulke dieren omdat ze humaan lactoferrine uitscheiden dat kan 
worden verwerkt in melkpoeder voor baby's of in vloeibaar voedsel voor patiënten 
met maagdarm infecties, werd in de eerste plaats bezien (en afgewezen) vanuit het 
perspectief van de melkveehouderijpraktijk. De gespecialiseerde voedsel-
productiepraktijk kwam niet eens serieus in beeld. 
Over de productie van lactoferrine als testcase voor de productie van medicijnen 
via koeienmelk is de discussie echter nog niet gesloten. Ook hier paste Stier 
Herman niet vanzelfsprekend in een van de bestaande praktijken, maar hier was 
kennelijk het doel zo krachtig dat het daarmee niet 'einde discussie' was. Er 
ontstond getouwtrek over welke van de beide relevante praktijken (de 
veehouderijpraktijk en de biomedische productiepraktijk, en de bijbehorende 
normen en waarden) dominant zou moeten zijn. Gene Pharming argumenteerde dat 
Stier Herman beoordeeld zou moeten worden volgens de normen en waarden van 
de melkveehouderijpraktijk. Zowel de Dierenbescherming als het Ministerie van 
Landbouw vonden dat transgenese bij dieren voor welke reden dan ook beoordeeld 
zou moeten onafhankelijk van enige bestaande praktijk. Dat opent twee 
perspectieven: of dierlijke transgenese ontwikkelt zieh tot een eigen praktijk met 
eigen normen en waarden, of dierlijke transgenese ontstijgt het denken dat is 
ingekaderd door praktijken met als consequentie dat meer algemene normen en 
waarden ontstaan voor de behandeling van dieren ongeacht de context en ongeacht 
het specifieke doel. 
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In het zevende hoofdstuk ga ik in op het debatteren zelf. De belangrijkste 
deelnemers aan het debat werden elk op enig moment ook besproken en 
bekritiseerd in het debat. En de bekritiseerden namen deze kritiek serieus. Ze 
reageerden erop; ze deden er wat mee. En daardoor kunnen wij weer veel leren 
over wat de impliciete referentiepunten voor wat een goed debat genoemd kan 
worden. AI eerder zijn door verschillende auteurs zulke referentiepunten 
gereconstrueerd van zuivere argumentaties. Daarmee kunnen echter, volgens mij, 
debatten via de media niet zonder meer gelijk worden gesteld. Debatten via de 
media zijn namelijk niet in de eerste plaats gericht op het elkaar overtuigen, maar 
op het overtuigen van het publiek om daarmee publiek draagvlak en dus invloed te 
verwerven. Dat betekent niet dat de argumentatieregels opeens geen rol meer 
speien, maar dat ze een andere Status krijgen. Een deel van de metadiscussies gaat 
over de momenten waarop de debatdeelnemers te ver gaan en dus bepaalde normen 
van beschaafd debatteren overschrijden. Bovendien worden ook nog andere 
aspecten bediscussieerd die ook een rol blijken te speken in publieke debatten in de 
media. Denk hierbij bijvoorbeeld aan allerlei theatrale dementen zoals foto's, 
tekeningen en posters; het plaatsen van andere deelnemers in een minder gunstig 
daglicht door informatie te onthullen; of aan suggestief te redeneren. Sommige van 
deze acties werden wel geaccepteerd terwijl andere te ver gingen en dus kritiek 
opriepen. Ik eindig het hoofdstuk met een aantal criteria waaraan debatten getoetst 
blijken te worden door de deelnemers zelf. 
Daarvoor ga ik echter nog in op een aantal kritieken op dit debat. Uit die kritieken 
blijkt dat veel critici te hoge (idealistische) verwachtingen hebben van publieke 
debatten in de media. De vruchtbaarheid en zinvolheid van publieke debatten moet 
mijns inziens niet worden afgemeten aan de convergentie van de meningen van of 
de gerichtheid op consensus door de participanten, maar aan de kwaliteit en 
rationaliteit van de argumentaties van de participanten. En dat is wat ik heb 
aangetroffen: alle deelnemers aan de het debat hebben hun opvattingen en 
redeneringen verder ontwikkeld, ze hebben naar anderen geluisterd en hebben 
daarop gereageerd door hun argumentaties aan te scherpen of hun handelen aan te 
passen. 
Het is ook onterecht te veronderstellen dat iedereen mee moet doen aan een debat 
om er een geslaagd debat van te maken. Het is voldoende als iedereen die 
gei'nteresseerd is het debat kän volgen en eraan kan meedoen als hij of zij dat wil. 
De kritiek dat niet alle participanten zieh altijd even netjes hebben gedragen, is 
terecht, maar het is ook zichtbaar geworden dat de participanten zieh die kritiek 
hebben aangetrokken en hun gedrag hebben aangepast. Transparantie is mede 
dankzij dit debat in de jaren '90 een serieus thema geworden binnen zowel 
maatschappelijke organisaties als het bedrijfsleven. 
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